Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Bladder Cancer, January 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1861 articles:
HTML format


 

Single Articles

  1. PRENDEVILLE S, Berney DM, Bubendorf L, Comperat E, et al
    Handling and Reporting of Pelvic Lymphadenectomy Specimens in Prostate and Bladder Cancer: A Web-based Survey by the European Network of Uropathologists (ENUP).
    Histopathology. 2019 Jan 3. doi: 10.1111/his.13818.
    Abstract     Related articles   

  2. SJODAHL G, Jackson Chelsea L, Bartlett J, Robert SD, et al
    Molecular Profiling In Muscle Invasive Bladder Cancer: More Than The Sum Of Its Parts.
    J Pathol. 2019 Jan 2. doi: 10.1002/path.5230.
    Abstract     Related articles   

  3. STUBENDORFF B, Wilhelm K, Posselt K, Catto J, et al
    A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Jan 2. pii: 10.1007/s00432-018-02829.
    Abstract     Related articles   

  4. VAN OSCH FHM, Vlaanderen J, Jochems SHJ, Bosetti C, et al
    Modeling the complex exposure history of smoking in predicting bladder cancer: a pooled analysis of 15 case-control studies.
    Epidemiology. 2018 Dec 26. doi: 10.1097/EDE.0000000000000964.
    Abstract     Related articles   

  5. TOKUNAGA K, Furuta A, Arizono S, Teramoto Y, et al
    Duodenal obstruction induced by retroperitoneal progression of bladder cancer: a report of two cases.
    Abdom Radiol (NY). 2019 Jan 1. pii: 10.1007/s00261-018-1874.
    Abstract     Related articles   

  6. GALLIOLI A, Boissier R, Territo A, Breda A, et al
    Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers.
    World J Urol. 2019 Jan 2. pii: 10.1007/s00345-018-2611.
    Abstract     Related articles   

  7. ZHANG W, Zhang J, Zhang Z, Guo Y, et al
    Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer.
    Transl Oncol. 2018;12:485-492.
    Abstract     Related articles   

  8. SMAL MP, Kuzhir TD, Savina NV, Nikitchenko NV, et al
    BER gene polymorphisms associated with key molecular events in bladder cancer.
    Exp Oncol. 2018;40:288-298.
    Abstract     Related articles   

  9. WU CH, Silvers CR, Messing EM, Lee YF, et al
    Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of non-malignant cells.
    J Biol Chem. 2018 Dec 28. pii: RA118.006682. doi: 10.1074/jbc.RA118.006682.
    Abstract     Related articles   

  10. SALMASI A, Elashoff DA, Guo R, Upfill-Brown A, et al
    Urinary cytokine profile to predict response to intravesical BCG with or without HS-410 therapy in patients with non-muscle invasive bladder cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Dec 28. pii: 1055-9965.EPI-18-0893.
    Abstract     Related articles   

  11. TRIPATHI A, Plimack ER
    Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
    Curr Urol Rep. 2018;19:109.
    Abstract     Related articles   

  12. CEANGA AI, Ceanga M, Eveslage M, Herrmann E, et al
    Preoperative anemia and extensive transfusion during stay-in-hospital are critical for patient`s mortality: A retrospective multicenter cohort study of oncological patients undergoing radical cystectomy.
    Transfus Apher Sci. 2018;57:739-745.
    Abstract     Related articles   

  13. RODRIGUEZ-VIDA A, Bellmunt J
    Avelumab for the treatment of urothelial cancer.
    Expert Rev Anticancer Ther. 2018;18:421-429.
    Abstract     Related articles   

  14. CHEN A, Chong J, Si Q, Haines K, et al
    Robotic approach to resection of villous adenoma of the urachus: a case report and literature review.
    J Robot Surg. 2018;12:567-570.
    Abstract     Related articles   

  15. HUANG CJ, Lee CH, Chang YH, Won JG, et al
    Paravesical (urachal) paraganglioma (PGL) presenting as hypertensive crisis during micturition, mimicking bladder PGL.
    J Formos Med Assoc. 2018;117:247-249.
    Abstract     Related articles   

  16. ONISHI T, Sekito S, Shibahara T, Uchida K, et al
    The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Jan 10:1-4. doi: 10.1080/21681805.2018.1548502.
    Abstract     Related articles   

  17. CHEN R, Zhou X, Liu J, Huang G, et al
    Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Jan 9. pii: 10.1007/s00259-018-4208.
    Abstract     Related articles   

  18. MATUSZEWSKI M, Szymanska B, Dlugosz A, Malkiewicz B, et al
    Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer.
    Biomed Res Int. 2018;2018:8693297.
    Abstract     Related articles   

  19. ELMUSSAREH M, Simonsen PC, Young M, Kingo PS, et al
    Correlation between organ-specific co-morbidities and complications in bladder cancer patients undergoing radical cystectomy.
    Scand J Urol. 2019 Jan 9:1-6. doi: 10.1080/21681805.2018.1531921.
    Abstract     Related articles   

  20. ABDEL-RAHMAN O
    Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
    J Comp Eff Res. 2019 Jan 9. doi: 10.2217/cer-2018-0113.
    Abstract     Related articles   

  21. NASRAZADANI M, Maracy MR, Dreassi E, Mahaki B, et al
    Mapping of Stomach, Colorectal, and Bladder Cancers in Iran, 2004-2009: Applying Bayesian Polytomous Logit Model.
    Int J Prev Med. 2018;9:104.
    Abstract     Related articles   

  22. DANIELSSON G, Malmstrom PU, Jahnson S, Wijkstrom H, et al
    Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment.
    Scand J Urol. 2019 Jan 8:1-8. doi: 10.1080/21681805.2018.1538162.
    Abstract     Related articles   

  23. WANG JR, Liu B, Zhou L, Huang YX, et al
    MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Cancer Biomark. 2018 Dec 27. pii: CBM182000. doi: 10.3233/CBM-182000.
    Abstract     Related articles   

  24. ZHANG LF, Ren KW, Zuo L, Zou JG, et al
    VEGF gene rs3025039C/T and rs833052C/A variants are associated with bladder cancer risk in Asian descendants.
    J Cell Biochem. 2019 Jan 4. doi: 10.1002/jcb.28324.
    Abstract     Related articles   

  25. CHEN JB, Zhu YW, Guo X, Yu C, et al
    Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
    J Cell Physiol. 2019 Jan 4. doi: 10.1002/jcp.28037.
    Abstract     Related articles   

  26. RYU H, Jin H, Ho JN, Bae J, et al
    Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.
    Biol Pharm Bull. 2019;42:66-72.
    Abstract     Related articles   

  27. WANG L, Xin F, Lin N, Wang Y, et al
    Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
    Medicine (Baltimore). 2018;97:e13786.
    Abstract     Related articles   

  28. WANG K, Zhou H, Lu Y, Lu Q, et al
    ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report.
    Medicine (Baltimore). 2018;97:e13619.
    Abstract     Related articles   

  29. ZHOU Y, Guan H, Fu Y, Mao L, et al
    The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.
    Medicine (Baltimore). 2018;97:e13479.
    Abstract     Related articles   

  30. YUK HD, Kim JK, Jeong CW, Kwak C, et al
    Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
    Biomed Res Int. 2018;2018:9432606.
    Abstract     Related articles   

  31. TUNG MC, Wen YC, Wang SS, Lin YW, et al
    Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
    Int J Med Sci. 2018;15:1187-1193.
    Abstract     Related articles   

  32. PAVONE C, Candela L, Fontana D, Simonato A, et al
    Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study.
    Urologia. 2018;85:111-117.
    Abstract     Related articles   

  33. FANG T, Liu DD, Ning HM, Dan Liu, et al
    Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
    Acta Pharmacol Sin. 2018;39:1885-1893.
    Abstract     Related articles   

  34. MCGRATH JS, Daneshmand S
    Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"?
    Eur Urol Focus. 2018;4:718-719.
    Abstract     Related articles   

  35. SILVA-SMITH R, Sussman DA
    Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.
    Fam Cancer. 2018;17:87-90.
    Abstract     Related articles   

  36. BAO F, Deng Y, Dai Q
    ACID: Association Correction for Imbalanced Data in GWAS.
    IEEE/ACM Trans Comput Biol Bioinform. 2018;15:316-322.
    Abstract     Related articles   

  37. PALMISANO F, Gadda F, Spinelli MG, Maggioni M, et al
    Symplastic glomus tumor of the urinary bladder treated by robot-assisted partial cystectomy: a case report and literature review.
    Urologia. 2018;85:130-132.
    Abstract     Related articles   

  38. AMARA CS, Ambati CR, Vantaku V, Piyarathna DWB, et al
    Serum metabolic profiling identified a distinct metabolic signature in Bladder Cancer Smokers: A key metabolic enzymes associated with patient survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0936.
    Abstract     Related articles   

  39. MONTEIRO-REIS S, Lobo J, Henrique R, Jeronimo C, et al
    Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  40. XIE X, Pan J, Han X, Chen W, et al
    Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/beta-catenin signaling.
    Chem Biol Interact. 2019 Jan 10. pii: S0009-2797(18)31262.
    Abstract     Related articles   

  41. MOROZUMI K, Mitsuzuka K, Takai Y, Katsumata Y, et al
    Intraoperative hypothermia is a significant prognostic predictor of radical cystectomy especially for stage II muscle-invasive bladder cancer.
    Medicine (Baltimore). 2019;98:e13962.
    Abstract     Related articles   

  42. LIU Y, Wu X, Wang G, Hu S, et al
    CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.
    Medicine (Baltimore). 2019;98:e13847.
    Abstract     Related articles   

  43. CRITSELIS E, Rava M, Marquez M, Lygirou V, et al
    Diagnostic and prognostic performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) assay for detecting primary and recurrent urinary bladder cancer.
    Proteomics Clin Appl. 2019 Jan 11:e1800148. doi: 10.1002/prca.201800148.
    Abstract     Related articles   

  44. WUJANTO C, Tey J, Chia D, Ho F, et al
    Radical radiotherapy in older patients with muscle invasive bladder cancer.
    J Geriatr Oncol. 2019 Jan 7. pii: S1879-4068(18)30302.
    Abstract     Related articles   

  45. NIWA N, Matsumoto K, Ide H
    The clinical implication of gamma globulin levels in patients with nonmuscle-invasive bladder cancer.
    Urol Oncol. 2019 Jan 7. pii: S1078-1439(18)30552.
    Abstract     Related articles   

  46. SONG D, Jiao W, Gao Z, Liu N, et al
    Inflammatory myofibroblastic tumor of urinary bladder with severe hematuria: A Case report and literature review.
    Medicine (Baltimore). 2019;98:e13987.
    Abstract     Related articles   

  47. THIBAULT C
    Bladder Cancer Treatment (PDQ(R)): Patient Version
    Bull Cancer. 2018;105 Suppl 1:S43-S49.
    Abstract     Related articles   

  48. HUANG Z, Xiao H, Lu X, Yan W, et al
    Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Int J Nanomedicine. 2018;13:7623-7631.
    Abstract     Related articles   

  49. KHAN FM, Gupta SK, Wolkenhauer O
    Integrative workflows for network analysis.
    Essays Biochem. 2018;62:549-561.
    Abstract     Related articles   

  50. DENG J, Peng M, Wang Z, Zhou S, et al
    Novel application of metformin combined with targeted drugs on anticancer treatment.
    Cancer Sci. 2019;110:23-30.
    Abstract     Related articles   

  51. BOSSERMAN AJ, Dai D, Lu Y
    Imaging Characteristics of a Bladder Wall Paraganglioma.
    Clin Nucl Med. 2019;44:66-67.
    Abstract     Related articles   

  52. DELAUNE T, Bernard F, Matres-Lorenzo L, Bernarde A, et al
    Radical cystectomy and subsequent ureterohysterostomy in a bitch.
    Vet Surg. 2018;47:1106-1111.
    Abstract     Related articles   

  53. ELAWDY MM, Osman Y, Taha DE, El-Halwagy S, et al
    Coincidental Bladder Cuff Transitional Cell Carcinoma in Nephroureterectomy Specimens: Risk Factors, Prognosis and Clinical Implementation.
    Urol J. 2018;15:256-260.
    Abstract     Related articles   

  54. XU Z, Zhang Q, Luh F, Jin B, et al
    Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
    Oncol Lett. 2019;17:1865-1876.
    Abstract     Related articles   

  55. LU JJ, Su YW, Wang CJ, Li DF, et al
    Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
    Tumori. 2019 Jan 24:300891618811280. doi: 10.1177/0300891618811280.
    Abstract     Related articles   

  56. RAJA SA, Abbas S, Shah STA, Tariq A, et al
    Increased expression levels of Syntaxin 1A and Synaptobrevin 2/Vesicle-Associated Membrane Protein-2 are associated with the progression of bladder cancer.
    Genet Mol Biol. 2019 Jan 21:0. doi: 10.1590/1678-4685-GMB-2017-0339.
    Abstract     Related articles   

  57. GUO CC, Czerniak B
    Bladder Cancer in the Genomic Era.
    Arch Pathol Lab Med. 2019 Jan 23. doi: 10.5858/arpa.2018-0329.
    Abstract     Related articles   

  58. QIU F, Zhang MR, Zhou Z, Pu JX, et al
    lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    J Cell Biochem. 2019 Jan 22. doi: 10.1002/jcb.28373.
    Abstract     Related articles   

  59. GUPTA M, Milbar N, Tema G, Pederzoli F, et al
    Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.
    World J Urol. 2019 Jan 23. pii: 10.1007/s00345-018-02624.
    Abstract     Related articles   

  60. YEE CH, Zheng Z, Shuman L, Yamashita H, et al
    Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
    Sci Rep. 2019;9:270.
    Abstract     Related articles   

  61. TAARNHOJ GA, Johansen C, Pappot H
    Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature.
    Health Qual Life Outcomes. 2019;17:20.
    Abstract     Related articles   

  62. RODRIGUES D, Pinto J, Araujo AM, Jeronimo C, et al
    GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells.
    Metabolites. 2019;9.
    Abstract     Related articles   

  63. DAGA M, Pizzimenti S, Dianzani C, Cucci MA, et al
    Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Phytomedicine. 2018;56:156-164.
    Abstract     Related articles   

  64. AMR S, Wolpert BJ, St George DM, James I, et al
    Body mass index modifies bladder cancer risk associated with low estrogen exposure among Egyptian women after menopause.
    Cancer Causes Control. 2019 Jan 21. pii: 10.1007/s10552-019-1131.
    Abstract     Related articles   

  65. WANG F, Chen HG, Zhang RY, Jin D, et al
    Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5977.
    Abstract     Related articles   

  66. GIRARD A, Rouanne M, Taconet S, Radulescu C, et al
    Integrated analysis of (18)F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5959.
    Abstract     Related articles   

  67. BLACK P, Gontero P
    SIU-ICUD consultation on bladder cancer 2018.
    World J Urol. 2019 Jan 21. pii: 10.1007/s00345-018-2601.
    Abstract     Related articles   

  68. ZHAO S, Xie Q, Yang R, Wang J, et al
    High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis.
    Cancer Manag Res. 2019;11:587-598.
    Abstract     Related articles   

  69. WU J, Li W, Ning J, Yu W, et al
    Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition.
    Onco Targets Ther. 2019;12:495-508.
    Abstract     Related articles   

  70. MIERZEJEWSKA P, Gawlik-Jakubczak T, Jablonska P, Czajkowski M, et al
    Nicotinamide metabolism alterations in bladder cancer: Preliminary studies.
    Nucleosides Nucleotides Nucleic Acids. 2019.
    Abstract     Related articles   

  71. JIN S, Wang B, Zhu Y, Dai W, et al
    Log Odds Could Better Predict Survival in Muscle-Invasive Bladder Cancer Patients Compared with pN and Lymph Node Ratio.
    J Cancer. 2019;10:249-256.
    Abstract     Related articles   

  72. CHEN Z, Chen X, Xie R, Huang M, et al
    DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.
    Mol Ther. 2019 Jan 9. pii: S1525-0016(19)30004.
    Abstract     Related articles   

  73. FU YR, Chen F, Luo Y, Yi YF, et al
    Nanoscale bubble ultrasound contrast agents-mediated suicide gene therapy system, Nanoscale bubble-LV5-YCD-TK/GCV/5-FC, effectively inhibits bladder cancer cell growth.
    Eur Rev Med Pharmacol Sci. 2019;23:75-86.
    Abstract     Related articles   

  74. KWAN ML, Kushi LH, Danforth KN, Roh JM, et al
    The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.
    Cancer Causes Control. 2019 Jan 17. pii: 10.1007/s10552-019-1130.
    Abstract     Related articles   

  75. WANG X, Wang H, Song Y
    Clinical efficacy and mechanism of Pralatrexate combined with Palbociclib Isethionate in treatment of bladder cancer patients.
    Oncol Lett. 2019;17:201-208.
    Abstract     Related articles   

  76. YE G, Kan S, Chen J, Lu X, et al
    Puerarin in inducing apoptosis of bladder cancer cells through inhibiting SIRT1/p53 pathway.
    Oncol Lett. 2019;17:195-200.
    Abstract     Related articles   

  77. HOU Y
    MiR-506 inhibits cell proliferation, invasion, migration and epithelial-to-mesenchymal transition through targeting RWDD4 in human bladder cancer.
    Oncol Lett. 2019;17:73-78.
    Abstract     Related articles   

  78. EISSA S, Safwat M, Matboli M, Zaghloul A, et al
    Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.
    Urol Oncol. 2019 Jan 14. pii: S1078-1439(18)30518.
    Abstract     Related articles   

  79. FURUYA H, Chan OTM, Pagano I, Zhu C, et al
    Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model.
    J Transl Med. 2019;17:29.
    Abstract     Related articles   

  80. MISTRETTA FA, Carrion DM, Nazzani S, Vasquez JL, et al
    Bladder recurrence of primary upper tract urinary carcinoma following nephro-ureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer: a contemporary non-systematic review of the
    Minerva Urol Nefrol. 2019 Jan 17. pii: S0393-2249.19.03311.
    Abstract     Related articles   

  81. DUNN JA, Jefferson K, MacDonald D, Iqbal G, et al
    LOW SERUM 25-HYDROXYVITAMIN D IS ASSOCIATED WITH INCREASED BLADDER CANCER RISK: A SYSTEMATIC REVIEW AND EVIDENCE OF A POTENTIAL MECHANISM.
    J Steroid Biochem Mol Biol. 2019 Jan 14. pii: S0960-0760(18)30620.
    Abstract     Related articles   

  82. RUSSO V, Roperto F, Taulescu M, De Falco F, et al
    Expression of the feline leukemia virus subgroup C receptors in normal and neoplastic urothelium of the urinary bladder of cattle associated with bovine papillomavirus infection.
    Vet Microbiol. 2019;229:147-152.
    Abstract     Related articles   

  83. KRASNOW RE, Rodriguez D, Nagle RT, Mossanen M, et al
    The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Urol Oncol. 2018;36:500.
    Abstract     Related articles   

  84. YAP SA, Brunson A, Pugashetti N, M P H RDC, et al
    Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence.
    Urol Oncol. 2018;36:498.
    Abstract     Related articles   

  85. COX RM, Magi-Galluzzi C, McKenney JK
    Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
    Adv Anat Pathol. 2018;25:387-399.
    Abstract     Related articles   

  86. WHONGSIRI P, Pimratana C, Wijitsettakul U, Sanpavat A, et al
    Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation.
    Free Radic Biol Med. 2019 Jan 28. pii: S0891-5849(18)32321.
    Abstract     Related articles   

  87. ANDREW AS, Karagas MR, Schroeck FR, Marsit CJ, et al
    MicroRNA dysregulation and non-muscle invasive bladder cancer prognosis.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 30. pii: 1055-9965.EPI-18-0884.
    Abstract     Related articles   

  88. RAVEN PA, D'Costa NM, Moskalev I, Tan Z, et al
    Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.
    Am J Clin Exp Urol. 2018;6:245-259.
    Abstract     Related articles   

  89. MENG XY, Shi MJ, Zeng ZH, Chen C, et al
    The Role of COL5A2 in Patients With Muscle-Invasive Bladder Cancer: A Bioinformatics Analysis of Public Datasets Involving 787 Subjects and 29 Cell Lines.
    Front Oncol. 2019;8:659.
    Abstract     Related articles   

  90. DOMINGOS-PEREIRA S, Sathiyanadan K, La Rosa S, Polak L, et al
    Intravesical Ty21a vaccine promotes dendritic cells and T cell-mediated tumor regression in the MB49 bladder cancer model.
    Cancer Immunol Res. 2019 Jan 29. pii: 2326-6066.CIR-18-0671.
    Abstract     Related articles   

  91. FONT A, Luque R, Villa JC, Domenech M, et al
    The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
    Target Oncol. 2019 Jan 29. pii: 10.1007/s11523-019-00619.
    Abstract     Related articles   

  92. RAMAKRISHNAN S, Granger V, Rak M, Hu Q, et al
    Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer.
    Cell Death Differ. 2019 Jan 28. pii: 10.1038/s41418-019-0278.
    Abstract     Related articles   

  93. VISNJAR T, Romih R, Zupancic D
    Lectins as possible tools for improved urinary bladder cancer management.
    Glycobiology. 2019 Jan 25. pii: 5301307. doi: 10.1093.
    Abstract     Related articles   

  94. SHI S, Tian B
    Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis.
    Cancer Biomark. 2019 Jan 18. pii: CBM181940. doi: 10.3233/CBM-181940.
    Abstract     Related articles   

  95. LOH-DOYLE JC
    Penile Implant Considerations in the Bladder Cancer Survivor.
    Curr Urol Rep. 2019;20:7.
    Abstract     Related articles   

  96. BIELLI P, Di Stasi SM, Sette C
    The emerging role of PTBP1 in human cancer: novel prognostic factor in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  97. PATHAK RA, Hemal AK
    Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  98. SORIA F, Shariat SF
    Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  99. NIEGISCH G
    Does robotic radical cystectomy impede oncological outcome in bladder cancer patients?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  100. PICHLER R, Loidl W, Pichler M
    High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  101. KAAG MG, Raman JD
    Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  102. BATURA D
    Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  103. AJIB K, Kulkarni GS
    Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  104. MAHENDRAN R
    Do we have all the facts to determine the impact of bacillus Calmette-Guerin therapy on bladder cancer?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  105. LEE KH, Ku JH
    Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  106. DAL MORO F, Colicchia M
    Does obesity impact bladder cancer prognosis?-a long-lasting debate.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  107. OOSTERLINCK W, Decaestecker K
    An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  108. VRIELING A
    The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  109. BRODIE A, McCauley N, Cresswell J, Vasdev N, et al
    T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  110. ROSSER CJ
    Nutritional implications for quality of life in bladder cancer survivors.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  111. JIANG DM, Jiang H, Chung PWM, Zlotta AR, et al
    Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019;17:38-45.
    Abstract     Related articles   

  112. ABDELRAHMAN AE, Rashed HE, Elkady E, Elsebai EA, et al
    Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer.
    Ann Diagn Pathol. 2019;39:42-52.
    Abstract     Related articles   

  113. LEOW JJ, Bedke J, Chamie K, Collins JW, et al
    SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.
    World J Urol. 2019 Jan 25. pii: 10.1007/s00345-018-2606.
    Abstract     Related articles   

  114. LORENZATTI HILES G, Cates AL, El-Sawy L, Day KC, et al
    A surgical orthotopic approach for studying the invasive progression of human bladder cancer.
    Nat Protoc. 2019 Jan 25. pii: 10.1038/s41596-018-0112.
    Abstract     Related articles   

  115. BLACK PC, Goebell PJ, Kamat AM, Nawroth R, et al
    Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series(1).
    Urol Oncol. 2019 Jan 22. pii: S1078-1439(19)30003.
    Abstract     Related articles   

  116. CHEN L, Long Y, Han Z, Yuan Z, et al
    MicroRNA-101 inhibits cell migration and invasion in bladder cancer via targeting FZD4.
    Exp Ther Med. 2019;17:1476-1485.
    Abstract     Related articles   

  117. WANG Y, Xu Z, Wang X
    miRNA-373 promotes urinary bladder cancer cell proliferation, migration and invasion through upregulating epidermal growth factor receptor.
    Exp Ther Med. 2019;17:1190-1195.
    Abstract     Related articles   

  118. CHO SK, Su LJ, Mao C, Wolenski CD, et al
    Multifunctional nanoclusters of NaYF4:Yb(3+),Er(3+) upconversion nanoparticle and gold nanorod for simultaneous imaging and targeted chemotherapy of bladder cancer.
    Mater Sci Eng C Mater Biol Appl. 2019;97:784-792.
    Abstract     Related articles   

  119. HA YS, Kim SW, Chun SY, Chung JW, et al
    Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
    BMC Urol. 2019;19:10.
    Abstract     Related articles   


  120. [Expert consensus on treatment of intravesical therapy in non-muscle invasive bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2019;41:42-45.
    Abstract     Related articles   

  121. ZHOU J, Yang C, Lu Z, Zhang L, et al
    Primary urothelial carcinoma of the prostate: A rare case report.
    Medicine (Baltimore). 2019;98:e14155.
    Abstract     Related articles   

  122. TONG S, Yang Z, Zu X, Li Y, et al
    Anterior versus posterior approach laparoscopic radical cystectomy: a retrospective analysis.
    World J Surg Oncol. 2019;17:9.
    Abstract     Related articles   

  123. MARTINI T, Heinkele J, Mayr R, Weis CA, et al
    Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
    Urol Oncol. 2018;36:530.
    Abstract     Related articles   

  124. LALANI AA, Sonpavde GP
    Systemic treatments for metastatic urothelial carcinoma.
    Expert Opin Pharmacother. 2019;20:201-208.
    Abstract     Related articles   

  125. GU YQ, Shen WY, Zhou Y, Chen SF, et al
    A pyrazolopyrimidine based fluorescent probe for the detection of Cu(2+) and Ni(2+) and its application in living cells.
    Spectrochim Acta A Mol Biomol Spectrosc. 2019;209:141-149.
    Abstract     Related articles   

  126. RIVA G, Mian C, Luchini C, Girolami I, et al
    Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
    Virchows Arch. 2019;474:13-20.
    Abstract     Related articles   

  127. MILLER R, Heinlen JE
    Reported rates of clostridium difficile following radical cystectomy in national datasets compared to individual institutions.
    Urol Oncol. 2018;36:526.
    Abstract     Related articles   

  128. MURAKAMI M, Kiyota H, Kasai K, Bando S, et al
    Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin.
    J Infect Chemother. 2018;24:954-957.
    Abstract     Related articles   

  129. LI CY, Dai YX, Chen YJ, Chu SY, et al
    Cancer Risks in Vitiligo Patients: A Nationwide Population-Based Study in Taiwan.
    Int J Environ Res Public Health. 2018;15.
    Abstract     Related articles   

  130. KONG V, Taylor A, Chung P, Rosewall T, et al
    Evaluation of resource burden for bladder adaptive strategies: A timing study.
    J Med Imaging Radiat Oncol. 2018;62:861-865.
    Abstract     Related articles   

  131. ADHYA AK, Pradhan MR
    Ectopic prostatic tissue presenting as a mucosal tumor in urinary bladder.
    Indian J Pathol Microbiol. 2018;61:452-453.
    Abstract     Related articles   

  132. LEFFLER AJ, Hostnik ET, Warry EE, Habing GG, et al
    Canine urinary bladder transitional cell carcinoma tumor volume is dependent on imaging modality and measurement technique.
    Vet Radiol Ultrasound. 2018;59:767-776.
    Abstract     Related articles   

  133. BURGER M
    Editorial Commentary on Gregers et al.
    Scand J Urol. 2018;52:199.
    Abstract     Related articles   

  134. MARQUEEN KE, Waingankar N, Sfakianos JP, Mehrazin R, et al
    Early Mortality in Patients With Muscle-Invasive Bladder Cancer Undergoing Cystectomy in the United States.
    JNCI Cancer Spectr. 2018;2:pky075.
    Abstract     Related articles   

  135. JORGENSEN MS, Oldenburg WA, Murray PM
    Mycotic Aneurysm of the Ulnar Artery Secondary to Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Rare Presentation of Hypothenar Hammer Syndrome.
    J Hand Surg Am. 2019 Feb 4. pii: S0363-5023(18)31479.
    Abstract     Related articles   

  136. SOUKUPOVA K, Rudolf E
    Suppression of proliferation and activation of cell death by sodium selenite involves mitochondria and lysosomes in chemoresistant bladder cancer cells.
    J Trace Elem Med Biol. 2019;52:58-67.
    Abstract     Related articles   

  137. MARCQ G, Jarry E, Ouzaid I, Hermieu JF, et al
    Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823678.
    Abstract     Related articles   

  138. RAO A, Patel MR
    A review of avelumab in locally advanced and metastatic bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823485.
    Abstract     Related articles   

  139. OSTERMAN CK, Babu DS, Geynisman DM, Lewis B, et al
    Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.
    Oncologist. 2019 Feb 6. pii: theoncologist.2018-0561.
    Abstract     Related articles   

  140. DI Y, Chen D, Yu W, Yan L, et al
    Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis.
    Hereditas. 2019;156:7.
    Abstract     Related articles   

  141. ZHANG X, Liu X, Jing Z, Bi J, et al
    The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.
    Cancer Gene Ther. 2019 Feb 6. pii: 10.1038/s41417-019-0085.
    Abstract     Related articles   

  142. BOC A, Crisan N, Vesa SC, Coman I, et al
    The impact of minimal invasive surgery on early complications and mortality after radical cystectomy for muscle-invasive urothelial bladder cancer.
    J BUON. 2018;23:104-110.
    Abstract     Related articles   

  143. SIGNES-PASTOR AJ, Scot Zens M, Seigne J, Schned A, et al
    Rice Consumption and Incidence of Bladder Cancer in the United States Population.
    Epidemiology. 2019;30:e4-e5.
    Abstract     Related articles   

  144. RAPHAEL MJ, Booth CM
    Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Underused across the 49(th) parallel.
    Can Urol Assoc J. 2019;13:29-31.
    Abstract     Related articles   

  145. OGIHARA K, Kikuchi E, Okazaki S, Hagiwara M, et al
    Sulfasalazine may modulate the CD44v9-xCT system and enhance CDDP-induced cytotoxic effects in metastatic bladder cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13960.
    Abstract     Related articles   

  146. TSAI YS, Jou YC, Tsai HT, Shiau AL, et al
    Prothymosin-alpha Enhances PTEN Expression and Binds with TRIM21 to Regulate Keap1/Nrf2 Signaling in Human Bladder Cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13963.
    Abstract     Related articles   

  147. HEIDE T, Maurer A, Eipel M, Knoll K, et al
    Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy.
    J Pathol. 2019 Feb 4. doi: 10.1002/path.5250.
    Abstract     Related articles   

  148. LEMKE EA, Shah AY
    Management of Advanced Bladder Cancer: An Update.
    J Adv Pract Oncol. 2018;9:410-416.
    Abstract     Related articles   

  149. XU C, Zhou J, Wang Y, Wang A, et al
    Inhibition of malignant human bladder cancer phenotypes through the down-regulation of the long non-coding RNA SNHG7.
    J Cancer. 2019;10:539-546.
    Abstract     Related articles   

  150. CHEN Y, Liu L, Guo Z, Wang Y, et al
    Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.
    Oncol Lett. 2019;17:2047-2056.
    Abstract     Related articles   

  151. COTRUVO JA, Amato H
    National Trends of Bladder Cancer and Trihalomethanes in Drinking Water: A Review and Multicountry Ecological Study.
    Dose Response. 2019;17:1559325818807781.
    Abstract     Related articles   

  152. LIU YN, Zhang H, Zhang L, Cai TT, et al
    Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer.
    Cell Death Dis. 2019;10:50.
    Abstract     Related articles   

  153. GUDJONSSON S
    Editorial comment on: The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Feb 4:1-2. doi: 10.1080/21681805.2018.1563629.
    Abstract     Related articles   

  154. HU G, Wang X, Han Y, Wang P, et al
    Protein arginine methyltransferase 5 promotes bladder cancer growth through inhibiting NF-kB dependent apoptosis.
    EXCLI J. 2018;17:1157-1166.
    Abstract     Related articles   

  155. PAK S, You D, Jeong IG, Song C, et al
    Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 9. pii: S1558-7673(19)30008.
    Abstract     Related articles   

  156. AL-DAGHMIN A, Alhamss S, Al-Najjar H, Al-Saidi I, et al
    Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatment.
    Ann Saudi Med. 2019;39:42-47.
    Abstract     Related articles   

  157. MINA S, Pardo Munevar CA, Osorio D, Garcia-Perdomo HA, et al
    Life quality evaluation in patients with bladder cancer: A systematic review.
    Actas Urol Esp. 2019 Jan 30. pii: S0210-4806(18)30230.
    Abstract     Related articles   

  158. SAFWAT O, Abd-Ellatif RN, Othman TS, Afifi M, et al
    The evolving role of protein disulfide isomerase A3 in Egyptian bladder cancer patients.
    Gene. 2019 Jan 29. pii: S0378-1119(19)30068-X. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  159. ISHII A, Tei Y, Murakami T, Notohara K, et al
    An unusual case of Abeta2M amyloid deposition in bladder cancer in a non-dialysis patient.
    Pathol Int. 2019 Feb 1. doi: 10.1111/pin.12770.
    Abstract     Related articles   

  160. BOSSCHIETER J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, et al
    A two-gene methylation signature for the diagnosis of bladder cancer in urine.
    Epigenomics. 2019 Feb 1. doi: 10.2217/epi-2018-0094.
    Abstract     Related articles   

  161. KATTEPUR AK, Patkar S, Goel M, Ramaswamy A, et al
    Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer.
    J Gastrointest Surg. 2019 Jan 31. pii: 10.1007/s11605-019-04104.
    Abstract     Related articles   

  162. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting.
    Front Oncol. 2019;8:642.
    Abstract     Related articles   

  163. YANG X, Zhao L, Zhang T, Xi J, et al
    Protosappanin B promotes apoptosis and causes G1 cell cycle arrest in human bladder cancer cells.
    Sci Rep. 2019;9:1048.
    Abstract     Related articles   

  164. MATULAY JT, Woldu SL, Lim A, Narayan VM, et al
    The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Urol Oncol. 2019 Jan 28. pii: S1078-1439(19)30021.
    Abstract     Related articles   

  165. BURKHARD FC, Thalmann GN
    No survival benefit with extended lymphadenectomy: now what?
    Nat Rev Urol. 2019;16:3-4.
    Abstract     Related articles   

  166. KONG V, Kwan M, Chen S, Chung P, et al
    Quantification of interobserver variability in image registration using conebeam CT for partial bladder radiotherapy - A Comparison between Lipiodol and Bladder Wall Surface.
    Br J Radiol. 2018 Nov 1:20180413. doi: 10.1259/bjr.20180413.
    Abstract     Related articles   

  167. FROEHNER M, Koch R, Hubler M, Heberling U, et al
    Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.
    BMC Urol. 2018;18:91.
    Abstract     Related articles   

  168. ELKADY N, Sultan M, Elkhouly E
    Evaluation of topoisomerase II, ki-67, and P53 expression in non-muscle-invasive urothelial carcinoma and their clinical significance.
    Indian J Pathol Microbiol. 2018;61:526-531.
    Abstract     Related articles   

  169. ADIL K, Popovic M, Cury FL, Faria SL, et al
    Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy.
    Pract Radiat Oncol. 2019;9:24-28.
    Abstract     Related articles   

  170. REDMAN JM, Madan RA
    Spotlight on atezolizumab and its potential as an oncology agent.
    Expert Rev Anticancer Ther. 2018;18:719-722.
    Abstract     Related articles   

  171. FREIFELD Y, Krabbe LM, Clinton TN, Woldu SL, et al
    Therapeutic strategies for upper tract urothelial carcinoma.
    Expert Rev Anticancer Ther. 2018;18:765-774.
    Abstract     Related articles   

  172. LIU K, Sun E, Lei M, Li L, et al
    BCG-induced formation of neutrophil extracellular traps play an important role in bladder cancer treatment.
    Clin Immunol. 2019 Feb 13. pii: S1521-6616(18)30633.
    Abstract     Related articles   

  173. MONTALBO R, Lozano JJ, Izquierdo L, Ingelmo-Torres M, et al
    Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients.
    Transl Res. 2019 Feb 7. pii: S1931-5244(19)30025.
    Abstract     Related articles   

  174. WITZKE KE, Grosserueschkamp F, Jutte H, Horn M, et al
    Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.
    Am J Pathol. 2019 Feb 9. pii: S0002-9440(18)30739.
    Abstract     Related articles   

  175. OEYEN E, Hoekx L, De Wachter S, Baldewijns M, et al
    Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  176. CHUNG J, Kulkarni GS, Morash R, Matthew A, et al
    Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
    Support Care Cancer. 2019 Feb 14. pii: 10.1007/s00520-019-4649.
    Abstract     Related articles   

  177. SIDDIQUI MR, Railkar R, Sanford T, Crooks DR, et al
    Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Sci Rep. 2019;9:2084.
    Abstract     Related articles   

  178. CAO YP, Sun JY, Li MQ, Dong Y, et al
    Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
    Acta Pharmacol Sin. 2019 Feb 14. pii: 10.1038/s41401-018-0205.
    Abstract     Related articles   

  179. KULKARNI GS, Black PC, Sridhar SS, Kapoor A, et al
    Canadian Urological Association guideline: Muscle-invasive bladder cancer.
    Can Urol Assoc J. 2019 Jan 31. pii: cuaj.5902. doi: 10.5489/cuaj.5902.
    Abstract     Related articles   

  180. LIN T, Jin H, Gong L, Yu R, et al
    Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization: Protocol for a systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e14573.
    Abstract     Related articles   

  181. KISPERT S, Marentette J, McHowat J
    Cigarette smoking promotes bladder cancer via increased platelet-activating factor.
    Physiol Rep. 2019;7:e13981.
    Abstract     Related articles   

  182. WU S, Ou T, Xing N, Lu J, et al
    Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.
    Nat Commun. 2019;10:720.
    Abstract     Related articles   

  183. DENG S, He SY, Zhao P, Zhang P, et al
    The role of oncostatin M receptor gene polymorphisms in bladder cancer.
    World J Surg Oncol. 2019;17:30.
    Abstract     Related articles   

  184. MAJ M, Kokocha A, Bajek A, Drewa T, et al
    The effects of adipose-derived stem cells on CD133-expressing bladder cancer cells.
    J Cell Biochem. 2019 Feb 11. doi: 10.1002/jcb.28436.
    Abstract     Related articles   

  185. DENG Y, Bi R, Guo H, Yang J, et al
    Andrographolide Enhances TRAIL-Induced Apoptosis via p53-Mediated Death Receptors Up-Regulation and Suppression of the NF-small ka, CyrillicB Pathway in Bladder Cancer Cells.
    Int J Biol Sci. 2019;15:688-700.
    Abstract     Related articles   

  186. SU Y, Yang W, Jiang N, Shi J, et al
    Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.
    Int J Biol Sci. 2019;15:441-452.
    Abstract     Related articles   

  187. XIE R, Chen X, Chen Z, Huang M, et al
    Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Cancer Lett. 2019 Feb 8. pii: S0304-3835(19)30071.
    Abstract     Related articles   

  188. KOSOVA IV, Loran OB, Sinyakova LA, Gundorova LV, et al
    [A prognostic value of level of antiviral antibodies in the development of recurrence of bladder cancer].
    Urologiia. 2018;:86-94.
    Abstract     Related articles   

  189. STONE L
    Treatment timing well tolerated in bladder cancer.
    Nat Rev Urol. 2019 Feb 11. pii: 10.1038/s41585-019-0162.
    Abstract     Related articles   

  190. ELIZALDE BENITO FX, Ucar Terren A, Monzon Alebesque F, Urra Palos M, et al
    Bladder cancer with Indian ink.
    Arch Esp Urol. 2019;72:89-90.
    Abstract     Related articles   

  191. GOMEZ RIVAS J, Eguibar Gonzalez A, Tortolero Blanco L, Aguilera Bazan A, et al
    [Usefulness of photodynamic diagnosis in high-grade Bladder Cancer and subsequent BCG failure. Bibliographic review.]
    Arch Esp Urol. 2019;72:2-8.
    Abstract     Related articles   

  192. EINSTEIN DJ, Sonpavde G
    Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer.
    Curr Treat Options Oncol. 2019;20:12.
    Abstract     Related articles   

  193. WITLOX WJA, van Osch FHM, Brinkman M, Jochems S, et al
    An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies.
    Eur J Nutr. 2019 Feb 8. pii: 10.1007/s00394-019-01907.
    Abstract     Related articles   

  194. IMAI Y, Noda S, Matsuyama C, Shimizu A, et al
    Sex steroid hormone receptors in bladder cancer: Usefulness in differential diagnosis and implications in histogenesis of bladder cancer.
    Urol Oncol. 2019 Feb 6. pii: S1078-1439(19)30024.
    Abstract     Related articles   

  195. KRAJEWSKI W, Zdrojowy R, Kolodziej A
    Purified protein derivative skin test-One swallow does not make a summer: Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calm
    Urol Oncol. 2019 Feb 5. pii: S1078-1439(19)30025.
    Abstract     Related articles   

  196. OZAWA M, Suenaga S, Ishii T, Suzuki H, et al
    [PRIMARY MALIGNANT LYMPHOMA OF THE BLADDER DIAGNOSED BY TRANSURETHRAL BLADDER TUMOR RESECTION: A CASE REPORT].
    Nihon Hinyokika Gakkai Zasshi. 2018;109:45-49.
    Abstract     Related articles   

  197. ITO A, Takata R, Matsuo T, Kimura T, et al
    [COMPLETE RESECTION OF URACHAL CARCINOMA WITH SIGMOID COLON INVASION AFTER FOLFOX CHEMOTHERAPY: A CASE REPORT].
    Nihon Hinyokika Gakkai Zasshi. 2018;109:35-39.
    Abstract     Related articles   

  198. MITA K, Kobatake K, Ohara S, Kato M, et al
    [LAPAROSCOPIC RADICAL CYSTECTOMY AT HIROSHIMA CITY ASA HOSPITAL].
    Nihon Hinyokika Gakkai Zasshi. 2018;109:1-6.
    Abstract     Related articles   

  199. LEE YL, Lai CR, Yen MS
    Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report.
    J Ovarian Res. 2019;12:2.
    Abstract     Related articles   

  200. WANG B, Pan W, Yang M, Yang W, et al
    Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder.
    Cancer Sci. 2019;110:489-498.
    Abstract     Related articles   

  201. PABO-CARRASCO S, Vallejo-Benitez A, Carmona-Pinelo E, Umbria-Jimenez S, et al
    [Nested variant Transitional Cell Carcinoma. Report of two cases and bibliographic review.]
    Arch Esp Urol. 2018;71:794-799.
    Abstract     Related articles   

  202. KONDO E, Maki S, Nii M, Yoshida K, et al
    Long-term survival of a patient with malignant transformation of extragonadal endometriosis treated solely with chemotherapy: A case report.
    J Obstet Gynaecol Res. 2018;44:2186-2189.
    Abstract     Related articles   

  203. CLEMENTS MB, Krupski TL, Culp SH
    Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis.
    Ann Surg Oncol. 2018;25:2550-2562.
    Abstract     Related articles   

  204. CRISCUOLO D, Morra F, Giannella R, Visconti R, et al
    New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment.
    J Exp Clin Cancer Res. 2019;38:91.
    Abstract     Related articles   

  205. KUMAR S, Bhoriwal S, Muduly D, Kar M, et al
    Multimodality management of incidentally detected gall bladder cancer: long term results from a tertiary care cancer centre.
    J Gastrointest Oncol. 2019;10:128-133.
    Abstract     Related articles   

  206. KARATZAS A, Tzortzis V
    Lower urinary tract symptoms and bladder cancer in children: The hidden scenario.
    Urol Ann. 2019;11:102-104.
    Abstract     Related articles   

  207. KALLIFATIDIS G, Smith DK, Morera DS, Gao J, et al
    beta-Arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer.
    Mol Cancer Ther. 2019 Feb 20. pii: 1535-7163.MCT-18-1167.
    Abstract     Related articles   

  208. MORRA F, Merolla F, Criscuolo D, Insabato L, et al
    CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.
    J Exp Clin Cancer Res. 2019;38:90.
    Abstract     Related articles   

  209. YU H, Wang S, Zhu H, Rao D, et al
    LncRNA MT1JP functions as a tumor suppressor via regulating miR-214-3p expression in bladder cancer.
    J Cell Physiol. 2019 Feb 20. doi: 10.1002/jcp.28274.
    Abstract     Related articles   

  210. RACIOPPI M, Di Gianfrancesco L, Ragonese M, Palermo G, et al
    Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
    Int Braz J Urol. 2018;45.
    Abstract     Related articles   

  211. XU X, You K, Wu B
    Zonula occludens-1 associated nucleic acid binding protein plays an invasion-promoting role in bladder cancer.
    Neoplasma. 2019 Feb 14. pii: 180725N530. doi: 10.4149/neo_2018_180725.
    Abstract     Related articles   

  212. SHADPOUR P, Zamani M, Aghaalikhani N, Rashtchizadeh N, et al
    Inflammatory cytokines in bladder cancer.
    J Cell Physiol. 2019 Feb 18. doi: 10.1002/jcp.28252.
    Abstract     Related articles   

  213. HU J, Zhou L, Song Z, Xiong M, et al
    The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets.
    J Cell Physiol. 2019 Feb 18. doi: 10.1002/jcp.28208.
    Abstract     Related articles   

  214. LI J, Wang AS, Wang S, Wang CY, et al
    LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
    Eur Rev Med Pharmacol Sci. 2019;23:1022-1029.
    Abstract     Related articles   

  215. CAO HL, Liu ZJ, Huang PL, Yue YL, et al
    lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206.
    Eur Rev Med Pharmacol Sci. 2019;23:1012-1021.
    Abstract     Related articles   

  216. KRAJEWSKI W, Rodriguez Faba O, Poletajew S, Palou J, et al
    New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details.
    World J Urol. 2019 Feb 18. pii: 10.1007/s00345-019-02680.
    Abstract     Related articles   

  217. TAN Y, Zhang T, Zhou L, Liu S, et al
    MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes.
    Med Sci Monit. 2019;25:1323-1335.
    Abstract     Related articles   

  218. CHERUKU RR, Cacaccio J, Durrani F, Tabaczynski WA, et al
    Epidermal Growth Factor Receptor Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy.
    J Med Chem. 2019 Feb 18. doi: 10.1021/acs.jmedchem.8b01927.
    Abstract     Related articles   

  219. LI S, Zhu Y, Liang Z, Wang X, et al
    Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
    Oncotarget. 2019;10:684.
    Abstract     Related articles   

  220. AMARA CS, Vantaku V, Lotan Y, Putluri N, et al
    Recent advances in the metabolomic study of bladder cancer.
    Expert Rev Proteomics. 2019 Feb 16. doi: 10.1080/14789450.2019.1583105.
    Abstract     Related articles   

  221. ZHANG G, Ma F, Li L, Li J, et al
    Palbociclib triggers apoptosis in bladder cancer cells by Cdk2-induced Rad9-mediated reorganization of the Bak.Bcl-xl complex.
    Biochem Pharmacol. 2019;163:133-141.
    Abstract     Related articles   

  222. SORIA F, Pisano F, Gontero P, Palou J, et al
    Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
    World J Urol. 2018;36:1775-1781.
    Abstract     Related articles   

  223. MARGULIS AV, Fortuny J, Kaye JA, Calingaert B, et al
    Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom.
    Epidemiology. 2018;29:e41-e42.
    Abstract     Related articles   

  224. SONPAVDE G, Pond GR, Rosenberg JE, Choueiri TK, et al
    Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy.
    Clin Genitourin Cancer. 2018;16:e961-e967.
    Abstract     Related articles   

  225. HERMANN GG, Mogensen K, Rosthoj S
    Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis.
    Scand J Urol. 2018;52:194-198.
    Abstract     Related articles   

  226. MENG X, Press B, Renson A, Wysock JS, et al
    Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index.
    Clin Genitourin Cancer. 2018;16:e843-e850.
    Abstract     Related articles   

  227. HENSLEY PJ, Goodwin J, Davenport DL, Strup SE, et al
    Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder.
    Clin Genitourin Cancer. 2018;16:e851-e858.
    Abstract     Related articles   

  228. BREYER J, Wirtz RM, Erben P, Worst TS, et al
    High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma.
    Clin Genitourin Cancer. 2018;16:248-256.
    Abstract     Related articles   

  229. LORENTZ CA, Gilbert K, Alemozaffar M, Patil D, et al
    Risk of Readmission After Uncomplicated Hospitalization After Radical Cystectomy.
    Clin Genitourin Cancer. 2018;16:e705-e710.
    Abstract     Related articles   

  230. HEMDAN T, Turker P, Malmstrom PU, Segersten U, et al
    Choline-phosphate cytidylyltransferase-alpha as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder.
    Scand J Urol. 2018;52:200-205.
    Abstract     Related articles   

  231. POWLES T, Necchi A, Rosen G, Hariharan S, et al
    Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.
    Clin Genitourin Cancer. 2018;16:117-129.
    Abstract     Related articles   

  232. LIU ST, Hui G, Mathis C, Chamie K, et al
    The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.
    Clin Genitourin Cancer. 2018;16:e269-e276.
    Abstract     Related articles   

  233. GUPTA S, Albertson D, Gaston D, Heilbrun ME, et al
    Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.
    Clin Genitourin Cancer. 2018;16:e373-e382.
    Abstract     Related articles   

  234. MIRSADRAEI L, Hodkoff A, Jones K, Shabaik A, et al
    Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall.
    Arch Pathol Lab Med. 2018;142:168-177.
    Abstract     Related articles   

  235. PEDERSEN M, Stafoggia M, Weinmayr G, Andersen ZJ, et al
    Is There an Association Between Ambient Air Pollution and Bladder Cancer Incidence? Analysis of 15 European Cohorts.
    Eur Urol Focus. 2018;4:113-120.
    Abstract     Related articles   

  236. DO NASCIMENTO ALVES SIPM, Lavalhegas Hallack M, Moreira Perez M, da Costa Aguiar Alves B, et al
    Application of the Z-scan technique for the detection of CFCDNA (cell-free circulating DNA) and urine DNA (uDNA) in patients with bladder cancer.
    Photodiagnosis Photodyn Ther. 2019 Feb 26. pii: S1572-1000(18)30338.
    Abstract     Related articles   

  237. JIANG G, Huang C, Liao X, Li J, et al
    The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells.
    J Biol Chem. 2019 Feb 28. pii: RA118.005621. doi: 10.1074/jbc.RA118.005621.
    Abstract     Related articles   

  238. LIN JJ, Huang CC, Su YL, Luo HL, et al
    Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  239. WU T, Duan X, Hu C, Wu C, et al
    Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells.
    Artif Cells Nanomed Biotechnol. 2019;47:512-523.
    Abstract     Related articles   

  240. LAZARO M, Gallardo E, Domenech M, Pinto A, et al
    Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Clin Transl Oncol. 2019 Feb 26. pii: 10.1007/s12094-019-02061.
    Abstract     Related articles   

  241. MATULAY JT, Narayan VM, Kamat AM
    Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.
    Curr Oncol Rep. 2019;21:23.
    Abstract     Related articles   

  242. CHOI JB, Kim JH, Hong SH, Han KD, et al
    Association of body mass index with bladder cancer risk in men depends on abdominal obesity.
    World J Urol. 2019 Feb 26. pii: 10.1007/s00345-019-02690.
    Abstract     Related articles   

  243. LIN JH, Chen SJ, Liu H, Yan Y, et al
    Vitamin E consumption and the risk of bladder cancer.
    Int J Vitam Nutr Res. 2019 Feb 26:1-8. doi: 10.1024/0300-9831/a000553.
    Abstract     Related articles   

  244. TURKER P, Segersten U, Malmstrom PU, Hemdan T, et al
    Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?
    Scand J Urol. 2019 Feb 26:1-6. doi: 10.1080/21681805.2019.1575467.
    Abstract     Related articles   

  245. DATOVO JCF, Neto WA, Mendonca GB, Andrade DL, et al
    Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC).
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02697.
    Abstract     Related articles   

  246. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience.
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02689.
    Abstract     Related articles   

  247. GURUNG PMS, Barnett AR, Wilson JS, Hudson J, et al
    Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation.
    Eur Urol Focus. 2019 Feb 22. pii: S2405-4569(19)30032.
    Abstract     Related articles   

  248. CHIANG CH, Chung JG, Hsu FT
    Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-kappaB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Environ Toxicol. 2019 Feb 25. doi: 10.1002/tox.22734.
    Abstract     Related articles   

  249. MEHTALA J, Khanfir H, Bennett D, Ye Y, et al
    Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies.
    Diabetol Int. 2018;10:24-36.
    Abstract     Related articles   

  250. POLETAJEW S, Fus L, Ilczuk T, Wojcieszak P, et al
    Expression of E-cadherin, beta-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer.
    Cent Eur J Immunol. 2018;43:421-427.
    Abstract     Related articles   

  251. BALAKRISHNAN AS, Washington SL 3rd, Meng MV, Porten SP, et al
    Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 19. pii: S1558-7673(19)30018.
    Abstract     Related articles   

  252. LI Y, Rapkin B, Atkinson TM, Schofield E, et al
    Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery.
    Qual Life Res. 2019 Feb 23. pii: 10.1007/s11136-019-02132.
    Abstract     Related articles   

  253. SATHIANATHEN NJ, Fan Y, Jarosek SL, Konety I, et al
    Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness.
    Eur Urol Focus. 2019 Feb 20. pii: S2405-4569(19)30027.
    Abstract     Related articles   

  254. SHIMIZU N, Hamaide A, Dourcy M, Noel S, et al
    Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumours.
    Vet Comp Oncol. 2019;17:11-20.
    Abstract     Related articles   

  255. AHSAINI M, Ouattar K, Azelmad H, Mellas S, et al
    A rare pure embryonal rhabdomyosarcoma of the urinary bladder in an adult successfully managed with neoadjuvant chemotherapy and surgery: a case report.
    J Med Case Rep. 2018;12:329.
    Abstract     Related articles   

  256. TALAT Z, Onal B, Cetinel B, Demirdag C, et al
    The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy.
    BMC Urol. 2018;18:94.
    Abstract     Related articles   

  257. JIN L, Wang M, Yang F, Niu Y, et al
    Surgical techniques for facilitating laparoscopic intracorporeal orthotopic neobladder: initial experience.
    Int Braz J Urol. 2018;44:1156-1165.
    Abstract     Related articles   

  258. FOGAZZI GB, Delanghe J
    Microscopic examination of urine sediment: Phase contrast versus bright field.
    Clin Chim Acta. 2018;487:168-173.
    Abstract     Related articles   

  259. KALETSCH A, Pinkerneil M, Hoffmann MJ, Jaguva Vasudevan AA, et al
    Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Clin Epigenetics. 2018;10:100.
    Abstract     Related articles   

  260. FIELDER S, Breshears M
    What is your diagnosis? Bladder mass in a mare.
    Vet Clin Pathol. 2018;47:665-666.
    Abstract     Related articles   

  261. FERSINO S, Arcangeli S, Jereczek-Fossa BA, D'Angelillo R, et al
    GUROPA survey: genito-urinary radiation oncology prescription attitudes.
    Radiol Med. 2018;123:879-884.
    Abstract     Related articles   

  262. JOHANSSON S, Walters R, Mayer K, Shippey S, et al
    Vaginal Myomectomy to Resolve Bladder Outlet Obstruction 50 Years After Hysterectomy.
    Female Pelvic Med Reconstr Surg. 2018;24:e26-e28.
    Abstract     Related articles   

  263. HORI S, Mitsui Y, Suzuki K, Nakajima K, et al
    [Penile Metastasis from Invasive Bladder Carcinoma Diagnosed by Needle Biopsy : A Case Report and Literature Review].
    Hinyokika Kiyo. 2018;64:127-130.
    Abstract     Related articles   

  264. UCHIDA M, Kawai K, Kurobe M, Ikeda A, et al
    [Metastases of Urothelial Carcinoma with Trophoblastic Differentiation that Responded to Combination Chemotherapy with Gemcitabine and Oxaliplatin : A Case Report].
    Hinyokika Kiyo. 2018;64:55-61.
    Abstract     Related articles   

  265. BRETSCHNEIDER CE, Share SM, Paraiso MFR
    Nephrogenic Adenoma in the Setting of Refractory Labial Agglutination in an Elderly Woman.
    Female Pelvic Med Reconstr Surg. 2018;24:e6-e8.
    Abstract     Related articles   

  266. SANFORD T, Meng MV, Railkar R, Agarwal PK, et al
    Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
    Clin Epigenetics. 2018;10:19.
    Abstract     Related articles   

  267. BOTELHO F
    Editorial Comment on: Isolated Red Patches Seen During Endoscopic Surveillance of Bladder Cancer: Incidence of Malignancy and When Should We Biopsy? by Nkwam et al.
    J Endourol. 2018;32:328.
    Abstract     Related articles   

  268. HOLSCHER AS, Schulz WA, Pinkerneil M, Niegisch G, et al
    Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.
    Clin Epigenetics. 2018;10:1.
    Abstract     Related articles   

  269. FERNANDEZ-ACENERO MJ, Perez Alonso P, Diaz Del Arco C
    Histiocytic sarcoma with bladder involvement: Case report and literature review.
    Rev Esp Patol. 2018;51:23-26.
    Abstract     Related articles   

  270. HUANG SY, Chien CC, Hseu RS, Huang VYJ, et al
    Ganoderma microsporum immunomodulatory protein induces apoptosis and potentiates mitomycin C-induced apoptosis in urinary bladder urothelial carcinoma cells.
    J Cell Biochem. 2018;119:4592-4606.
    Abstract     Related articles   

  271. SMITH AH, Marshall G, Roh T, Ferreccio C, et al
    Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction.
    J Natl Cancer Inst. 2018;110:241-249.
    Abstract     Related articles   

  272. AFSHARPAD M, Nowroozi MR, Mobasheri MB, Ayati M, et al
    Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
    Pathol Oncol Res. 2019;25:191-199.
    Abstract     Related articles   

  273. MOSCHINI M, Morlacco A, Briganti A, Hu B, et al
    Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
    Eur Urol Focus. 2018;4:245-251.
    Abstract     Related articles   

  274. VETTERLEIN MW, Seisen T, May M, Nuhn P, et al
    Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Eur Urol Focus. 2018;4:252-259.
    Abstract     Related articles   

  275. JOSHI M, Millis SZ, Arguello D, Holder SL, et al
    Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.
    Eur Urol Focus. 2018;4:94-97.
    Abstract     Related articles   

  276. COLOMBO R, Hurle R, Moschini M, Freschi M, et al
    Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Eur Urol Focus. 2018;4:87-93.
    Abstract     Related articles   

  277. OKUBO K, Isono M, Asano T, Sato A, et al
    Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase.
    Transl Oncol. 2019;12:669-682.
    Abstract     Related articles   

  278. SONG Y, Yang Y, Liu L, Liu X, et al
    Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
    Gene. 2019 Mar 5. pii: S0378-1119(19)30211-2. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  279. ZHANG W, Shi L, Zhao Z, Du P, et al
    Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer.
    Cancer Chemother Pharmacol. 2019 Mar 8. pii: 10.1007/s00280-019-03800.
    Abstract     Related articles   

  280. HOU T, Zhou L, Wang L, Kazobinka G, et al
    Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
    Oncotarget. 2019;10:1010.
    Abstract     Related articles   

  281. FAN J, Wu K, Zhang P, He D, et al
    Green-laser assisted laparoscopic partial cystectomy for selective muscle-invasive bladder cancer: technique and initial outcome.
    World J Urol. 2019 Mar 6. pii: 10.1007/s00345-019-02712.
    Abstract     Related articles   

  282. KONALA VM, Adapa S, Aronow WS
    Immunotherapy in Bladder Cancer.
    Am J Ther. 2019 Feb 28. doi: 10.1097/MJT.0000000000000934.
    Abstract     Related articles   

  283. GOK B, Atmaca AF, Canda AE, Asil E, et al
    Robotic radical cystectomy with intracorporeal Studer pouch formation for bladder cancer: Experience in 98 cases.
    J Endourol. 2019 Mar 6. doi: 10.1089/end.2019.0036.
    Abstract     Related articles   

  284. KIM DK, Lee JY, Jung JH, Hah YS, et al
    Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials.
    Investig Clin Urol. 2019;60:64-74.
    Abstract     Related articles   

  285. GILD P, Nguyen DD, Fletcher SA, Cole AP, et al
    Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy.
    Clin Genitourin Cancer. 2019 Jan 29. pii: S1558-7673(19)30036.
    Abstract     Related articles   

  286. TEMRAZ S, Haibe Y, Charafeddine M, Saifi O, et al
    The unveiling of a new risk factor associated with bladder cancer in Lebanon.
    BMC Urol. 2019;19:16.
    Abstract     Related articles   

  287. HUMAYUN-ZAKARIA N, Arnold R, Goel A, Ward D, et al
    Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  288. BABJUK M
    En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
    World J Urol. 2019 Mar 5. pii: 10.1007/s00345-019-02710.
    Abstract     Related articles   

  289. RODRIGUES D, Pinto J, Araujo AM, Monteiro-Reis S, et al
    Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Metabolomics. 2018;14:62.
    Abstract     Related articles   

  290. LIANG H, Yang T, Wu K, He D, et al
    En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer.
    World J Urol. 2019 Mar 4. pii: 10.1007/s00345-019-02672.
    Abstract     Related articles   

  291. SAWICKA E, Kratz EM, Szymanska B, Guzik A, et al
    Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer.
    Pathol Oncol Res. 2019 Mar 4. pii: 10.1007/s12253-019-00620.
    Abstract     Related articles   

  292. WANG J, Zhang J, Li T, Shen R, et al
    Strand displacement amplification-coupled dynamic light scattering method to detect urinary telomerase for non-invasive detection of bladder cancer.
    Biosens Bioelectron. 2019;131:143-148.
    Abstract     Related articles   

  293. HUANG C, Liao X, Jin H, Xie F, et al
    MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion.
    Mol Ther Nucleic Acids. 2019;16:51-62.
    Abstract     Related articles   

  294. LINDNER AK, Klatte T, Comperat E, Heidegger I, et al
    Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?
    Urol Oncol. 2019 Feb 27. pii: S1078-1439(19)30054.
    Abstract     Related articles   

  295. GIRARD A, Rouanne M
    Comment on: Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Mar 1. pii: 10.1007/s00259-019-04296.
    Abstract     Related articles   

  296. BERNDT-PAETZ M, Schulze P, Stenglein PC, Weimann A, et al
    Reduction of muscle-invasive tumors by photodynamic therapy with Tetrahydroporphyrin-Tetratosylat in an orthotopic rat bladder cancer model.
    Mol Cancer Ther. 2019 Mar 1. pii: 1535-7163.MCT-18-1194.
    Abstract     Related articles   

  297. GAO R, Zhang N, Yang J, Zhu Y, et al
    Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-beta1 in bladder cancer cells.
    J Exp Clin Cancer Res. 2019;38:111.
    Abstract     Related articles   

  298. MA Y, Mao G, Zhong Y, Wu G, et al
    Highly sensitive ratiometric fluorescent paper sensor for the urine assay of cancer.
    Talanta. 2019;194:199-204.
    Abstract     Related articles   

  299. MITRA AP, Fairey AS, Skinner EC, Boorjian SA, et al
    Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
    Urol Oncol. 2019;37:48-56.
    Abstract     Related articles   

  300. SASAHARA T, Sasaki H, Yoshiyama Y, Kimura S, et al
    [A Case of Urachal Carcinoma Treated with Laparoscopic Resection of Urachal Remnants with Partial Cystectomy that was Difficult to Diagnose Preoperatively by Transurethral Biopsy].
    Hinyokika Kiyo. 2018;64:345-348.
    Abstract     Related articles   

  301. BARNES JL, Zubair M, John K, Poirier MC, et al
    Carcinogens and DNA damage.
    Biochem Soc Trans. 2018;46:1213-1224.
    Abstract     Related articles   

  302. PAI A, Mackie S, Watson G
    Novel use of air in laser ablation of bladder transitional cell carcinoma.
    Ann R Coll Surg Engl. 2019;101:227.
    Abstract     Related articles   

  303. DENIZE J, Bugel H, Bou Nasr E, Delcourt C, et al

    Gynecol Obstet Fertil Senol. 2018;46.
    Abstract     Related articles   

  304. QIN ZJ, Bi H, Ma LL, Huang Y, et al
    [A primary intestinal-derived adenocarcinoma in intestine bladder substitutes: a case report].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:737-739.
    Abstract     Related articles   

  305. TANG XG, Yan Y, Qiu M, Lu J, et al
    [Retrospective study of young bladder urothelial carcinoma from a single center within 16 years].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:630-633.
    Abstract     Related articles   

  306. AKHTAR S, Al-Shammari A, Al-Abkal J
    Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies.
    World J Urol. 2018 Feb 5. pii: 10.1007/s00345-018-2206.
    Abstract     Related articles   

  307. KIM BS, Tae BS, Ku JH, Kwak C, et al
    Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor.
    Investig Clin Urol. 2018;59:10-17.
    Abstract     Related articles   

  308. CENCINI E, Fabbri A, Schiattone L, Gentili F, et al
    Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
    Acta Clin Belg. 2018;73:408-412.
    Abstract     Related articles   

  309. INOUE S, Mizushima T, Miyamoto H
    Role of the androgen receptor in urothelial cancer.
    Mol Cell Endocrinol. 2018;465:73-81.
    Abstract     Related articles   

  310. GIANNOPOULOU AF, Velentzas AD, Konstantakou EG, Avgeris M, et al
    Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  311. STEELE TM, Talbott GC, Sam A, Tepper CG, et al
    Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  312. LUNDBERG E, Hagberg O, Jahnson S, Ljungberg B, et al
    Association between occurrence of urinary bladder cancer and treatment with statin medication.
    Turk J Urol. 2019;45:97-102.
    Abstract     Related articles   

  313. HAIDER M, Ladurner C, Mayr R, Tandogdu Z, et al
    Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series.
    Urol Oncol. 2019 Mar 12. pii: S1078-1439(19)30018.
    Abstract     Related articles   

  314. ZHU J, Li Y, Luo Y, Xu J, et al
    A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-Like Properties and Invasion in Human Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  315. POLETAJEW S, Krajewski W, Adamowicz J, Radziszewski P, et al
    A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guerin immunotherapy.
    Anticancer Drugs. 2019 Mar 11. doi: 10.1097/CAD.0000000000000775.
    Abstract     Related articles   

  316. BAI ZJ, Liu Q, Wang XS, Liu WY, et al
    APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis.
    Neoplasma. 2019 Mar 7. pii: 181009N753. doi: 10.4149/neo_2018_181009.
    Abstract     Related articles   

  317. CHEN J, Cao L, Li Z, Li Y, et al
    SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake.
    Hum Cell. 2019 Mar 13. pii: 10.1007/s13577-019-00237.
    Abstract     Related articles   

  318. CADIOU S, Al Tabaa O, Nguyen CD, Faccin M, et al
    Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
    Clin Rheumatol. 2019 Mar 13. pii: 10.1007/s10067-019-04500.
    Abstract     Related articles   

  319. PHILLIPS RM, Loadman PM, Reddy G
    Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.
    Cancer Chemother Pharmacol. 2019 Mar 13. pii: 10.1007/s00280-019-03812.
    Abstract     Related articles   

  320. WEN W, Gong J, Wu P, Zhao M, et al
    Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis.
    FEBS Open Bio. 2019;9:457-467.
    Abstract     Related articles   

  321. LIN G, Sheng H, Xie H, Zheng Q, et al
    circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762.
    Oncol Lett. 2019;17:3537-3547.
    Abstract     Related articles   

  322. ALBERTO M, Cuello HA, Gulino CA, Pifano M, et al
    Expression of bladder cancer-associated glycans in murine tumor cell lines.
    Oncol Lett. 2019;17:3141-3150.
    Abstract     Related articles   

  323. WANG Z, Zhou Q, Li A, Huang W, et al
    Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer.
    Onco Targets Ther. 2019;12:1423-1432.
    Abstract     Related articles   

  324. YANG Y, Wang F, Huang H, Zhang Y, et al
    lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4.
    Onco Targets Ther. 2019;12:1351-1358.
    Abstract     Related articles   

  325. SUO N, Wang M, Jin Y, Ding J, et al
    Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer.
    Int J Nanomedicine. 2019;14:1241-1254.
    Abstract     Related articles   

  326. KLAASSEN Z, Lokeshwar SD, Lowery-Allison A, Wallis CJD, et al
    Mental Illness and Bladder Cancer Patients: The Time for Assertive Intervention Is Now.
    Eur Urol Focus. 2019 Mar 9. pii: S2405-4569(19)30075.
    Abstract     Related articles   

  327. LIM CS, Tirumani S, van der Pol CB, Alessandrino F, et al
    Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection.
    AJR Am J Roentgenol. 2019 Mar 12:1-10. doi: 10.2214/AJR.18.20718.
    Abstract     Related articles   

  328. JOSHUA JM, Vijayan M, Pooleri GK
    A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer.
    Ther Adv Urol. 2019;11:1756287219833056.
    Abstract     Related articles   

  329. WANG F, Wu D, Xu Z, Chen J, et al
    miR-182-5p affects human bladder cancer cell proliferation, migration and invasion through regulating Cofilin 1.
    Cancer Cell Int. 2019;19:42.
    Abstract     Related articles   

  330. OUYANG XL, Yang L, Huang L, Pan YM, et al
    Antitumor activity on human bladder cancer T-24 cells and composition analysis of the core of Camellia osmantha fruit.
    Nat Prod Res. 2019 Mar 11:1-5. doi: 10.1080/14786419.2018.1550763.
    Abstract     Related articles   

  331. WU E, Hadjiiski LM, Samala RK, Chan HP, et al
    Deep Learning Approach for Assessment of Bladder Cancer Treatment Response.
    Tomography. 2019;5:201-208.
    Abstract     Related articles   

  332. CHAND D, Dhawan D, Sankin A, Ren X, et al
    Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model.
    Bladder Cancer. 2019;5:63-71.
    Abstract     Related articles   

  333. LIU NW, Murray KS, Donat SM, Herr HW, et al
    The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum.
    Bladder Cancer. 2019;5:13-19.
    Abstract     Related articles   

  334. AQUILA L, Ohm J, Woloszynska-Read A
    Corrigendum to "The role of STAG2 in bladder cancer" [Pharmacol. Res. 131 (2018) 143-149].
    Pharmacol Res. 2019 Mar 7. pii: S1043-6618(19)30336.
    Abstract     Related articles   

  335. BOORMANS JL, Zwarthoff EC, Black PC, Goebell PJ, et al
    New horizons in bladder cancer research.
    Urol Oncol. 2019 Mar 7. pii: S1078-1439(18)30508.
    Abstract     Related articles   

  336. MARKS P, Gild P, Soave A, Janisch F, et al
    The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
    Surg Oncol. 2019;28:208-213.
    Abstract     Related articles   

  337. LI R, Zhang L, Qin Z, Wei Y, et al
    High LINC00536 expression promotes tumor progression and poor prognosis in bladder cancer.
    Exp Cell Res. 2019 Mar 6. pii: S0014-4827(19)30103.
    Abstract     Related articles   

  338. BRANT A, Daniels M, Chappidi MR, Joice GA, et al
    Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer.
    World J Urol. 2019 Mar 8. pii: 10.1007/s00345-019-02673.
    Abstract     Related articles   

  339. MOSCHINI M, Martini A, Zamboni S, Mattei A, et al
    Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery.
    Clin Genitourin Cancer. 2019 Feb 13. pii: S1558-7673(19)30045.
    Abstract     Related articles   

  340. SILVERDALE N, Wherry M, Roodhouse A
    Massage and reflexology for post-operative cancer cystectomy patients: Evaluation of a pilot service.
    Complement Ther Clin Pract. 2019;34:109-112.
    Abstract     Related articles   

  341. KIM SC, Park S, Song SH, Kim KS, et al
    Clinicopathological Characteristics of Urinary Bladder Tumors in Korean Patients 20 Years or Younger.
    J Korean Med Sci. 2018;33:e242.
    Abstract     Related articles   

  342. LI P, Ning J, Luo X, Du H, et al
    New method to preserve the original proportion and integrity of urinary cell-free DNA.
    J Clin Lab Anal. 2019;33:e22668.
    Abstract     Related articles   

  343. GE Y, Zhu J, Wang X, Zheng N, et al
    Mapping dynamic histone modification patterns during arsenic-induced malignant transformation of human bladder cells.
    Toxicol Appl Pharmacol. 2018;355:164-173.
    Abstract     Related articles   

  344. SILLS WS, Howerth EW
    Pathology in Practice.
    J Am Vet Med Assoc. 2018;252:1063-1066.
    Abstract     Related articles   

  345. LOERTZER P, Siemer S, Stockle M, Ohlmann CH, et al
    Robot-sewn ileoileal anastomosis during robot-assisted cystectomy.
    World J Urol. 2018;36:1079-1084.
    Abstract     Related articles   

  346. HA YS, Kim SW, Kwon TG, Chung SK, et al
    Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.
    Int Braz J Urol. 2019;45.
    Abstract     Related articles   

  347. LIAN F, Chen W, Liu Y, Shen L, et al
    Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Mar 21. pii: 10.1007/s00432-019-02900.
    Abstract     Related articles   

  348. FU S, Luan T, Jiang C, Huang Y, et al
    miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2.
    Gene. 2019 Mar 18. pii: S0378-1119(19)30247-1. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  349. CHEN J, Song B, Kong G
    MicroRNA663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2.
    Mol Med Rep. 2019 Mar 14. doi: 10.3892/mmr.2019.10023.
    Abstract     Related articles   

  350. BABJUK M
    En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
    World J Urol. 2019 Mar 20. pii: 10.1007/s00345-019-02715.
    Abstract     Related articles   

  351. GUPTA M, Kates M, Bivalacqua TJ
    Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments.
    Curr Opin Oncol. 2019 Mar 15. doi: 10.1097/CCO.0000000000000533.
    Abstract     Related articles   

  352. AL KHADER AM, Abu Shahin NI, Obeidat FN, Al-Chalabi MA, et al
    Urinary bladder cancer in Jordanian adults: A histopathological and epidemiological study from a tertiary care center in Amman.
    J Pak Med Assoc. 2019;69:415-417.
    Abstract     Related articles   

  353. YAJIMA S, Yoshida S, Takahara T, Arita Y, et al
    Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression.
    Eur Radiol. 2019 Mar 19. pii: 10.1007/s00330-019-06119.
    Abstract     Related articles   

  354. HAN Y, Zheng Q, Tian Y, Ji Z, et al
    Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25446.
    Abstract     Related articles   

  355. WALKER AK, Karaszi K, Valentine H, Strauss VY, et al
    MRE11 as a predictive biomarker of outcome following radiotherapy in bladder cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 15. pii: S0360-3016(19)30371.
    Abstract     Related articles   

  356. SHAKIBAIE M, Vaezjalali M, Rafii-Tabar H, Sasanpour P, et al
    Synergistic effect of phototherapy and chemotherapy on bladder cancer cells.
    J Photochem Photobiol B. 2019;193:148-154.
    Abstract     Related articles   

  357. AMIR H, Khan MA, Feroz S, Bibi N, et al
    CARLo-7-A plausible biomarker for bladder cancer.
    Int J Exp Pathol. 2019 Mar 18. doi: 10.1111/iep.12305.
    Abstract     Related articles   

  358. HUANG D, Jin YH, Weng H, Huang Q, et al
    Combination of Intravesical Bacille Calmette-Guerin and Chemotherapy vs. Bacille Calmette-Guerin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis.
    Front Oncol. 2019;9:121.
    Abstract     Related articles   

  359. MA J, Sun G, Zhu P, Liu S, et al
    Determination of the complexity and diversity of the TCR beta-chain CDR3 repertoire in bladder cancer using high-throughput sequencing.
    Oncol Lett. 2019;17:3808-3816.
    Abstract     Related articles   

  360. ZHAO H, Bo Q, Wu Z, Liu Q, et al
    KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway.
    Cancer Manag Res. 2019;11:1857-1868.
    Abstract     Related articles   

  361. FAN Z, Liang Y, Yang X, Li B, et al
    A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer.
    Onco Targets Ther. 2019;12:1791-1801.
    Abstract     Related articles   

  362. LEKKA M, Pabijan J, Orzechowska B
    Morphological and mechanical stability of bladder cancer cells in response to substrate rigidity.
    Biochim Biophys Acta Gen Subj. 2019 Mar 13. pii: S0304-4165(19)30060.
    Abstract     Related articles   

  363. LARCHER A, Gandaglia G, Wiklund P, Mottrie A, et al
    Robot-assisted versus open cystectomy in the RAZOR trial.
    Lancet. 2019;393:645.
    Abstract     Related articles   

  364. PAREKH DJ, Venkatramani V
    Robot-assisted versus open cystectomy in the RAZOR trial - Authors' reply.
    Lancet. 2019;393:645-646.
    Abstract     Related articles   

  365. KHETRAPAL P, Catto JWF, Kelly JD
    Robot-assisted versus open cystectomy in the RAZOR trial.
    Lancet. 2019;393:644-645.
    Abstract     Related articles   

  366. DAL MORO F
    Tomorrow (and surgery) never dies.
    Lancet. 2019;393:642-644.
    Abstract     Related articles   

  367. ROCHEL N, Krucker C, Coutos-Thevenot L, Osz J, et al
    Recurrent activating mutations of PPARgamma associated with luminal bladder tumors.
    Nat Commun. 2019;10:253.
    Abstract     Related articles   

  368. ERBEN P, Sikic D, Wirtz RM, Martini T, et al
    Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder.
    Virchows Arch. 2019;474:209-217.
    Abstract     Related articles   

  369. ALTUN E
    MR Imaging of the Urinary Bladder: Added Value of PET-MR Imaging.
    Magn Reson Imaging Clin N Am. 2019;27:105-115.
    Abstract     Related articles   

  370. CHEN YT, Yang CC, Shao PL, Huang CR, et al
    Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
    J Pineal Res. 2019;66:e12536.
    Abstract     Related articles   

  371. HAN YS, Kim SM, Lee JH, Jung SK, et al
    Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP(C) -dependent enhancement of the mitochondrial function.
    J Pineal Res. 2019;66:e12535.
    Abstract     Related articles   

  372. AGGARWAL A, Agarwal S, Pandey S, Sankhwar S, et al
    Urachal adenocarcinoma.
    BMJ Case Rep. 2018;2018.
    Abstract     Related articles   

  373. HODGSON A, Liu SK, Vesprini D, Xu B, et al
    Basal-subtype bladder tumours show a 'hot' immunophenotype.
    Histopathology. 2018;73:748-757.
    Abstract     Related articles   

  374. ANDRES-LENCINA JJ, Burillo-Martinez S, Aragon-Miguel R, Calleja-Algarra A, et al
    Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.
    Australas J Dermatol. 2018;59:e302-e304.
    Abstract     Related articles   

  375. BRIMO F, Downes MR, Jamaspishvili T, Berman D, et al
    Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.
    Histopathology. 2018;73:732-740.
    Abstract     Related articles   

  376. DELLABELLA M, Branchi A, Gasparri L, Claudini R, et al
    Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.
    World J Urol. 2018;36:1629-1634.
    Abstract     Related articles   

  377. TAYLOR JM, McTyre ER, Tatter SB, Laxton AW, et al
    Gamma Knife Stereotactic Radiosurgery for the Treatment of Brain Metastases from Primary Tumors of the Urinary Bladder.
    Stereotact Funct Neurosurg. 2018;96:108-112.
    Abstract     Related articles   

  378. YU G, Zhou H, Yao W, Meng L, et al
    lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer.
    Mol Ther Nucleic Acids. 2019;16:257-271.
    Abstract     Related articles   

  379. HASSANIEN OA, Abouelkheir RT, Abou El-Ghar MI, Badawy ME, et al
    Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.
    Can Assoc Radiol J. 2019 Mar 25. pii: S0846-5371(18)30206.
    Abstract     Related articles   

  380. AMIN RW, Stafford B, Guttmann RP
    A spatial study of bladder cancer mortality and incidence in the contiguous US: 2000-2014.
    Sci Total Environ. 2019;670:806-813.
    Abstract     Related articles   

  381. HERNANDEZ P, Alem D, Nieves M, Cerecetto H, et al
    Chemosensitizer effect of cisplatin-treated bladder cancer cells by phenazine-5,10-dioxides.
    Environ Toxicol Pharmacol. 2019;69:9-15.
    Abstract     Related articles   

  382. WISSING MD, Santos F, Zakaria AS, O'Flaherty A, et al
    Short- and long-term survival has improved after radical cystectomy for bladder cancer in Quebec during the years 2000-2015.
    J Surg Oncol. 2019 Mar 28. doi: 10.1002/jso.25456.
    Abstract     Related articles   

  383. ZHANG L, Wu B, Zha Z, Zhao H, et al
    Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
    World J Urol. 2019 Mar 27. pii: 10.1007/s00345-019-02738.
    Abstract     Related articles   

  384. LUO H, Xu C, Le W, Ge B, et al
    lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.
    J Cell Biochem. 2019 Mar 27. doi: 10.1002/jcb.28622.
    Abstract     Related articles   

  385. ZHANG L, Yan R, Zhang SN, Zhang HZ, et al
    MicroRNA-338-3p inhibits the progression of bladder cancer through regulating ETS1 expression.
    Eur Rev Med Pharmacol Sci. 2019;23:1986-1995.
    Abstract     Related articles   

  386. BRIEU N, Gavriel CG, Nearchou IP, Harrison DJ, et al
    Automated tumour budding quantification by machine learning augments TNM staging in muscle-invasive bladder cancer prognosis.
    Sci Rep. 2019;9:5174.
    Abstract     Related articles   

  387. LI A, Zhu X, Wang C, Yang S, et al
    Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
    Sci Rep. 2019;9:5166.
    Abstract     Related articles   

  388. CHENG S, Qian K, Wang Y, Wang G, et al
    PPARgamma inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
    J Cell Mol Med. 2019 Mar 25. doi: 10.1111/jcmm.14280.
    Abstract     Related articles   

  389. ZHANG G, Steinbach D, Grimm MO, Horstmann M, et al
    Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection.
    World J Urol. 2019 Mar 25. pii: 10.1007/s00345-019-02681.
    Abstract     Related articles   

  390. YOSHIKAWA Y, Taniguchi K, Tsujino T, Heishima K, et al
    Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment.
    Mol Ther Methods Clin Dev. 2019;13:290-302.
    Abstract     Related articles   

  391. SUBIRA-RIOS D, Herranz-Amo F, Renedo-Villar T, Moralejo-Garate M, et al
    Influence of laparoscopic access in cancer-specific mortality of patients with pTa-2pN0R0 bladder cancer treated with radical cistectomy.
    Actas Urol Esp. 2019 Mar 22. pii: S0210-4806(19)30004.
    Abstract     Related articles   

  392. CAO W, Zhao Y, Wang L, Huang X, et al
    Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression.
    Cancer Biomark. 2019 Mar 12. pii: CBM182380. doi: 10.3233/CBM-182380.
    Abstract     Related articles   

  393. SU H, Jiang H, Tao T, Kang X, et al
    Hope and challenge: Precision medicine in bladder cancer.
    Cancer Med. 2019 Mar 24. doi: 10.1002/cam4.1979.
    Abstract     Related articles   

  394. ROSSI M, Strikoudi P, Spei ME, Parpinel M, et al
    Flavonoids and bladder cancer risk.
    Cancer Causes Control. 2019 Mar 22. pii: 10.1007/s10552-019-01158.
    Abstract     Related articles   

  395. GUO X, Liu M, Hou H, Liu S, et al
    Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
    Int J Clin Oncol. 2019 Mar 22. pii: 10.1007/s10147-019-01427.
    Abstract     Related articles   

  396. VAN OSCH FHM, Nekeman D, Aaronson NK, Billingham LJ, et al
    Patients choose certainty over burden in bladder cancer surveillance.
    World J Urol. 2019 Mar 23. pii: 10.1007/s00345-019-02728.
    Abstract     Related articles   

  397. ZHOU Q, Zhan H, Lin F, Liu Y, et al
    LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase (GLS) expression.
    Biosci Rep. 2019 Mar 22. pii: BSR20182372. doi: 10.1042/BSR20182372.
    Abstract     Related articles   

  398. OGAWA K, Shimizu Y, Tsuchihashi K, Kida K, et al
    [Two Cases of Inflammatory Myofibroblastic Tumor of the Urinary Bladder].
    Hinyokika Kiyo. 2018;64:445-450.
    Abstract     Related articles   

  399. CAO Q, Li P, Yang X, Qian J, et al
    Laparoscopic radical cystectomy with pelvic re-peritonealization: the technique and initial clinical outcomes.
    BMC Urol. 2018;18:113.
    Abstract     Related articles   

  400. OSMANOV YI, Gaibov ZA, Kogan EA, Radenska-Lopovok SG, et al
    [Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder].
    Arkh Patol. 2018;80:23-32.
    Abstract     Related articles   

  401. MURAKAMI M, Kimura T, Iwamoto M, Honda M, et al
    [A Case of Metachronous Cancer Originating from Five Different Organs].
    Hinyokika Kiyo. 2018;64:231-234.
    Abstract     Related articles   

  402. KURAMOTO T, Nishikawa T, Nanpou Y
    [A Case Report of Granulomatous Renal Masses Following Intravesical Instillation of Bacillus Calmette-Guerin Therapy].
    Hinyokika Kiyo. 2018;64:225-230.
    Abstract     Related articles   

  403. SHI H, Yu H, Bellmunt J, Leow JJ, et al
    Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis.
    Qual Life Res. 2018;27:2759-2775.
    Abstract     Related articles   

  404. OKUMURA A, Morii A, Takagawa K, Kitamura H, et al
    [A Case of Metastasis of Cholangiocarcinoma to the Bladder].
    Hinyokika Kiyo. 2018;64:165-168.
    Abstract     Related articles   

  405. SHIMURA S, Matsumoto K, Tabata KI, Fujita T, et al
    [Recurrent Urothelial Carcinoma in the Uretero-Vesical Junction Treated with Partial Ureterectomy and Ureteroneocystostomy during Long-Term Follow-Up : A Case Report].
    Hinyokika Kiyo. 2018;64:157-160.
    Abstract     Related articles   

  406. MU XY, Wang RJ, Yao ZX, Zheng Z, et al
    RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment.
    Mol Immunol. 2019;109:140-148.
    Abstract     Related articles   

  407. PRAKASH G, Pal M, Odaiyappan K, Shinde R, et al
    Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India.
    Indian J Cancer. 2019;56:54-58.
    Abstract     Related articles   

  408. ZHU Q, Sheng Y, Li W, Wang J, et al
    Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways.
    Toxicol Appl Pharmacol. 2019 Apr 1. pii: S0041-008X(19)30117.
    Abstract     Related articles   

  409. YU CC, Li CF, Chen IH, Lai MT, et al
    YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis.
    J Pathol. 2019 Apr 3. doi: 10.1002/path.5274.
    Abstract     Related articles   

  410. BOERI L, Montanari E, Karnes RJ
    Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535-1542.
    World J Urol. 2019 Apr 3. pii: 10.1007/s00345-019-02751.
    Abstract     Related articles   

  411. NICOLAZZO C, Busetto GM, Gradilone A, Sperduti I, et al
    Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
    Oncologist. 2019 Apr 3. pii: theoncologist.2018-0784.
    Abstract     Related articles   

  412. FLANNERY K, Boyd M, Black-Shinn J, Robert N, et al
    Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.
    Future Oncol. 2019 Apr 3. doi: 10.2217/fon-2018-0654.
    Abstract     Related articles   

  413. KACHRILAS S, Dellis A, Papatsoris A, Avgeris S, et al
    PI3K/AKT pathway genetic alterations and dysregulation of expression in bladder cancer.
    J BUON. 2019;24:329-337.
    Abstract     Related articles   

  414. LIANG T, Wang Y, Wang Y, Wang Y, et al
    Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.
    J Cell Physiol. 2019 Apr 2. doi: 10.1002/jcp.28574.
    Abstract     Related articles   

  415. OH JJ, Byun SS, Jeong CW, Kwak C, et al
    Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis.
    Front Oncol. 2019;9:158.
    Abstract     Related articles   

  416. BODGI L, Bahmad HF, Araji T, Al Choboq J, et al
    Assessing Radiosensitivity of Bladder Cancer in vitro: A 2D vs. 3D Approach.
    Front Oncol. 2019;9:153.
    Abstract     Related articles   

  417. MIAO L, Liu HY, Zhou C, He X, et al
    LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
    J Exp Clin Cancer Res. 2019;38:143.
    Abstract     Related articles   

  418. HAGGSTROM C, Garmo H, de Luna X, Van Hemelrijck M, et al
    Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study.
    Cancer Med. 2019 Apr 1. doi: 10.1002/cam4.2126.
    Abstract     Related articles   

  419. XIE Q, Chen C, Li H, Xu J, et al
    miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
    Mol Ther. 2019 Mar 15. pii: S1525-0016(19)30092.
    Abstract     Related articles   

  420. SUBIRA-RIOS D, Herranz-Amo F, Moralejo-Garate M, Cano-Velasco J, et al
    Post-surgical complications in patients with bladder cancer treated with cystectomy: Differences between open and laparoscopic approach.
    Actas Urol Esp. 2019 Mar 29. pii: S0210-4806(19)30006.
    Abstract     Related articles   

  421. GAO H, Yu G, Zhang X, Yu S, et al
    BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
    J Cell Mol Med. 2019 Apr 1. doi: 10.1111/jcmm.14266.
    Abstract     Related articles   

  422. BEULENS AJW, van der Toorn PP, de Wildt MJ, Scheepens WA, et al
    High-precision Bladder Cancer Irradiation in the Elderly: Clinical Results for a Plan-of-the-day Integrated Boost Technique with Image Guidance Using Lipiodol Markers.
    Eur Urol Oncol. 2019;2:39-46.
    Abstract     Related articles   

  423. ZEKRI AN, Khaled HM, Mohammed MB, Diab FM, et al
    Microsatellite instability profiling in Egyptian bladder cancer patients: A pilot study.
    Curr Probl Cancer. 2019 Mar 26. pii: S0147-0272(18)30459.
    Abstract     Related articles   

  424. YAN X, Guo ZX, Liu XP, Feng YJ, et al
    Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    J Cell Physiol. 2019 Mar 29. doi: 10.1002/jcp.28546.
    Abstract     Related articles   

  425. MAIA MC, Hansen A, Alves C, Salah S, et al
    Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review.
    Crit Rev Oncol Hematol. 2019;135:76-84.
    Abstract     Related articles   

  426. IZUMI K, Iwamoto H, Yaegashi H, Shigehara K, et al
    Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function.
    In Vivo. 2019;33:167-172.
    Abstract     Related articles   

  427. GARG G, Sharma A, Sharma A, Sankhwar S, et al
    Metastatic adenocarcinoma of bladder presenting with skin and visceral metastasis.
    BMJ Case Rep. 2018;11.
    Abstract     Related articles   

  428. PARK S, Reuter VE, Hansel DE
    Non-urothelial carcinomas of the bladder.
    Histopathology. 2019;74:97-111.
    Abstract     Related articles   

  429. MCKENNEY JK
    Precursor lesions of the urinary bladder.
    Histopathology. 2019;74:68-76.
    Abstract     Related articles   

  430. JAYARAJAH U, Fernando MH, Herath KB, Kuruppu SN, et al
    Clinico-pathological characteristics and outcome of upper urinary tract urothelial carcinoma presenting to a tertiary care urology unit in Sri Lanka
    Ceylon Med J. 2018;63:129-132.
    Abstract     Related articles   

  431. NILBERT M, Blackberg M, Ceberg J, Hagberg O, et al
    Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.
    Scand J Urol. 2018;52:237-243.
    Abstract     Related articles   

  432. MINATO A, Noguchi H, Tomisaki I, Fukuda A, et al
    Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Cancer Control. 2018;25:1073274818800269.
    Abstract     Related articles   

  433. KARAOSMANOGLU AD, Onur MR, Karcaaltincaba M, Akata D, et al
    Secondary Tumors of the Urinary System: An Imaging Conundrum.
    Korean J Radiol. 2018;19:742-751.
    Abstract     Related articles   

  434. MORGANSTERN BA, Scaccia S, Wu W, Williamson AK, et al
    Synchronous, but separate, bladder and vaginal rhabdomyosarcoma: a novel genetic case report.
    Can J Urol. 2018;25:9357-9359.
    Abstract     Related articles   

  435. LEE AJ, Yabes JG, Hale N, Hrebinko RL, et al
    The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients.
    Can J Urol. 2018;25:9255-9261.
    Abstract     Related articles   

  436. HAO YC, Xiao CL, Liu K, Liu YQ, et al
    [Application of narrow-band imaging flexible ureteroscopy in the diagnosis, treatment and follow-up of upper tract urothelial carcinomas].
    Zhonghua Wai Ke Za Zhi. 2018;56:222-226.
    Abstract     Related articles   

  437. MCARDLE BJ, Vidal P, Psutka SP, Hollowell CMP, et al
    T4 urothelial carcinoma in undiagnosed closed bladder exstrophy in a post-menopausal female.
    Can J Urol. 2018;25:9214-9216.
    Abstract     Related articles   

  438. PIERCONTI F, Rossi ED, Straccia P, Fadda G, et al
    The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.
    Cancer Cytopathol. 2018;126:200-206.
    Abstract     Related articles   

  439. WANG F, Zhang H, Ma AH, Yu W, et al
    COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin.
    Mol Cancer Ther. 2018;17:474-483.
    Abstract     Related articles   

  440. WANG Y, Auger M, Kanber Y, Caglar D, et al
    Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Cancer Cytopathol. 2018;126:207-214.
    Abstract     Related articles   

  441. TRETIAKOVA M, Fulton R, Kocherginsky M, Long T, et al
    Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression.
    Mod Pathol. 2018;31:623-632.
    Abstract     Related articles   

  442. HINDY JR, Souaid T, Kourie HR, Kattan J, et al
    Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?
    Future Oncol. 2019 Apr 12. doi: 10.2217/fon-2018-0459.
    Abstract     Related articles   

  443. YE X, Guo J, Zhang H, Meng Q, et al
    The enhanced expression of estrogen-related receptor alpha in human bladder cancer tissues and the effects of estrogen-related receptor alpha knockdown on bladder cancer cells.
    J Cell Biochem. 2019 Apr 11. doi: 10.1002/jcb.28657.
    Abstract     Related articles   

  444. PANG KH, Noon AP
    Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:101-107.
    Abstract     Related articles   

  445. HENDRICKSEN K
    Device-assisted intravesical therapy for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:94-100.
    Abstract     Related articles   

  446. D'ANDREA D, Gontero P, Shariat SF, Soria F, et al
    Intravesical bacillus Calmette-Guerin for bladder cancer: are all the strains equal?
    Transl Androl Urol. 2019;8:85-93.
    Abstract     Related articles   

  447. ZAMBONI S, Baumeister P, Mattei A, Mordasini L, et al
    Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication?
    Transl Androl Urol. 2019;8:76-84.
    Abstract     Related articles   

  448. RINK M, Schwarzenbach H, Vetterlein MW, Riethdorf S, et al
    The current role of circulating biomarkers in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:61-75.
    Abstract     Related articles   

  449. MARCQ G, Henon F, Ouzaid I, Fantoni JC, et al
    Active surveillance for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:54-60.
    Abstract     Related articles   

  450. SORIA F, Marra G, D'Andrea D, Gontero P, et al
    The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer.
    Transl Androl Urol. 2019;8:46-53.
    Abstract     Related articles   

  451. ZAMBONI S, Moschini M, Simeone C, Antonelli A, et al
    Prediction tools in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:39-45.
    Abstract     Related articles   

  452. BAUMEISTER P, Zamboni S, Mattei A, Antonelli A, et al
    Histological variants in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:34-38.
    Abstract     Related articles   

  453. BILSKI K, Zapala L, Skrzypczyk MA, Oszczudlowski M, et al
    Review on gender differences in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:12-20.
    Abstract     Related articles   

  454. CUMBERBATCH MGK, Noon AP
    Epidemiology, aetiology and screening of bladder cancer.
    Transl Androl Urol. 2019;8:5-11.
    Abstract     Related articles   

  455. MOSCHINI M, Roghmann F, Xylinas E
    The present and future of non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:1.
    Abstract     Related articles   

  456. WISHAHI M, Ismail MA, Elganzoury H, Elkholy A, et al
    Genital-Sparing Cystectomy versus Standard Urethral-Sparing Cystectomy Followed with Orthotopic Neobladder in Women with Bladder Cancer: Incidence and Causes of Hypercontinence with an Ultrastructure Study of Urethral Smooth Muscles.
    Open Access Maced J Med Sci. 2019;7:978-981.
    Abstract     Related articles   

  457. LENFANT L, Roupret M
    [Immunotherapy and bladder cancer].
    Biol Aujourdhui. 2018;212.
    Abstract     Related articles   

  458. BUNCH BL, Ma Y, Attwood K, Amable L, et al
    Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.
    Cancer Med. 2019 Apr 10. doi: 10.1002/cam4.2119.
    Abstract     Related articles   

  459. MORTADA WI, Abdelghany AM
    Preconcentration of Lead in Blood and Urine Samples Among Bladder Cancer Patients Using Mesoporous Strontium Titanate Nanoparticles.
    Biol Trace Elem Res. 2019 Apr 10. pii: 10.1007/s12011-019-01704.
    Abstract     Related articles   

  460. JIANG Y, Wei T, Li W, Zhang R, et al
    Circular RNA hsa_circ_0002024 suppresses cell proliferation, migration, and invasion in bladder cancer by sponging miR-197-3p.
    Am J Transl Res. 2019;11:1644-1652.
    Abstract     Related articles   

  461. BAYKAN O, Akgul M, Uren N, Yaman A, et al
    The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
    Clin Lab. 2019;65.
    Abstract     Related articles   

  462. SUN J, Zhang H, Tao D, Xie F, et al
    CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer.
    Artif Cells Nanomed Biotechnol. 2019;47:1349-1356.
    Abstract     Related articles   

  463. CHENG XZ, Zhou HL, Tang SX, Jiang T, et al
    Intercellular transfer of P-glycoprotein mediates the formation of stable multidrug resistance in human bladder cancer BIU-87 cells.
    Biol Open. 2019 Apr 9. pii: bio.041889. doi: 10.1242/bio.041889.
    Abstract     Related articles   

  464. ERMAN A, Veranic P
    The Use of Polymer Chitosan in Intravesical Treatment of Urinary Bladder Cancer and Infections.
    Polymers (Basel). 2018;10.
    Abstract     Related articles   

  465. SHIVAPPA N, Hebert JR, Mirsafa F, Rashidkhani B, et al
    Increased Inflammatory Potential of Diet Is Associated with Increased Risk of Bladder Cancer in an Iranian Case-Control Study.
    Nutr Cancer. 2019 Apr 9:1-8. doi: 10.1080/01635581.2019.1597902.
    Abstract     Related articles   

  466. LIU XK, Chen D, Li X
    MiR-335 suppresses cell proliferation and migration by upregulating CRKL in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:2399-2408.
    Abstract     Related articles   

  467. TYAGI S, Nelivigi G, Bhagat S
    Management of Bladder Cancer in the Second Trimester of Pregnancy.
    J Obstet Gynaecol India. 2019;69.
    Abstract     Related articles   

  468. MIYAKE M, Owari T, Tomizawa M, Matsui M, et al
    Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer.
    Urol J. 2019 Apr 7. pii: 4531/1360. doi: 10.22037/uj.v0i0.4531.
    Abstract     Related articles   

  469. JIANG F, Qi W, Wang Y, Wang W, et al
    lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.
    Biomed Pharmacother. 2019;114:108814.
    Abstract     Related articles   

  470. YANG Z, Liu A, Xiong Q, Xue Y, et al
    Prognostic value of differentially methylated gene profiles in bladder cancer.
    J Cell Physiol. 2019 Apr 5. doi: 10.1002/jcp.28515.
    Abstract     Related articles   

  471. PEARCE S, Daneshmand S
    Correction to: Enhanced Endoscopy in Bladder Cancer.
    Curr Urol Rep. 2019;20:25.
    Abstract     Related articles   

  472. DI MARTINO E, Alder O, Hurst CD, Knowles MA, et al
    ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer.
    Sci Rep. 2019;9:5740.
    Abstract     Related articles   

  473. WANG J, Li J, Yan G, Gao M, et al
    Preparation of a thickness-controlled Mg-MOFs-based magnetic graphene composite as a novel hydrophilic matrix for the effective identification of the glycopeptide in the human urine.
    Nanoscale. 2019;11:3701-3709.
    Abstract     Related articles   

  474. OKAMOTO M, Soeda T, Asamura A, Tanaka K, et al
    Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells.
    J Vet Med Sci. 2019;81:397-400.
    Abstract     Related articles   

  475. WANG G, Zhou C, Conklin C, Hayes MM, et al
    Metastatic breast carcinoma to the urinary bladder-a report of 11 cases including a tumor to tumor metastasis.
    Virchows Arch. 2019;474:333-339.
    Abstract     Related articles   

  476. FERREIRA R, Neuparth MJ, Nogueira-Ferreira R, Magalhaes S, et al
    Exercise Training Impacts Cardiac Mitochondrial Proteome Remodeling in Murine Urothelial Carcinoma.
    Int J Mol Sci. 2018;20.
    Abstract     Related articles   

  477. TANAKA Y, Okamura T, Chaya R, Nagai T, et al
    Outcomes and Complications of Simultaneous Laparoscopic Cystectomy and Laparoscopic Nephroureterectomy with Umbilical Reduced Port Surgery
    Asian Pac J Cancer Prev. 2018;19:3495-3500.
    Abstract     Related articles   

  478. MATHES J, Todenhofer T
    Managing Toxicity of Intravesical Therapy.
    Eur Urol Focus. 2018;4:464-467.
    Abstract     Related articles   

  479. MOSCHINI M, Zamboni S, Mattei A, Amparore D, et al
    Bacillus Calmette-Guerin unresponsiveness in non-muscle-invasive bladder cancer patients: what the urologists should know.
    Minerva Urol Nefrol. 2019;71:17-30.
    Abstract     Related articles   

  480. RENTSCH CA, Derre L, Dugas SG, Wetterauer C, et al
    Building on a Solid Foundation: Enhancing Bacillus Calmette-Guerin Therapy.
    Eur Urol Focus. 2018;4:485-493.
    Abstract     Related articles   

  481. ERMAN A, Kapun G, Novak S, Pavlin M, et al
    How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model.
    Histochem Cell Biol. 2019;151:263-273.
    Abstract     Related articles   

  482. KIM TN, Chung MK, Nam JK, Lee JZ, et al
    Effectiveness of hyaluronic acid/carboxymethylcellulose in preventing adhesive bowel obstruction after laparoscopic radical cystectomy.
    Asian J Surg. 2019;42:394-400.
    Abstract     Related articles   

  483. O'BRIEN T
    The Case for Photodynamic Diagnosis-assisted Resection Without Intravesical Single-shot Chemotherapy.
    Eur Urol Focus. 2018;4:470-471.
    Abstract     Related articles   

  484. GOEL R, Westblade LF, Kessler DA, Sfeir M, et al
    Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017.
    Emerg Infect Dis. 2018;24:1548-1550.
    Abstract     Related articles   

  485. BANDARI J, Maganty A, MacLeod LC, Davies BJ, et al
    Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guerin.
    Eur Urol Focus. 2018;4:481-484.
    Abstract     Related articles   

  486. BURGER M
    Hexvix plus Chemo.
    Eur Urol Focus. 2018;4:468-469.
    Abstract     Related articles   

  487. CIMADAMORE A, Gasparrini S, Santoni M, Cheng L, et al
    Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer.
    Expert Rev Mol Diagn. 2018;18:645-655.
    Abstract     Related articles   

  488. ST BLANC A, Crossland NA, DiGeronimo PM, Cianciolo RE, et al
    Pathology in Practice.
    J Am Vet Med Assoc. 2018;253:53-56.
    Abstract     Related articles   

  489. ISHARWAL S, Huang H, Nanjangud G, Audenet F, et al
    Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
    Hum Pathol. 2018;77:63-69.
    Abstract     Related articles   

  490. ZHANG Q, Mao Z, Sun J
    NF-kappaB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-kappaB/Snail signaling in bladder cancer cells.
    Gene. 2019 Apr 16. pii: S0378-1119(19)30392-0. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  491. ZHUO D, Wu Y, Luo J, Deng L, et al
    CSTP1 inhibits IL-6 expression through targeting Akt/FoxO3a signaling pathway in bladder cancer cells.
    Exp Cell Res. 2019 Apr 16. pii: S0014-4827(19)30193.
    Abstract     Related articles   

  492. LI Z, Liu Z, Yao K, Qin Z, et al
    An improved ileal conduit surgery for bladder cancer with fewer complications.
    Cancer Commun (Lond). 2019;39:19.
    Abstract     Related articles   

  493. MAO W, Huang X, Wang L, Zhang Z, et al
    Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
    J Exp Clin Cancer Res. 2019;38:169.
    Abstract     Related articles   

  494. NGUYEN MH, Giordani MM, Thompson GR 3rd
    The double-edged sword - prosthetic joint infection following BCG treatment for bladder cancer: a case report.
    BMC Infect Dis. 2019;19:331.
    Abstract     Related articles   

  495. WANG Q, Zhang T, Wu J, Wen J, et al
    Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
    BMC Urol. 2019;19:24.
    Abstract     Related articles   

  496. SZARVAS T, Jardin-Watelet B, Bourgoin N, Hoffmann MJ, et al
    High soluble CGA levels are associated with poor survival in bladder cancer.
    Endocr Connect. 2019 Apr 1. pii: EC-19-0068.R1. doi: 10.1530/EC-19-0068.
    Abstract     Related articles   

  497. ZACHOS I, Zachou K, Dalekos GN, Tzortzis V, et al
    Management of Patients with Liver Cirrhosis and Invasive Bladder Cancer: A Case-series.
    J Transl Int Med. 2019;7:29-33.
    Abstract     Related articles   

  498. FERRO M, Di Lorenzo G, Vartolomei MD, Bruzzese D, et al
    Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor.
    World J Urol. 2019 Apr 16. pii: 10.1007/s00345-019-02754.
    Abstract     Related articles   

  499. XIANG M, Yuan W, Zhang W, Huang J, et al
    Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells.
    Oncol Lett. 2019;17:4437-4442.
    Abstract     Related articles   

  500. WU X, Chen B, Shi H, Zhou J, et al
    miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.
    Exp Ther Med. 2019;17:4273-4278.
    Abstract     Related articles   

  501. HSIAO CH, Yao CJ, Lai GM, Lee LM, et al
    Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells.
    Exp Ther Med. 2019;17:4213-4222.
    Abstract     Related articles   

  502. PFANNSTIEL C, Strissel PL, Chiappinelli KB, Sikic D, et al
    The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes.
    Cancer Immunol Res. 2019 Apr 15. pii: 2326-6066.CIR-18-0758.
    Abstract     Related articles   

  503. CHEN YT, Huang HC, Hsieh YJ, Fu SH, et al
    Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
    J Food Drug Anal. 2019;27:460-474.
    Abstract     Related articles   

  504. HUANG Y, Cen J, Liu Z, Wei J, et al
    A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
    Technol Cancer Res Treat. 2019;18:1533033819844483.
    Abstract     Related articles   

  505. LI M, Wang Y, Liu Y, Zhang X, et al
    Low Expression of hsa_circ_0018069 in Human Bladder Cancer and Its Clinical Significance.
    Biomed Res Int. 2019;2019:9681863.
    Abstract     Related articles   

  506. DING B, Yan L, Zhang Y, Wang Z, et al
    Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
    FEBS Open Bio. 2019;9:693-706.
    Abstract     Related articles   

  507. YANG L, Li YL, Li XQ, Zhang Z, et al
    High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer.
    Dis Markers. 2019;2019:4586405.
    Abstract     Related articles   

  508. LIU Y, Lu J, Huang Y, Ma L, et al
    Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guerin for Bladder Cancer.
    J Oncol. 2019;2019:6230409.
    Abstract     Related articles   

  509. LI Y, Shi B, Dong F, Zhu X, et al
    Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis.
    Front Genet. 2019;10:280.
    Abstract     Related articles   

  510. YANG FY, Wang WK, Liu S, Song LM, et al
    [Clinical experiences of laparoscopic radical cystectomy and urinary diversion in the elderly patients with bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2019;99:1101-1105.
    Abstract     Related articles   

  511. HOUEDE N, Milano G
    [Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine].
    Bull Cancer. 2019 Apr 10. pii: S0007-4551(19)30146.
    Abstract     Related articles   

  512. XU X, Wang H, Du P, Zhang F, et al
    A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
    J Magn Reson Imaging. 2019 Apr 13. doi: 10.1002/jmri.26749.
    Abstract     Related articles   

  513. ROUVINOV K, Plimack ER, Zibelman M, Ghatalia P, et al
    Update on perioperative systemic therapy for urothelial carcinoma.
    Clin Adv Hematol Oncol. 2019;17:176-183.
    Abstract     Related articles   

  514. HANNA KS
    Updates and novel treatments in urothelial carcinoma.
    J Oncol Pharm Pract. 2019;25:648-656.
    Abstract     Related articles   

  515. PENG H, Li H
    The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis.
    Mol Carcinog. 2019 Apr 26. doi: 10.1002/mc.23028.
    Abstract     Related articles   

  516. BUSS JH, Begnini KR, Bruinsmann FA, Ceolin T, et al
    Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell.
    Front Oncol. 2019;9:203.
    Abstract     Related articles   

  517. XU Z, Wang C, Xiang X, Li J, et al
    Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
    Med Sci Monit. 2019;25:3041-3060.
    Abstract     Related articles   

  518. JERLSTROM T, Chen R, Liedberg F, Andren O, et al
    No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
    World J Urol. 2019 Apr 24. pii: 10.1007/s00345-019-02770.
    Abstract     Related articles   

  519. LOTAN Y, Bivalacqua TJ, Downs T, Huang W, et al
    Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018.
    Nat Rev Urol. 2019 Apr 24. pii: 10.1038/s41585-019-0184.
    Abstract     Related articles   

  520. GANDAGLIA G, Larcher A, Gallina A, Fossati N, et al
    Requiem for Open Radical Cystectomy in Bladder Cancer Patients.
    Eur Urol Oncol. 2019;2:196-197.
    Abstract     Related articles   

  521. WILLIAMS SB, Hudgins HK, Ray-Zack MD, Chamie K, et al
    Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer.
    Eur Urol Oncol. 2019;2:119-125.
    Abstract     Related articles   

  522. RAI BP, Bondad J, Vasdev N, Adshead J, et al
    Robotic versus open radical cystectomy for bladder cancer in adults.
    Cochrane Database Syst Rev. 2019;4:CD011903.
    Abstract     Related articles   

  523. WANG H, Hu D, Yao H, Chen M, et al
    Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
    Eur Radiol. 2019 Apr 23. pii: 10.1007/s00330-019-06222.
    Abstract     Related articles   

  524. ZHU J, Tian Z, Li Y, Hua X, et al
    ATG7 Promotes Bladder Cancer Invasion via Autophagy-Mediated Increased ARHGDIB mRNA Stability.
    Adv Sci (Weinh). 2019;6:1801927.
    Abstract     Related articles   

  525. MARTINEZ-BOSCH N, Rodriguez-Vida A, Juanpere N, Lloreta J, et al
    Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities.
    Nat Rev Urol. 2019 Apr 23. pii: 10.1038/s41585-019-0183.
    Abstract     Related articles   

  526. AYOUB M, Shinde-Jadhav S, Mansure JJ, Alvarez F, et al
    The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance.
    Sci Rep. 2019;9:6348.
    Abstract     Related articles   

  527. MARGOLIS DJA, Hu JC
    Vying for Standardization of Bladder Cancer MRI Interpretation and Reporting: VI-RADS.
    Radiology. 2019 Apr 23:190648. doi: 10.1148/radiol.2019190648.
    Abstract     Related articles   

  528. WANG H, Luo C, Zhang F, Guan J, et al
    Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion.
    Radiology. 2019 Apr 23:182506. doi: 10.1148/radiol.2019182506.
    Abstract     Related articles   

  529. RAVEN PA, Lysakowski S, Tan Z, D'Costa NM, et al
    Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.
    J Cell Physiol. 2019 Apr 22. doi: 10.1002/jcp.28669.
    Abstract     Related articles   

  530. FLORES-MARTIN JF, Perea F, Exposito-Ruiz M, Carretero FJ, et al
    A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07371.
    Abstract     Related articles   

  531. KRAJEWSKI W, Poletajew S
    The TaHG bladder cancer - the devil is as black as he is painted.
    Cent European J Urol. 2019;72:76-77.
    Abstract     Related articles   

  532. MORTAZAVI N, Asadikaram G, Ebadzadeh MR, Kamalati A, et al
    Organochlorine and organophosphorus pesticides and bladder cancer: A case-control study.
    J Cell Biochem. 2019 Apr 22. doi: 10.1002/jcb.28746.
    Abstract     Related articles   

  533. DENG S, Ren ZJ, Jin T, Yang B, et al
    Contribution of prostate stem cell antigen variation rs2294008 to the risk of bladder cancer.
    Medicine (Baltimore). 2019;98:e15179.
    Abstract     Related articles   

  534. UMEZAWA Y, Shirotake S, Kaneko G, Nishimoto K, et al
    Meningeal carcinomatosis from bladder cancer: A case report and review of the literature.
    Mol Clin Oncol. 2019;10:506-510.
    Abstract     Related articles   

  535. OURFALI S, Ohannessian R, Fassi-Fehri H, Pages A, et al
    Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guerin Connaught Strain for Bladder Cancer Patients.
    Eur Urol Focus. 2019 Apr 17. pii: S2405-4569(19)30109.
    Abstract     Related articles   

  536. LI T, Zou L, Zhang J, Li G, et al
    Non-invasive diagnosis of bladder cancer by detecting telomerase activity in human urine using hybridization chain reaction and dynamic light scattering.
    Anal Chim Acta. 2019;1065:90-97.
    Abstract     Related articles   

  537. HOU G, Jiang Y, Jian S, Niu Y, et al
    Hemolymphangioma involving bones and bladder detected on 68Ga-NEB PET/CT: A rare case report.
    Medicine (Baltimore). 2019;98:e15213.
    Abstract     Related articles   

  538. LIN Z, Hu WM, Li YH, Jiang LJ, et al
    [Surgical treatment for inflammatory myofibroblastic tumor in genito-urinary system: a study of 15 cases].
    Zhonghua Yi Xue Za Zhi. 2019;99:947-949.
    Abstract     Related articles   

  539. LEE HY, Chen YJ, Li CC, Li WM, et al
    Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches.
    Int J Med Sci. 2019;16:93-105.
    Abstract     Related articles   

  540. KUMAR P, Nayyar R, Seth A, Gupta D, et al
    Management of cavernous abdominal wall defects post radical cystectomy in adult exstrophy complex.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  541. CRONISE KE, Hernandez BG, Gustafson DL, Duval DL, et al
    Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer.
    Mol Pharmacol. 2019 May 2. pii: mol.119.115808. doi: 10.1124/mol.119.115808.
    Abstract     Related articles   

  542. LI Y, Tindle HA, Hendryx MS, Xun P, et al
    Smoking Cessation and the Risk of Bladder Cancer among Postmenopausal Women.
    Cancer Prev Res (Phila). 2019;12:305-314.
    Abstract     Related articles   

  543. XIAN-LI T, Hong L, Hong Z, Yuan L, et al
    Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/beta-Catenin Signaling Pathway.
    Med Sci Monit. 2019;25:3221-3230.
    Abstract     Related articles   

  544. YANG Y, Cheng Z, Jia X, Shi N, et al
    Mortality trends of bladder cancer in China from 1991 to 2015: an age-period-cohort analysis.
    Cancer Manag Res. 2019;11:3043-3051.
    Abstract     Related articles   

  545. ZHANG C, Wang W, Lin J, Xiao J, et al
    lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion.
    Int Braz J Urol. 2019;45.
    Abstract     Related articles   

  546. LEKO V, McDuffie LA, Zheng Z, Gartner JJ, et al
    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.
    J Immunol. 2019 Apr 29. pii: jimmunol.1801022. doi: 10.4049/jimmunol.1801022.
    Abstract     Related articles   

  547. KIM S, Kim Y, Kong J, Kim E, et al
    Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer.
    Elife. 2019;8.
    Abstract     Related articles   


  548. Erratum to "Re: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic".
    J Natl Cancer Inst. 2019 Apr 29. pii: 5481408. doi: 10.1093.
    Abstract     Related articles   

  549. HECK CL, Schwartzbauer GT
    BCG-induced discitis and osteomyelitis in a patient with a history of bladder cancer.
    JAAPA. 2019;32:1-4.
    Abstract     Related articles   

  550. HEYES SM, Prior KN, Whitehead D, Bond MJ, et al
    Toward an Understanding of Patients' and Their Partners' Experiences of Bladder Cancer.
    Cancer Nurs. 2019 Apr 25. doi: 10.1097/NCC.0000000000000718.
    Abstract     Related articles   

  551. FAN L, Wang Y, Wang W, Wei X, et al
    Carcinogenic role of K-Ras-ERK1/2 signaling in bladder cancer via inhibition of H1.2 phosphorylation at T146.
    J Cell Physiol. 2019 Apr 29. doi: 10.1002/jcp.28716.
    Abstract     Related articles   

  552. CHEN W, Jiang T, Mao H, Gao R, et al
    Nodal Promotes the Migration and Invasion of Bladder Cancer Cells via Regulation of Snail.
    J Cancer. 2019;10:1511-1519.
    Abstract     Related articles   

  553. NAGAI T, Okamura T, Yanase T, Chaya R, et al
    Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients
    Asian Pac J Cancer Prev. 2019;20:1271-1273.
    Abstract     Related articles   

  554. RENNINGER M, Fahmy O, Schubert T, Schmid MA, et al
    The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.
    World J Urol. 2019 Apr 27. pii: 10.1007/s00345-019-02780.
    Abstract     Related articles   

  555. NADAL R, Bellmunt J
    Management of metastatic bladder cancer.
    Cancer Treat Rev. 2019;76:10-21.
    Abstract     Related articles   

  556. PALMISANO F, Boeri L, Montanari E
    Reply letter to: Loh-Doyle JC, Ashrafi A, Nazemi A, et al. Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    J Sex Med. 2019;16:760-761.
    Abstract     Related articles   

  557. GARCIA-PERDOMO HA, Usubillaga-Velasquez JP, Zapata-Copete JA, Reis LO, et al
    Mutations in CDKN2A and the FGFR3 genes on bladder cancer diagnosis: a systematic review and meta-analysis.
    World J Urol. 2019 Apr 27. pii: 10.1007/s00345-019-02779.
    Abstract     Related articles   

  558. STONE L
    Budding prognostic technique for muscle-invasive bladder cancer.
    Nat Rev Urol. 2019 Apr 26. pii: 10.1038/s41585-019-0187.
    Abstract     Related articles   

  559. JHA S, Mitra S, Adhya AK, Nayak P, et al
    Urothelial carcinoma with villoglandular differentiation (UCVGD) with small cell neuroendocrine carcinoma of urinary bladder.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  560. NGWESO S, Mukhtar S, Forrest C, Mander J, et al
    Rare case of bladder chondroma causing lower urinary tract symptoms.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  561. LI G, Lei Q, Wang F, Deng D, et al
    Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer.
    Small. 2019 May 10:e1900936. doi: 10.1002/smll.201900936.
    Abstract     Related articles   

  562. NUMMI A, Jarvinen R, Sairanen J, Huotari K, et al
    A retrospective study on tolerability and complications of bacillus Calmette-Guerin (BCG) instillations for non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 May 10:1-7. doi: 10.1080/21681805.2019.1609080.
    Abstract     Related articles   

  563. ZHUANG C, Huang X, Yu J, Gui Y, et al
    Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1.
    BMB Rep. 2019 May 10. pii: 4552.
    Abstract     Related articles   

  564. ZHU J, Xu C, Ruan L, Wu J, et al
    MicroRNA-146b Overexpression Promotes Human Bladder Cancer Invasion via Enhancing ETS2-Mediated mmp2 mRNA Transcription.
    Mol Ther Nucleic Acids. 2019;16:531-542.
    Abstract     Related articles   

  565. SUN W, Li S, Yu Y, Jin H, et al
    MicroRNA-3648 Is Upregulated to Suppress TCF21, Resulting in Promotion of Invasion and Metastasis of Human Bladder Cancer.
    Mol Ther Nucleic Acids. 2019;16:519-530.
    Abstract     Related articles   

  566. CONG L, Yang Q, Hu C, Yu Q, et al
    Current Status of Functional Studies on Circular RNAs in Bladder Cancer and their Potential Role as Diagnostic and Prognostic Biomarkers: A Review.
    Med Sci Monit. 2019;25:3425-3434.
    Abstract     Related articles   

  567. ZHANG Z, Qin H, Jiang B, Chen W, et al
    miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.
    J Cell Biochem. 2019 May 8. doi: 10.1002/jcb.28866.
    Abstract     Related articles   

  568. BORCOMAN E, De La Rochere P, Richer W, Vacher S, et al
    Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer.
    Oncoimmunology. 2019;8:e1581556.
    Abstract     Related articles   

  569. ZHAOJIE L, Yuchen L, Miao C, Yacun C, et al
    Gelsolin-like actin-capping protein has prognostic value and promotes tumorigenesis and epithelial-mesenchymal transition via the Hippo signaling pathway in human bladder cancer.
    Ther Adv Med Oncol. 2019;11:1758835919841235.
    Abstract     Related articles   

  570. GUO CC, Majewski T, Zhang L, Yao H, et al
    Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
    Cell Rep. 2019;27:1781-1793.
    Abstract     Related articles   

  571. CLERIGO V, Castro A, Mourato T, Gomes C, et al
    A Rare Case of Granulomatous Pneumonitis Due to Intravesical BCG for Bladder Cancer.
    Acta Med Port. 2019;32:316-320.
    Abstract     Related articles   

  572. TSUJINO T, Sugito N, Taniguchi K, Honda R, et al
    MiR-143/MSI2/KRAS Cascade Contributes Positively to Carcinogenesis in Human Bladder Cancer.
    Cancer Sci. 2019 May 7. doi: 10.1111/cas.14035.
    Abstract     Related articles   

  573. ZHU W, Liu H, Wang X, Lu J, et al
    Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
    Pathol Res Pract. 2019 Apr 29:152429. doi: 10.1016/j.prp.2019.
    Abstract     Related articles   

  574. SORENBY A, Baseckas G, Bendahl PO, Brandstedt J, et al
    Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients.
    Scand J Urol. 2019 May 8:1-7. doi: 10.1080/21681805.2019.1604568.
    Abstract     Related articles   

  575. KRISHNATREYA M
    Gall bladder cancer in Delhi - some thoughts.
    Indian J Cancer. 2019;56:182.
    Abstract     Related articles   

  576. FARHOOD B, Raei B, Ameri H, Shirvani M, et al
    A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.
    Contemp Oncol (Pozn). 2019;23:7-15.
    Abstract     Related articles   

  577. LYON TD, Frank I, Takahashi N, Boorjian SA, et al
    Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Mar 25. pii: S1558-7673(19)30102.
    Abstract     Related articles   

  578. HU X, Guo Z, Xu J, Mei X, et al
    Role of feline sarcomarelated protein in the viability and apoptosis of bladder cancer cells.
    Mol Med Rep. 2019 Apr 30. doi: 10.3892/mmr.2019.10204.
    Abstract     Related articles   

  579. BEN FRADJ MK, Mrad Dali K, Kallel A, Bibi M, et al
    Interaction Effects of Plasma Vitamins A, E, D, B9, and B12 and Tobacco Exposure in Urothelial Bladder Cancer: A Multifactor Dimensionality Reduction Analysis.
    Nutr Cancer. 2019 May 6:1-8. doi: 10.1080/01635581.2019.1609531.
    Abstract     Related articles   

  580. ABBAS W, Goel V, Verma A, Gupta VG, et al
    Harnessing the Immunomodulatory Effects of Radiation in Urinary Bladder Cancer.
    Cureus. 2019;11:e4108.
    Abstract     Related articles   

  581. ABDOLMALEKI F, Ghafoui-Fard S, Taheri M, Mordadi A, et al
    Expression analysis of a panel of long non-coding RNAs (lncRNAs) revealed their potential as diagnostic biomarkers in bladder cancer.
    Genomics. 2019 May 2. pii: S0888-7543(19)30012.
    Abstract     Related articles   

  582. MACLEOD LC, Yabes JG, Yu M, Fam MM, et al
    Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
    Urol Oncol. 2019 Apr 30. pii: S1078-1439(19)30139.
    Abstract     Related articles   

  583. KRAFFT U, Tschirdewahn S, Hess J, Harke NN, et al
    Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.
    Urol Oncol. 2019 Apr 30. pii: S1078-1439(19)30148.
    Abstract     Related articles   

  584. RUI X, Gu TT, Pan HF, Zhang HZ, et al
    Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis.
    Int Immunopharmacol. 2019;67:378-385.
    Abstract     Related articles   

  585. SUN P, Wu T, Sun X, Cui Z, et al
    KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
    Biomed Pharmacother. 2019;115:108924.
    Abstract     Related articles   

  586. AKAND M, Muilwijk T, Raskin Y, De Vrieze M, et al
    Quality Control Indicators for Transurethral Resection of Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Apr 19. pii: S1558-7673(19)30140.
    Abstract     Related articles   

  587. AGREDA CASTANEDA F, Raventos Busquets CX, Morote Robles J
    Urinary markers in the surveillance of non-muscle invasive bladder cancer. A literature review.
    Actas Urol Esp. 2019 May 13. pii: S0210-4806(19)30041.
    Abstract     Related articles   

  588. ALMEIDA TC, Guerra CCC, Assis BLG, Soares RDOA, et al
    Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status.
    Environ Mol Mutagen. 2019 May 16. doi: 10.1002/em.22297.
    Abstract     Related articles   

  589. SHEN T, Yang L, Zhang Z, Yu J, et al
    KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
    Dis Markers. 2019;2019:4863182.
    Abstract     Related articles   

  590. WASHINGTON SL, Neuhaus J, Meng MV, Porten SP, et al
    Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 May 15. pii: 1055-9965.EPI-18-1280.
    Abstract     Related articles   

  591. BOLENZ C, Hautmann RE
    [Surgical treatment of bladder cancer: advances made in the past 50 years].
    Aktuelle Urol. 2019 May 15. doi: 10.1055/a-0884-2792.
    Abstract     Related articles   

  592. ZHU Z, Wang X, Wang J, Wang S, et al
    Preoperative predictors of early death risk in bladder cancer patients treated with robot-assisted radical cystectomy.
    Cancer Med. 2019 May 15. doi: 10.1002/cam4.2237.
    Abstract     Related articles   

  593. LEE YH, Tuyet PT
    Synthesis and biological evaluation of quercetin-zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells.
    In Vitro Cell Dev Biol Anim. 2019 May 14. pii: 10.1007/s11626-019-00363.
    Abstract     Related articles   

  594. MA JY, Hu G, Liu Q
    Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals.
    Dis Markers. 2019;2019:7593560.
    Abstract     Related articles   

  595. XU Y, Kim YH, Jeong P, Piao XM, et al
    Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Apr 9. pii: S1558-7673(19)30012.
    Abstract     Related articles   

  596. GARRY EM, Buse JB, Gokhale M, Lund JL, et al
    Study Design Choices for Evaluating Comparative Safety of Diabetic Medications: An Evaluation of Pioglitazone and Bladder Cancer Risk Among Older US Adults with Type-2 Diabetes.
    Diabetes Obes Metab. 2019 May 14. doi: 10.1111/dom.13774.
    Abstract     Related articles   

  597. TYRITZIS SI, Gaya JM, Wallestedt-Lantz A, Pini G, et al
    Current role of robotic bladder cancer surgery.
    Minerva Urol Nefrol. 2019 May 7. pii: S0393-2249.19.03435.
    Abstract     Related articles   

  598. WU YJ, Su TR, Dai GF, Su JH, et al
    Flaccidoxide-13-Acetate-Induced Apoptosis in Human Bladder Cancer Cells is through Activation of p38/JNK, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress Regulated Pathway.
    Mar Drugs. 2019;17.
    Abstract     Related articles   

  599. LUO F, Ma C, Wu J, Li J, et al
    Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Nonmuscle-Invasive Bladder Cancer Treated with GreenLight Laser Vaporization.
    Photobiomodul Photomed Laser Surg. 2019;37:312-317.
    Abstract     Related articles   

  600. LI J, Wang F, Gao H, Huang S, et al
    ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
    J Cell Biochem. 2019 May 13. doi: 10.1002/jcb.28642.
    Abstract     Related articles   

  601. SORIA F, Mosca A, Gontero P
    Drug strategies for bladder cancer in the elderly: is there promise for the future?
    Expert Opin Pharmacother. 2019 May 13:1-10. doi: 10.1080/14656566.2019.1615055.
    Abstract     Related articles   

  602. MELEIS L, Moore R, Inman BA, Harrison MR, et al
    Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer.
    J Oncol Pharm Pract. 2019 May 12:1078155219845434. doi: 10.1177/1078155219845434
    Abstract     Related articles   

  603. CHEN J, Miranda G, Cai J, Daneshmand S, et al
    Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy.
    Scand J Urol. 2019 May 13:1-6. doi: 10.1080/21681805.2019.1613445.
    Abstract     Related articles   

  604. XIE Y, Li P, Gao Y, Gu L, et al
    Correction: Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2019;10:2657.
    Abstract     Related articles   

  605. PANDEY S, Garg RK, Malhotra HS, Uniyal R, et al
    Atypical frontal lobe seizure as the first manifestation of gall-bladder cancer: a case report.
    BMC Neurol. 2019;19:95.
    Abstract     Related articles   

  606. LONG X, Xiong W, Zeng X, Qi L, et al
    Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERbeta/Bcl-2 signalling.
    Cell Death Dis. 2019;10:375.
    Abstract     Related articles   

  607. WESTHOFF E, Kampman E, Aben KK, Hendriks IG, et al
    Low awareness, adherence, and practice but positive attitudes regarding lifestyle recommendations among non-muscle-invasive bladder cancer patients.
    Urol Oncol. 2019 May 8. pii: S1078-1439(19)30149.
    Abstract     Related articles   

  608. NAZEMI A, Ghodoussipour S, Pearce S, Bhanvadia S, et al
    Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer.
    Urol Oncol. 2019 May 8. pii: S1078-1439(19)30154.
    Abstract     Related articles   

  609. HAYASHI Y, Fujita K, Matsuzaki K, Matsushita M, et al
    Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
    Cancer Sci. 2019;110:1771-1779.
    Abstract     Related articles   

  610. KOGUCHI D, Matsumoto K, Ikeda M, Taoka Y, et al
    Histologic variants associated with biological aggressiveness and poor prognosis in patients treated with radical cystectomy.
    Jpn J Clin Oncol. 2019;49:373-378.
    Abstract     Related articles   

  611. ANWAR T, Malm-Buatsi E
    Propranolol as an effective therapy for infantile haemangioma of the urinary bladder.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  612. JUNG M, Lee JH, Kim B, Park JH, et al
    Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  613. PEREIRA R, McGeorge S, Perera M, Vela I, et al
    Urachal Mucinous Cystadenocarcinoma.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  614. BAGHDADI A, Hussein AA, Ahmed Y, Cavuoto LA, et al
    A computer vision technique for automated assessment of surgical performance using surgeons' console-feed videos.
    Int J Comput Assist Radiol Surg. 2019;14:697-707.
    Abstract     Related articles   

  615. LI JR, Chiu KY, Ou YC, Wang SS, et al
    Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.
    Biofactors. 2019;45:62-68.
    Abstract     Related articles   

  616. FISCHER-VALUCK BW, Michalski JM, Mitra N, Christodouleas JP, et al
    Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.
    Cancer Med. 2019 May 22. doi: 10.1002/cam4.2102.
    Abstract     Related articles   

  617. GIL D, Zarzycka M, Dulinska-Litewka J, Ciolczyk-Wierzbicka D, et al
    Dihydrotestosterone increases the risk of bladder cancer in men.
    Hum Cell. 2019 May 22. pii: 10.1007/s13577-019-00255.
    Abstract     Related articles   

  618. WANG C, Zhu X, Li A, Yang S, et al
    S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway.
    Cancer Manag Res. 2019;11:2449-2456.
    Abstract     Related articles   

  619. FLAIG TW
    NCCN Guidelines Updates: Management of Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2019;17.
    Abstract     Related articles   

  620. LI B, Xie D, Zhang H
    Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer.
    Cancer Chemother Pharmacol. 2019 May 21. pii: 10.1007/s00280-019-03873.
    Abstract     Related articles   

  621. ZHAO X, Wang D, Ding Y, Zhou J, et al
    lncRNA ZEB1-AS1 promotes migration and metastasis of bladder cancer cells by post-transcriptional activation of ZEB1.
    Int J Mol Med. 2019 May 8. doi: 10.3892/ijmm.2019.4187.
    Abstract     Related articles   

  622. NAKAHARA K, Yamasaki K, Nagai T, Fujii M, et al
    Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis.
    Res Rep Urol. 2019;11:97-104.
    Abstract     Related articles   

  623. MAURYA N, Singh R, Goel A, Singhai A, et al
    Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3beta/ beta-catenin in urinary bladder cancer patients.
    World J Clin Oncol. 2019;10:166-182.
    Abstract     Related articles   

  624. SHI MJ, Meng XY, Wu QJ, Zhou XH, et al
    High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer.
    Cancer Manag Res. 2019;11:2987-2995.
    Abstract     Related articles   

  625. HAN C, Ma T, Lei D, Xie S, et al
    Effect of ultrasound-guided proximal and distal approach for obturator nerve block in transurethral resection of bladder cancer under spinal anesthesia.
    Cancer Manag Res. 2019;11:2499-2505.
    Abstract     Related articles   

  626. XU X, Zhang G, He L, Zhu Y, et al
    Clinicopathological impacts of c-Met overexpression in bladder cancer: evidence from 1,336 cases.
    Onco Targets Ther. 2019;12:2695-2702.
    Abstract     Related articles   

  627. KROCHMAL M, van Kessel KEM, Zwarthoff EC, Belczacka I, et al
    Urinary peptide panel for prognostic assessment of bladder cancer relapse.
    Sci Rep. 2019;9:7635.
    Abstract     Related articles   

  628. SANCAR F
    Precision Approach to Bladder Cancer.
    JAMA. 2019;321:1862.
    Abstract     Related articles   

  629. KONG J, Diao X, Diao F, Fan X, et al
    Causes of death in long-term bladder cancer survivors: A population-based study.
    Asia Pac J Clin Oncol. 2019 May 20. doi: 10.1111/ajco.13156.
    Abstract     Related articles   

  630. WAINGANKAR N, Jia R, Marqueen KE, Audenet F, et al
    The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer.
    Urol Oncol. 2019 May 18. pii: S1078-1439(19)30160.
    Abstract     Related articles   

  631. BURDEN S, Billson HA, Lal S, Owen KA, et al
    Perioperative nutrition for the treatment of bladder cancer by radical cystectomy.
    Cochrane Database Syst Rev. 2019;5:CD010127.
    Abstract     Related articles   

  632. HUANG J, Shiao SL, Furuya H, Rosser CJ, et al
    Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the Literature.
    J Immunother. 2019 May 15. doi: 10.1097/CJI.0000000000000269.
    Abstract     Related articles   

  633. WU SC, Kwon D, Jue JS, Chen FV, et al
    Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2019 May 15. pii: S2405-4569(19)30141.
    Abstract     Related articles   

  634. SANKIN A, Chand D, Schoenberg M, Zang X, et al
    Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencing.
    Urol Oncol. 2019 May 15. pii: S1078-1439(19)30144.
    Abstract     Related articles   

  635. SONG D, Powles T, Shi L, Zhang L, et al
    Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches.
    J Pathol. 2019 May 18. doi: 10.1002/path.5306.
    Abstract     Related articles   

  636. STANIK M, Poprach A, Zapletalova M, Krejci D, et al
    Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry.
    Clin Genitourin Cancer. 2019 Apr 16. pii: S1558-7673(19)30133.
    Abstract     Related articles   

  637. DONG W, Bi J, Liu H, Yan D, et al
    Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis.
    Mol Cancer. 2019;18:95.
    Abstract     Related articles   

  638. LORAS A, Suarez-Cabrera C, Martinez-Bisbal MC, Quintas G, et al
    Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  639. BERMEJO LM, Lopez-Plaza B, Santurino C, Cavero-Redondo I, et al
    Milk and Dairy Product Consumption and Bladder Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies.
    Adv Nutr. 2019;10.
    Abstract     Related articles   

  640. FLAUS A, Longo MG, Dematons M, Granjon D, et al
    18F-FDG PET/CT in Urachal Abscess.
    Clin Nucl Med. 2019 Mar 1. doi: 10.1097/RLU.0000000000002524.
    Abstract     Related articles   

  641. BILLGER M, Kirk J, Chang J, Bedard A, et al
    A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Regul Toxicol Pharmacol. 2019;103:166-173.
    Abstract     Related articles   

  642. JOHANSSON VR, von Vogelsang AC
    Patient-reported extremity symptoms after robot-assisted laparoscopic cystectomy.
    J Clin Nurs. 2019;28.
    Abstract     Related articles   

  643. EL RASSY E, Assi T, Bakouny Z, Pavlidis N, et al
    Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder.
    Clin Transl Oncol. 2019;21:280-288.
    Abstract     Related articles   

  644. YU EY, Wesselius A, van Osch F, Stern MC, et al
    The association between coffee consumption and bladder cancer in the bladder cancer epidemiology and nutritional determinants (BLEND) international pooled study.
    Cancer Causes Control. 2019 May 30. pii: 10.1007/s10552-019-01191.
    Abstract     Related articles   

  645. TIAN H, Wang X, Lu J, Tian W, et al
    MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/beta-catenin signaling.
    Chem Biol Interact. 2019 May 27. pii: S0009-2797(19)30587.
    Abstract     Related articles   

  646. JAHNSON S, Gardmark T, Hosseini A, Jerlstrom T, et al
    Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe).
    Scand J Urol. 2019 May 30:1-6. doi: 10.1080/21681805.2019.1621377.
    Abstract     Related articles   

  647. POLI G, Egidi MG, Cochetti G, Brancorsini S, et al
    Relationship between cellular and exosomal miRNAs targeting NOD-like receptors in bladder cancer: preliminary results.
    Minerva Urol Nefrol. 2019 May 28. pii: S0393-2249.19.03297.
    Abstract     Related articles   

  648. DUMONT C, Gauthier H, Bonnet C, Culine S, et al
    Understanding chemotherapy-induced changes in bladder cancer biology: a necessary step towards tailored treatment in cisplatin-refractory disease.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  649. JOSHI M, Warrick JI, Yin M, Holder SL, et al
    Need for a personalized approach for muscle invasive bladder cancer: role of tumor biology in response to neoadjuvant chemotherapy.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  650. VANDERWEELE DJ, Meeks JJ, Hussain M
    Can post-neoadjuvant therapy molecular classification guide future treatment selection for muscle-invasive bladder cancer?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  651. LI Q, Zhang P, Wang Y, Zhang Y, et al
    Association between AXIN1 Gene Polymorphisms and Bladder Cancer in Chinese Han Population.
    Dis Markers. 2019;2019:3949343.
    Abstract     Related articles   

  652. ZHOU ZF, Fang JB, Chen L, Wang HF, et al
    Effects of intraoperative PEEP on postoperative pulmonary complications in patients undergoing robot-assisted laparoscopic radical resection for bladder cancer or prostate cancer: study protocol for a randomized controlled trial.
    Trials. 2019;20:304.
    Abstract     Related articles   

  653. YOSHIDA K, Tsuda M, Matsumoto R, Semba S, et al
    Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
    Cancer Sci. 2019 May 29. doi: 10.1111/cas.14080.
    Abstract     Related articles   

  654. BUCKWALTER JM, Chan W, Shuman L, Wildermuth T, et al
    Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  655. GARG M, Singh R
    Epithelial-to-mesenchymal transition: Event and core associates in bladder cancer.
    Front Biosci (Elite Ed). 2019;11:150-165.
    Abstract     Related articles   

  656. YAN X, Liu XP, Guo ZX, Liu TZ, et al
    Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer.
    Front Genet. 2019;10:408.
    Abstract     Related articles   

  657. WANG Y, Chang A, Tan WP, Fantony JJ, et al
    Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer.
    Eur Urol Oncol. 2019 May 25. pii: S2588-9311(19)30061.
    Abstract     Related articles   

  658. YUAN W, Zhou R, Wang J, Han J, et al
    Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
    Mol Oncol. 2019 May 26. doi: 10.1002/1878-0261.12523.
    Abstract     Related articles   

  659. CHEN L, Xiong W, Guo W, Su S, et al
    Significance of CLASP2 expression in prognosis for muscle-invasive bladder cancer patients: A propensity score-based analysis.
    Urol Oncol. 2019 May 23. pii: S1078-1439(19)30189.
    Abstract     Related articles   

  660. LI Z, Li Y, Wang Y
    miR-19a promotes invasion and epithelial to mesenchymal transition of bladder cancer cells by targeting RhoB.
    J BUON. 2019;24:797-804.
    Abstract     Related articles   

  661. LIU X, Zhao W, Wang X, Zhu Y, et al
    Expression of mir-143 in serum of bladder cancer patients and its correlation with clinical features and prognosis.
    J BUON. 2019;24:791-796.
    Abstract     Related articles   

  662. LV WL, Liu Q, An JH, Song XY, et al
    Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells.
    J Cell Physiol. 2019 May 24. doi: 10.1002/jcp.28883.
    Abstract     Related articles   

  663. DI MAIDA F, Mari A, Scalici Gesolfo C, Cangemi A, et al
    Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression.
    Clin Genitourin Cancer. 2019 Apr 26. pii: S1558-7673(19)30134.
    Abstract     Related articles   

  664. WANG X, Lyu J, Ji A, Zhang Q, et al
    Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
    Life Sci. 2019 May 21. pii: S0024-3205(19)30409.
    Abstract     Related articles   

  665. ZHU H, Chen H, Wang J, Zhou L, et al
    Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer.
    Onco Targets Ther. 2019;12:3441-3457.
    Abstract     Related articles   

  666. VARUGHESE M, Treece S, Drinkwater KJ
    Radiotherapy Management of Muscle Invasive Bladder Cancer: Evaluation of a National Cohort.
    Clin Oncol (R Coll Radiol). 2019 May 20. pii: S0936-6555(19)30184.
    Abstract     Related articles   

  667. SHI G, Liu Q, Chen H, Feng F, et al
    Percutaneous osteoplasty for the management of a humeral head metastasis: Two case reports.
    Medicine (Baltimore). 2019;98:e15727.
    Abstract     Related articles   

  668. KOYANAGI Y, Kubo C, Nagata S, Ryu A, et al
    Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.
    Diagn Pathol. 2019;14:9.
    Abstract     Related articles   

  669. GOFRIT ON, Bercovier H, Klein BY, Cohen IR, et al
    Can immunization with Bacillus Calmette-Guerin (BCG) protect against Alzheimer's disease?
    Med Hypotheses. 2019;123:95-97.
    Abstract     Related articles   

  670. ITANO N
    Implications of altered O-glycosylation in tumour immune evasion.
    J Biochem. 2019;165:387-390.
    Abstract     Related articles   

  671. FILICE FP, Ding Z
    Analysing single live cells by scanning electrochemical microscopy.
    Analyst. 2019;144:738-752.
    Abstract     Related articles   

  672. MATSUURA H, Arase S, Hori Y
    Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Int J Clin Oncol. 2019;24:306-312.
    Abstract     Related articles   

  673. KOO CH, Chung SH, Kim BG, Min BH, et al
    Comparison between the effects of deep and moderate neuromuscular blockade during transurethral resection of bladder tumor on endoscopic surgical condition and recovery profile: a prospective, randomized, and controlled trial.
    World J Urol. 2019;37:359-365.
    Abstract     Related articles   

  674. VARTOLOMEI MD, Iwata T, Roth B, Kimura S, et al
    Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2019 Jun 6. pii: 10.1007/s00345-019-02825.
    Abstract     Related articles   

  675. JACYNA J, Wawrzyniak R, Balayssac S, Gilard V, et al
    Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach.
    Talanta. 2019;202:572-579.
    Abstract     Related articles   

  676. RYBICKI F JR, Glanc P
    Patient-Friendly Summary of the ACR Appropriateness Criteria: Pretreatment Staging of Muscle-Invasive Bladder Cancer.
    J Am Coll Radiol. 2019;16:e25.
    Abstract     Related articles   

  677. LIU L, Wu SQ, Zhu X, Xu R, et al
    Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer.
    Neoplasma. 2019;2019.
    Abstract     Related articles   

  678. LIU L, Wu SQ, Zhu X, Xu R, et al
    Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer.
    Neoplasma. 2019;2019.
    Abstract     Related articles   

  679. JUENGEL E, Natsheh I, Najafi R, Rutz J, et al
    Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  680. TIAN Z, Luo Y, Zhu J, Hua X, et al
    Transcriptionally elevation of miR-494 by new ChlA-F compound via a HuR/JunB axis inhibits human bladder cancer cell invasion.
    Biochim Biophys Acta Gene Regul Mech. 2019 Jun 2. pii: S1874-9399(19)30018.
    Abstract     Related articles   

  681. WILLIAMS SB, Shan Y, Ray-Zack MD, Hudgins HK, et al
    Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
    JAMA Surg. 2019 Jun 5:e191629. doi: 10.1001/jamasurg.2019.1629.
    Abstract     Related articles   

  682. COLE AP, Trinh QD
    Trimodal Therapy for Bladder Cancer: You Get What You Don't Pay for.
    JAMA Surg. 2019 Jun 5:e191637. doi: 10.1001/jamasurg.2019.1637.
    Abstract     Related articles   

  683. PAK S, You D, Jeong IG, Song C, et al
    Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.
    Sci Rep. 2019;9:8305.
    Abstract     Related articles   

  684. LU BS, Yin YW, Zhang YP, Guo PY, et al
    Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA.
    Cancer Cell Int. 2019;19:149.
    Abstract     Related articles   

  685. KORPAL M, Puyang X, Wu ZJ, Seiler R, et al
    Author Correction: Evasion of immunosurveillance by genomic alterations of PPARgamma/RXRalpha in bladder cancer.
    Nat Commun. 2019;10:2527.
    Abstract     Related articles   

  686. HUANG J, Lo UG, Wu S, Wang B, et al
    The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
    Cell Death Dis. 2019;10:437.
    Abstract     Related articles   

  687. AYDIN M, Bitkin A, Kadihasanoglu M, Irkilata L, et al
    Correlation of neutrophil-lymphocyte ratio and risk scores in non-muscle invasive bladder cancer.
    Actas Urol Esp. 2019 Jun 1. pii: S0210-4806(19)30073.
    Abstract     Related articles   

  688. DUPLISEA JJ, Dinney CPN
    Should chemotherapy still be used to treat all muscle invasive bladder cancer in the "era of immunotherapy"?
    Expert Rev Anticancer Ther. 2019 Jun 5:1-3. doi: 10.1080/14737140.2019.1625773.
    Abstract     Related articles   

  689. SHIGEMATSU Y, Oue N, Sekino Y, Sakamoto N, et al
    SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival.
    Pathobiology. 2019 Jun 4:1-9. doi: 10.1159/000497206.
    Abstract     Related articles   

  690. LI G, Zhang Y, Mao J, Hu P, et al
    lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer.
    J Cell Biochem. 2019 Jun 4. doi: 10.1002/jcb.29104.
    Abstract     Related articles   

  691. HERNANDEZ-PRAT A, Rodriguez-Vida A, Juanpere-Rodero N, Arpi O, et al
    Novel oral mTORC1/2 inhibitor TAK-228 has synergistic antitumor effects when combined with paclitaxel or PI3Kalpha inhibitor TAK-117 in preclinical bladder cancer models.
    Mol Cancer Res. 2019 Jun 3. pii: 1541-7786.MCR-18-0923.
    Abstract     Related articles   

  692. MAEDA S, Murakami K, Inoue A, Yonezawa T, et al
    CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer.
    Cancer Immunol Res. 2019 Jun 3. pii: 2326-6066.CIR-18-0751.
    Abstract     Related articles   

  693. CARNEIRO BDB, Sanches BCF, Andrade DL, Voris BRI, et al
    Moreau Strain Bacillus Calmette-Guerin Low Versus Standard Dose in the Treatment of High-Grade T1 Bladder Cancer: A Retrospective Observational Cohort Study.
    Clin Genitourin Cancer. 2019 Apr 16. pii: S1558-7673(19)30129.
    Abstract     Related articles   

  694. BLINOVA E, Roshchin D, Kogan E, Samishina E, et al
    Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment.
    Cells. 2019;8.
    Abstract     Related articles   

  695. TRENTI E, D'Elia C, Mian C, Schwienbacher C, et al
    Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
    Cancer Cytopathol. 2019 Jun 2. doi: 10.1002/cncy.22152.
    Abstract     Related articles   

  696. BOCHENEK K, Aebisher D, Miedzybrodzka A, Cieslar G, et al
    Methods of bladder cancer diagnostics - the role of autofluorescence and photodynamic diagnosis.
    Photodiagnosis Photodyn Ther. 2019 May 29. pii: S1572-1000(19)30126.
    Abstract     Related articles   

  697. THUENER JE
    Urologic Malignancies.
    Prim Care. 2019;46:275-285.
    Abstract     Related articles   

  698. HOLLAND BC, Sood A, Delfino K, Dynda DI, et al
    Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy.
    Cancer Immunol Immunother. 2019;68:991-997.
    Abstract     Related articles   

  699. TSUI KH, Hou CP, Chang KS, Lin YH, et al
    Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  700. TSE J, Ghandour R, Singla N, Lotan Y, et al
    Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  701. LAMBERT E, D'Hondt F, Mazzone E, Vollemaere J, et al
    Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.
    Eur Urol Focus. 2019 Jun 11. pii: S2405-4569(19)30152.
    Abstract     Related articles   

  702. WEINER AB, Desai AS, Meeks JJ
    Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study.
    Eur Urol Oncol. 2019;2:304-310.
    Abstract     Related articles   

  703. RUAN JL, Hsu JW, Browning RJ, Stride E, et al
    Mouse Models of Muscle-invasive Bladder Cancer: Key Considerations for Clinical Translation Based on Molecular Subtypes.
    Eur Urol Oncol. 2019;2:239-247.
    Abstract     Related articles   

  704. MAN X, Piao C, Lin X, Kong C, et al
    USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
    J Exp Clin Cancer Res. 2019;38:259.
    Abstract     Related articles   

  705. HAU AM, Gupta S, Leivo MZ, Nakashima K, et al
    Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells.
    Am J Pathol. 2019 Jun 11. pii: S0002-9440(19)30079.
    Abstract     Related articles   

  706. YAMADA Y, Kato M, Arai T, Sanada H, et al
    Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target.
    Mol Oncol. 2019 Jun 14. doi: 10.1002/1878-0261.12532.
    Abstract     Related articles   

  707. LIU X, Wu Y, Zhou Z, Huang M, et al
    Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis.
    Int J Mol Med. 2019 Jun 12. doi: 10.3892/ijmm.2019.4241.
    Abstract     Related articles   

  708. SONG YP, McWilliam A, Hoskin PJ, Choudhury A, et al
    Organ preservation in bladder cancer: an opportunity for truly personalized treatment.
    Nat Rev Urol. 2019 Jun 13. pii: 10.1038/s41585-019-0199.
    Abstract     Related articles   

  709. ZHANG P, Zhang Y, Liu W, Cui D, et al
    A Molecular Beacon Based Surface-Enhanced Raman Scattering Nanotag for Noninvasive Diagnosis of Bladder Cancer.
    J Biomed Nanotechnol. 2019;15:1589-1597.
    Abstract     Related articles   

  710. QIN MM, Chai X, Huang HB, Feng G, et al
    let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1.
    BMC Urol. 2019;19:53.
    Abstract     Related articles   

  711. GRUNEWALD CM, Niegisch G
    [Personalised medicine in urothelial bladder cancer].
    Aktuelle Urol. 2019 Jun 13. doi: 10.1055/a-0927-6725.
    Abstract     Related articles   

  712. ISLAM MO, Bacchetti T, Ferretti G
    Alterations of Antioxidant Enzymes and Biomarkers of Nitro-oxidative Stress in Tissues of Bladder Cancer.
    Oxid Med Cell Longev. 2019;2019:2730896.
    Abstract     Related articles   

  713. YANG Y, Zhang G, Li C, Wang S, et al
    Metabolic profile and structure-activity relationship of resveratrol and its analogs in human bladder cancer cells.
    Cancer Manag Res. 2019;11:4631-4642.
    Abstract     Related articles   

  714. WANG SS, Chen G, Li SH, Pang JS, et al
    Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients.
    Onco Targets Ther. 2019;12:3695-3712.
    Abstract     Related articles   

  715. CAO Z, Xu L, Zhao S, Zhu X, et al
    The functions of microRNA-124 on bladder cancer.
    Onco Targets Ther. 2019;12:3429-3439.
    Abstract     Related articles   

  716. XU N, Qu GY, Wu YP, Lin YZ, et al
    ARPC4 promotes bladder cancer cell invasion and is associated with lymph node metastasis.
    J Cell Biochem. 2019 Jun 12. doi: 10.1002/jcb.29136.
    Abstract     Related articles   

  717. STEWART TF, Petrylak DP
    Atezolizumab in understudied populations with bladder cancer.
    Nat Rev Urol. 2019 Jun 11. pii: 10.1038/s41585-019-0200.
    Abstract     Related articles   

  718. XIONG YQ, Tan J, Liu YM, Li YZ, et al
    Diagnostic accuracy of optical coherence tomography for the diagnosis of bladder cancer: A systematic review and meta-analysis.
    Photodiagnosis Photodyn Ther. 2019 Jun 8. pii: S1572-1000(19)30134.
    Abstract     Related articles   

  719. KOUHSAR M, Azimzadeh Jamalkandi S, Moeini A, Masoudi-Nejad A, et al
    Detection of novel biomarkers for early detection of Non-Muscle-Invasive Bladder Cancer using Competing Endogenous RNA network analysis.
    Sci Rep. 2019;9:8434.
    Abstract     Related articles   

  720. QIU J, Zeng FR, Fang Y, Li J, et al
    Increased miR-323a induces bladder cancer cell apoptosis by suppressing c-Met.
    Kaohsiung J Med Sci. 2019 Jun 10. doi: 10.1002/kjm2.12091.
    Abstract     Related articles   

  721. CAO Z, Peng L, He K, Wang X, et al
    Value of quantitative and qualitative analyses of serum and urine cell-free DNA as diagnostic tools for bladder cancer: a meta-analysis.
    Expert Rev Anticancer Ther. 2019 Jun 10. doi: 10.1080/14737140.2019.1626723.
    Abstract     Related articles   

  722. SELL V, Ettala O, Montoya Perez I, Jarvinen R, et al
    Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial.
    World J Urol. 2019 Jun 8. pii: 10.1007/s00345-019-02841.
    Abstract     Related articles   

  723. MAO W, Luo M, Huang X, Wang Q, et al
    Knockdown of Lumican Inhibits Proliferation and Migration of Bladder Cancer.
    Transl Oncol. 2019;12:1072-1078.
    Abstract     Related articles   

  724. LIU X, Jiang J, Yu C, Wang Y, et al
    Secular trends in incidence and mortality of bladder cancer in China, 1990-2017: A joinpoint and age-period-cohort analysis.
    Cancer Epidemiol. 2019;61:95-103.
    Abstract     Related articles   

  725. MA QY, Li SY, Li XZ, Zhou TF, et al
    Long non-coding RNA DILC suppresses bladder cancer cells progression.
    Gene. 2019;710:193-201.
    Abstract     Related articles   

  726. SCHULZ GB, Grimm T, Sers C, Riemer P, et al
    Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
    Urol Oncol. 2019 Jun 5. pii: S1078-1439(19)30197.
    Abstract     Related articles   

  727. MOHAMED N, Leung TM, Shah QN, Pisipati S, et al
    Involving Patients in the Development and Evaluation of an Educational and Training Experiential Intervention (ETEI) to Improve Muscle Invasive Bladder Cancer Treatment Decision-making and Post-operative Self-care: a Mixed Methods Approach.
    J Cancer Educ. 2019 Jun 7. pii: 10.1007/s13187-019-01534.
    Abstract     Related articles   

  728. SCHULZ GB, Schlenker B, Stief CG
    [Aftercare of non-muscle invasive bladder cancer].
    Urologe A. 2019 Jun 7. pii: 10.1007/s00120-019-0956.
    Abstract     Related articles   

  729. VIDOTTO T, Nersesian S, Graham C, Siemens DR, et al
    DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.
    J Immunother Cancer. 2019;7:148.
    Abstract     Related articles   

  730. RUSSELL B, Sherif A, Haggstrom C, Josephs D, et al
    Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival.
    Scand J Urol. 2019 Jun 7:1-7. doi: 10.1080/21681805.2019.1624611.
    Abstract     Related articles   

  731. NIELSEN N, Wrist Lam G, Fabrin K, Holt P, et al
    Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy.
    Scand J Urol. 2019 Jun 7:1-4. doi: 10.1080/21681805.2019.1624608.
    Abstract     Related articles   

  732. LEE YC, Kurtova AV, Xiao J, Nikolos F, et al
    Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung.
    Nat Commun. 2019;10:2131.
    Abstract     Related articles   

  733. JIAO J, Wang W, Guang H, Lin H, et al
    2,4,5-Trichloro-6-((2,4,6-trichlorophenyl)amino)isophthalonitrile, Exerts Anti-bladder Activities through IGF-1R/STAT3 Signaling.
    Chem Pharm Bull (Tokyo). 2019;67:410-418.
    Abstract     Related articles   

  734. KANG H, Kim DH, Lee W, Ha J, et al
    First Case of Cellular Cannibalism in Small-Cell Carcinoma of the Bladder Detected in Peripheral Blood.
    Ann Lab Med. 2019;39:400-402.
    Abstract     Related articles   

  735. SU H, Tao T, Yang Z, Kang X, et al
    Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
    Mol Cancer. 2019;18:27.
    Abstract     Related articles   

  736. GHALLEB M, Ayadi MA, Slim S, Zemni I, et al
    Multiple cutaneous metastasis of synchronous urothelial carcinoma of the bladder and the renal pelvis: a case report.
    J Med Case Rep. 2019;13:34.
    Abstract     Related articles   

  737. TSUBOI M, Sakai K, Maeda S, Chambers JK, et al
    Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder.
    Vet Pathol. 2019;56:369-376.
    Abstract     Related articles   

  738. WANG J, Wang G, Shan H, Wang X, et al
    Gradiently degraded electrospun polyester scaffolds with cytostatic for urothelial carcinoma therapy.
    Biomater Sci. 2019;7:963-974.
    Abstract     Related articles   

  739. SANGUEDOLCE F, Russo D, Mancini V, Selvaggio O, et al
    Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review.
    Int J Surg Pathol. 2019;27:120-133.
    Abstract     Related articles   

  740. LUO J, Lou Z, Zheng J
    Targeted regulation by ROCK2 on bladder carcinoma via Wnt signaling under hypoxia.
    Cancer Biomark. 2019;24:109-116.
    Abstract     Related articles   

  741. NOMURA M, Matsumoto K, Shimizu Y, Ikeda M, et al
    TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy.
    Cancer Biomark. 2019;24:91-96.
    Abstract     Related articles   

  742. VASDEV N, Zargar H, Noel JP, Veeratterapillay R, et al
    Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
    World J Urol. 2019;37:165-172.
    Abstract     Related articles   

  743. BHANVADIA S, Kazerouni K, Bazargani ST, Miranda G, et al
    Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy.
    World J Urol. 2019;37:173-179.
    Abstract     Related articles   

  744. LI J, Huang C, Xiong T, Zhuang C, et al
    A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro.
    Int J Biol Sci. 2019;15:1276-1286.
    Abstract     Related articles   

  745. KOUZNETSOVA VL, Kim E, Romm EL, Zhu A, et al
    Recognition of early and late stages of bladder cancer using metabolites and machine learning.
    Metabolomics. 2019;15:94.
    Abstract     Related articles   

  746. LUO Y, Tian Z, Hua X, Huang M, et al
    Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression.
    Cell Mol Life Sci. 2019 Jun 20. pii: 10.1007/s00018-019-03185.
    Abstract     Related articles   

  747. LI F, Zhao H, Su M, Xie W, et al
    HnRNP-F regulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3' UTR.
    EBioMedicine. 2019 Jun 17. pii: S2352-3964(19)30398.
    Abstract     Related articles   

  748. DAVIDSON PJ, McGeoch G, Shand B
    Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy.
    N Z Med J. 2019;132:55-64.
    Abstract     Related articles   

  749. COBAN N, Varol N
    The effect of heat shock protein 90 inhibitors on histone 4 lysine 20 methylation in bladder cancer.
    EXCLI J. 2019;18:195-203.
    Abstract     Related articles   

  750. JIA LH, Hu MD, Liu Y, Xiong X, et al
    HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo.
    Int J Med Sci. 2019;16:654-659.
    Abstract     Related articles   

  751. GUO H, Hou Y, Ding J
    Nanomedicines for Intravesical Chemotherapy in Bladder Cancer.
    Curr Pharm Des. 2019;25:371-373.
    Abstract     Related articles   

  752. RYDER REJ, DeFronzo RA
    Pioglitazone: inexpensive; very effective at reducing HbA1c ; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit.
    Diabet Med. 2019 Jun 18. doi: 10.1111/dme.14053.
    Abstract     Related articles   

  753. SETTI BOUBAKER N, Cicchillitti L, Said R, Gurtner A, et al
    The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.
    Mol Biol Rep. 2019 Jun 18. pii: 10.1007/s11033-019-04920.
    Abstract     Related articles   

  754. CALO B, Chirico M, Fortunato F, Sanguedolce F, et al
    Is Repeat Transurethral Resection Always Needed in High-Grade T1 Bladder Cancer?
    Front Oncol. 2019;9:465.
    Abstract     Related articles   

  755. MASON SJ, Downing A, Wright P, Bottomley SE, et al
    Life and bladder cancer: protocol for a longitudinal and cross-sectional patient-reported outcomes study of Yorkshire (UK) patients.
    BMJ Open. 2019;9:e030850.
    Abstract     Related articles   

  756. LI G, Wang M, Ren L, Li H, et al
    Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-kappaB signaling.
    Biomed Pharmacother. 2019;117:109112.
    Abstract     Related articles   

  757. ANDO T, Watanabe K, Nakayama R, Mizusawa T, et al
    Trousseau's syndrome manifesting as multiple cerebral infarctions caused by bladder cancer.
    Urol Case Rep. 2019;24:100884.
    Abstract     Related articles   

  758. DENSMORE R, Hajizadeh M, Hu M
    Trends in socio-economic inequalities in bladder cancer incidence in Canada: 1992-2010.
    Can J Public Health. 2019 Jun 17. pii: 10.17269/s41997-019-00227.
    Abstract     Related articles   

  759. ACHAM M, Wesselius A, van Osch FHM, Yu EY, et al
    Intake of milk and other dairy products and the risk of bladder cancer: a pooled analysis of 13 cohort studies.
    Eur J Clin Nutr. 2019 Jun 17. pii: 10.1038/s41430-019-0453.
    Abstract     Related articles   

  760. ANGELE CM, Alessandra C, Martina D, Margherita G, et al
    Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells.
    Free Radic Biol Med. 2019 Jun 14. pii: S0891-5849(18)32523.
    Abstract     Related articles   

  761. MASAOKA H, Matsuo K, Oze I, Ito H, et al
    Alcohol drinking and bladder cancer risk from a pooled analysis of ten cohort studies in Japan.
    J Epidemiol. 2019 Jun 15. doi: 10.2188/jea.JE20190014.
    Abstract     Related articles   

  762. LUO Y, Barrios-Rodiles M, Gupta GD, Zhang YY, et al
    Atypical function of a centrosomal module in WNT signalling drives contextual cancer cell motility.
    Nat Commun. 2019;10:2356.
    Abstract     Related articles   

  763. PIETILA M, Sahgal P, Peuhu E, Jantti NZ, et al
    SORLA regulates endosomal trafficking and oncogenic fitness of HER2.
    Nat Commun. 2019;10:2340.
    Abstract     Related articles   

  764. WEI Y, Wang M, Liu H, Niu Y, et al
    Simultaneous determination of seven endogenous aldehydes in human blood by headspace gas chromatography-mass spectrometry.
    J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1118-1119:85-92.
    Abstract     Related articles   

  765. HURST EA, Pang LY, Argyle DJ
    The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels.
    Vet Comp Oncol. 2019;17:194-207.
    Abstract     Related articles   

  766. MAO S, Zhang J, Guo Y, Zhang Z, et al
    Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report.
    Drug Des Devel Ther. 2019;13:291-300.
    Abstract     Related articles   

  767. KATO D, Kawase M, Ishida T, Kato S, et al
    [Investigation of Clinical Outcome and Prognosis of 2nd TUR-Bt for T1 High Grade Bladder Cancer].
    Hinyokika Kiyo. 2019;65:105-109.
    Abstract     Related articles   

  768. HUA X, Huang M, Deng X, Xu J, et al
    The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein.
    Cell Death Differ. 2019 Jun 26. pii: 10.1038/s41418-019-0377.
    Abstract     Related articles   

  769. RETZ M, von Amsberg G, Horn T, Gschwend JE, et al
    [50 years of systemic therapy of urinary bladder cancer].
    Aktuelle Urol. 2019 Jun 26. doi: 10.1055/a-0945-8340.
    Abstract     Related articles   

  770. XIA Y, Kang TW, Jung DY, Zhang C, et al
    Sulforaphane inhibits non-muscle invasive bladder cancer cells proliferation through suppression of HIF-1alpha-mediated glycolysis in hypoxia.
    J Agric Food Chem. 2019 Jun 26. doi: 10.1021/acs.jafc.9b03027.
    Abstract     Related articles   

  771. JIN H, Xue L, Mo L, Zhang D, et al
    Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer.
    Cell Adh Migr. 2019;13:236-248.
    Abstract     Related articles   

  772. REBOLA J, Aguiar P, Blanca A, Montironi R, et al
    Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype.
    Virchows Arch. 2019 Jun 25. pii: 10.1007/s00428-019-02593.
    Abstract     Related articles   

  773. SCHULSTER M
    Bladder Cancer Academy 2019 Selected Summaries.
    Rev Urol. 2019;21:23-28.
    Abstract     Related articles   

  774. SHI X, Chen S, Zhang Y, Xie W, et al
    Norcantharidin inhibits the DDR of bladder cancer stem-like cells through cdc6 degradation.
    Onco Targets Ther. 2019;12:4403-4413.
    Abstract     Related articles   

  775. SUNG JM, Martin JW, Jefferson FA, Sidhom DA, et al
    Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
    Clin Genitourin Cancer. 2019 May 31. pii: S1558-7673(19)30146.
    Abstract     Related articles   

  776. ROUPRET M, Malmstrom PU, Black P
    Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?
    Eur Urol Oncol. 2019 Jun 22. pii: S2588-9311(19)30078.
    Abstract     Related articles   

  777. MITCHELL KA, Williams H
    Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
    Urol Oncol. 2019 Jun 22. pii: S1078-1439(19)30157.
    Abstract     Related articles   

  778. STOJNEV S, Krstic M, Cukuranovic Kokoris J, Conic I, et al
    Prognostic Impact of Canonical TGF-beta Signaling in Urothelial Bladder Cancer.
    Medicina (Kaunas). 2019;55.
    Abstract     Related articles   

  779. ABDEL-RAHMAN O
    Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinoma.
    Future Oncol. 2019 Jun 25. doi: 10.2217/fon-2018-0861.
    Abstract     Related articles   

  780. SCHULPEN M, van den Brandt PA
    Adherence to the Mediterranean diet and risks of prostate and bladder cancer in the Netherlands Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2019 Jun 24. pii: 1055-9965.EPI-19-0224.
    Abstract     Related articles   

  781. HUANG CP, Chen J, Chen CC, Liu G, et al
    ASC-J9(R) increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-kappaB survival signals.
    J Exp Clin Cancer Res. 2019;38:275.
    Abstract     Related articles   

  782. HAYASHIDA Y, Miyata Y, Matsuo T, Ohba K, et al
    A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer.
    BMC Urol. 2019;19:56.
    Abstract     Related articles   

  783. JORDAHL KM, Phipps AI, Randolph TW, Tindle HA, et al
    Differential DNA methylation in blood as a mediator of the association between cigarette smoking and bladder cancer risk among postmenopausal women.
    Epigenetics. 2019 Jun 23:1-9. doi: 10.1080/15592294.2019.1631112.
    Abstract     Related articles   

  784. BLANCA A, Sanchez-Gonzalez A, Requena MJ, Carrasco-Valiente J, et al
    Expression of miR-100 and miR-138 as prognostic biomarkers in Non- Muscle Invasive Bladder Cancer.
    APMIS. 2019 Jun 24. doi: 10.1111/apm.12973.
    Abstract     Related articles   

  785. ZAHOOR H, Mir MC, Barata PC, Stephenson AJ, et al
    Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.
    Invest New Drugs. 2019 Jun 24. pii: 10.1007/s10637-018-00716.
    Abstract     Related articles   

  786. HAN J, Wang JZ, Yang X, Yu H, et al
    METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Mol Cancer. 2019;18:110.
    Abstract     Related articles   

  787. LU Q, Liu T, Feng H, Yang R, et al
    Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.
    Mol Cancer. 2019;18:111.
    Abstract     Related articles   

  788. KRIMPHOVE MJ, Szymaniak J, Marchese M, Tully KH, et al
    Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy.
    Eur Urol Focus. 2019 Jun 18. pii: S2405-4569(19)30156.
    Abstract     Related articles   

  789. ROPERTO S, Russo V, De Falco F, Urraro C, et al
    Bovine papillomavirus E5 oncoprotein expression and its association with an interactor network in aggresome-autophagy pathway.
    Vet Microbiol. 2019;233:39-46.
    Abstract     Related articles   

  790. GHATE K, Amir E, Kuksis M, Hernandez-Barajas D, et al
    PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis.
    Cancer Treat Rev. 2019;76:51-56.
    Abstract     Related articles   

  791. KRISTYNA P, Tomas P, Ondrej H
    Current status of urine cytology: What new does The Paris System for Reporting Urine Cytology bring?
    Cesk Patol. 2019;55:34-41.
    Abstract     Related articles   

  792. MASSIE J, Howling S
    Schistosoma haematobium causing pulmonary schistosomiasis in a returning traveller.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  793. JAYAWARDHANA T, Alsayed H, Goel A, Madaan S, et al
    Non-muscle-invasive clear cell carcinoma of the urinary bladder: Is cystectomy necessary?
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  794. HUANG C, Zhou W, Song P, Yuan N, et al
    Comparison of different prognostic models for predicting cancer-specific survival in bladder transitional cell carcinoma.
    Future Oncol. 2019;15:851-864.
    Abstract     Related articles   

  795. VURUSKAN BA, Ozsen M, Coskun B, Yalcinkaya U, et al
    Evaluation of incidence and histolopathological findings of soft tissue sarcomas in genitourinary tract: Uludag university experience.
    Int Braz J Urol. 2019;45:68-73.
    Abstract     Related articles   

  796. ZHANG G, Wang Q, Yang M, Yuan Q, et al
    OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients.
    Front Oncol. 2019;9:466.
    Abstract     Related articles   

  797. KRAJEWSKI W, Rodriguez-Faba O, Breda A, Pisano F, et al
    The 1973 WHO and 2004 WHO grading systems are not equal in prediction of survival among stage T1 bladder cancer patients.
    Actas Urol Esp. 2019 Jul 2. pii: S0210-4806(19)30100.
    Abstract     Related articles   

  798. RICCARDI N, Ferrarese M, Castellotti P, Mazzola E, et al
    A rare case of multi-focal human TB after BCG instillation for non-muscle-invasive bladder cancer.
    Urologia. 2019 Jul 4:391560319860396. doi: 10.1177/0391560319860396.
    Abstract     Related articles   

  799. SEGOVIA C, San Jose-Eneriz E, Munera-Maravilla E, Martinez-Fernandez M, et al
    Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
    Nat Med. 2019 Jul 3. pii: 10.1038/s41591-019-0499.
    Abstract     Related articles   

  800. GAO BS, Rong CS, Xu HM, Sun T, et al
    Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
    Pathol Oncol Res. 2019 Jul 2. pii: 10.1007/s12253-019-00687.
    Abstract     Related articles   

  801. SCHWAMBORN K, Ammann JU, Knuchel R, Hartmann A, et al
    Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.
    Virchows Arch. 2019 Jul 2. pii: 10.1007/s00428-019-02610.
    Abstract     Related articles   

  802. FROEHNER M, Koch R, Heberling U, Hubler M, et al
    Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy?
    World J Urol. 2019 Jul 2. pii: 10.1007/s00345-019-02860.
    Abstract     Related articles   

  803. PEREIRA R, Perera M, Rhee H
    Metastatic plasmacytoid bladder cancer causing malignant priapism.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  804. LI Y, Zhang X, Zhou X, Zhang X, et al
    LHPP suppresses the bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
    Biosci Rep. 2019 Jul 1. pii: BSR20182270. doi: 10.1042/BSR20182270.
    Abstract     Related articles   

  805. MALMSTROM PU, Gardmark T, Sherif A, Strock V, et al
    Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016.
    Scand J Urol. 2019 Jul 2:1-7. doi: 10.1080/21681805.2019.1632380.
    Abstract     Related articles   

  806. YAKOVLEV PG, Klyushin DA, Vereshchako RI
    Bladder sparing surgery in high-grade bladder cancer.
    Exp Oncol. 2019;41:160-165.
    Abstract     Related articles   

  807. LORAS A, Martinez-Bisbal MC, Quintas G, Gil S, et al
    Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  808. HUAQI Y, Caipeng Q, Qiang W, Yiqing D, et al
    The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.
    Life Sci. 2019 Jun 28:116614. doi: 10.1016/j.lfs.2019.116614.
    Abstract     Related articles   

  809. WANG W, Xu Z, Wang J, Chen R, et al
    LINC00978 promotes bladder cancer cell proliferation, migration and invasion by sponging miR4288.
    Mol Med Rep. 2019;20:1866-1872.
    Abstract     Related articles   

  810. ZHENG F, Wang M, Li Y, Huang C, et al
    CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression.
    Cancer Lett. 2019 Jun 27. pii: S0304-3835(19)30379.
    Abstract     Related articles   

  811. IWATA T, Kimura S, Abufaraj M, Janisch F, et al
    Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer.
    Urol Oncol. 2019 Jun 26. pii: S1078-1439(19)30219.
    Abstract     Related articles   

  812. DANIELS MJ, Barry E, Schoenberg M, Lamm DL, et al
    Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer.
    Urol Oncol. 2019 Jun 26. pii: S1078-1439(19)30218.
    Abstract     Related articles   

  813. ELBADAWY M, Usui T, Mori T, Tsunedomi R, et al
    Establishment of a novel experimental model for muscle-invasive bladder cancer by using dog bladder cancer organoid culture.
    Cancer Sci. 2019 Jun 29. doi: 10.1111/cas.14118.
    Abstract     Related articles   

  814. TSAI YS, Jou YC, Tsai HT, Cheong IS, et al
    Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer.
    Urol Oncol. 2019 Jun 25. pii: S1078-1439(19)30191.
    Abstract     Related articles   

  815. CHEN X, Wang P, Wang S, Li J, et al
    CIZ1 knockdown suppresses the proliferation of bladder cancer cells by inducing apoptosis.
    Gene. 2019 Jun 25:143946. doi: 10.1016/j.gene.2019.143946.
    Abstract     Related articles   

  816. LI F, Yang C, Zhang HB, Ma J, et al
    BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells.
    Cancer Med. 2019 Jun 28. doi: 10.1002/cam4.2385.
    Abstract     Related articles   

  817. RAKHSHAN A, Esmaeili MH, Kahaei MS, Taheri M, et al
    A Single Nucleotide Polymorphism in GAS5 lncRNA is Associated with Risk of Bladder Cancer in Iranian Population.
    Pathol Oncol Res. 2019 Jun 27. pii: 10.1007/s12253-019-00693.
    Abstract     Related articles   

  818. KRAFFT U, Tschirdewahn S, Hess J, Harke NN, et al
    STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.
    Pathol Oncol Res. 2019 Jun 27. pii: 10.1007/s12253-019-00689.
    Abstract     Related articles   

  819. CHIRIFE AM, Villasante N, Rojas Bilbao E, Casas G, et al
    Individual patient risk of progression of urinary bladder papillary tumors estimated from biomarkers at initial transurethral resection of bladder tumor.
    J Cancer Res Clin Oncol. 2019;145:1709-1718.
    Abstract     Related articles   

  820. XIAO J, Wang M, He W, Wang J, et al
    Does Postoperative Rehabilitation for Radical Cystectomy Call for Enhanced Recovery after Surgery? A Systematic Review and Meta-analysis.
    Curr Med Sci. 2019;39:99-110.
    Abstract     Related articles   

  821. HSU FS, Wu JT, Lin JY, Yang SP, et al
    Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  822. MUJUKIAN A, Innamaa A, Lippiatt J, Melson L, et al
    Extensive extramammary Paget's disease of the vulva involving the bladder postradical split skin graft reconstruction.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  823. CHAN VSH, Chan DLH, Hui SY, Lam WWM, et al
    Occult extra-adrenal pheochromocytoma in the urinary bladder.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  824. XU J, Hua X, Jin H, Zhu J, et al
    NFkappaB2 p52 stabilizes rhogdibeta mRNA by inhibiting AUF1 protein degradation via a miR-145/Sp1/USP8-dependent axis.
    Mol Carcinog. 2019;58:777-793.
    Abstract     Related articles   

  825. TAN TW, Nair R, Saad S, Thurairaja R, et al
    Safe transition from extracorporeal to intracorporeal urinary diversion following robot-assisted cystectomy: a recipe for reducing operative time, blood loss and complication rates.
    World J Urol. 2019;37:367-372.
    Abstract     Related articles   


  826. G9a Inhibition Has Antitumor Activity in Bladder Cancer.
    Cancer Discov. 2019 Jul 12. pii: 2159-8290.CD-RW2019.
    Abstract     Related articles   

  827. ZHUANG C, Ma Q, Zhuang C, Ye J, et al
    LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC.
    FASEB J. 2019 Jul 12:fj201900078RR. doi: 10.1096/fj.201900078.
    Abstract     Related articles   

  828. REZAEI F, Tabatabaee HR, Rahmanian V, Mirahmadizadeh A, et al
    The Correlation Between Bladder Cancer and Obesity, Overweight, Physical Inactivity, and Tobacco Use: An Ecological Study in Asian Countries.
    Ann Glob Health. 2019;85.
    Abstract     Related articles   

  829. YAN T, Ye XX
    MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5139-5148.
    Abstract     Related articles   

  830. DONG ZC, Zhang D, Zhang XX, Yao ZQ, et al
    MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3beta/beta-catenin pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5682-5690.
    Abstract     Related articles   

  831. ALANEE S
    Pyeloduodenal fistula complicating neoadjuvant chemotherapy in a patient diagnosed with muscle invasive bladder cancer.
    Urol Case Rep. 2019;26:100931.
    Abstract     Related articles   

  832. GOEL S, Sinha RJ, Bhaskar V, Aeron R, et al
    Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade.
    Asian J Urol. 2019;6:222-229.
    Abstract     Related articles   

  833. RODRIGUEZ D, Goulart C, Pagliarone AC, Silva EP, et al
    In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment.
    Front Immunol. 2019;10:1460.
    Abstract     Related articles   

  834. MENESES-GUTIERREZ CL, Hernandez-Damian J, Pedraza-Chaverri J, Guerrero-Legarreta I, et al
    Antioxidant Capacity and Cytotoxic Effects of Catechins and Resveratrol Oligomers Produced by Enzymatic Oxidation against T24 Human Urinary Bladder Cancer Cells.
    Antioxidants (Basel). 2019;8.
    Abstract     Related articles   

  835. WU J, Yu Y, Huang L, Li Z, et al
    Dairy Product Consumption and Bladder Cancer Risk: A Meta-Analysis.
    Nutr Cancer. 2019 Jul 11:1-9. doi: 10.1080/01635581.2019.1637909.
    Abstract     Related articles   

  836. CAPUTO JM, Moran G, Muller B, Keller AT, et al
    The Management of Newly-Diagnosed Non-muscle Invasive Bladder Cancer in Veterans Integrated Services Network 02 of the Veterans Health Administration.
    Mil Med. 2019 Jul 11. pii: 5531171. doi: 10.1093.
    Abstract     Related articles   

  837. SHAN G, Tang T, Xia Y, Qian HJ, et al
    MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN.
    J Cell Physiol. 2019 Jul 11. doi: 10.1002/jcp.29025.
    Abstract     Related articles   

  838. MERTEN R, Ott O, Haderlein M, Bertz S, et al
    Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2).
    Oncologist. 2019 Jul 10. pii: theoncologist.2018-0280.
    Abstract     Related articles   

  839. KIM TJ, Moon HW, Kang S, Yang J, et al
    Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients.
    J Cancer. 2019;10:3259-3266.
    Abstract     Related articles   

  840. CHEN Z, Du Y, Liu X, Chen H, et al
    EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway.
    Oncol Lett. 2019;18:907-915.
    Abstract     Related articles   

  841. YU Z, Xu Q, Wang G, Rowe M, et al
    DNA topoisomerase IIalpha and RAD21 cohesin complex component are predicted as potential therapeutic targets in bladder cancer.
    Oncol Lett. 2019;18:518-528.
    Abstract     Related articles   

  842. RAJA SA, Shah STA, Tariq A, Bibi N, et al
    Caveolin-1 and dynamin-2 overexpression is associated with the progression of bladder cancer.
    Oncol Lett. 2019;18:219-226.
    Abstract     Related articles   

  843. LUCCA I, Hofbauer SL, Haitel A, Susani M, et al
    Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria.
    Oncol Lett. 2019;18:57-62.
    Abstract     Related articles   

  844. LIU C, Ge M, Ma J, Zhang Y, et al
    Homeobox A10 promotes the proliferation and invasion of bladder cancer cells via regulation of matrix metalloproteinase-3.
    Oncol Lett. 2019;18:49-56.
    Abstract     Related articles   

  845. ALIFRANGIS C, McGovern U, Freeman A, Powles T, et al
    Molecular and histopathology directed therapy for advanced bladder cancer.
    Nat Rev Urol. 2019 Jul 9. pii: 10.1038/s41585-019-0208.
    Abstract     Related articles   


  846. Correction: Life and bladder cancer: protocol for a longitudinal and cross-sectional patient-reported outcomes study of Yorkshire (UK) patients.
    BMJ Open. 2019;9:e030850corr1.
    Abstract     Related articles   

  847. RICHTER C, Marquardt S, Li F, Spitschak A, et al
    Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    J Exp Clin Cancer Res. 2019;38:292.
    Abstract     Related articles   

  848. ISLAM A, Yang YT, Wu WH, Chueh PJ, et al
    Capsaicin attenuates cell migration via SIRT1 targeting and inhibition to enhance cortactin and beta-catenin acetylation in bladder cancer cells.
    Am J Cancer Res. 2019;9:1172-1182.
    Abstract     Related articles   

  849. CHAKRABORTY A, Dasari S, Long W, Mohan C, et al
    Urine protein biomarkers for the detection, surveillance, and treatment response prediction of bladder cancer.
    Am J Cancer Res. 2019;9:1104-1117.
    Abstract     Related articles   

  850. ALI A, Song YP, Mehta S, Mistry H, et al
    Palliative radiotherapy in bladder cancer - importance of patient selection: A retrospective multicenter study.
    Int J Radiat Oncol Biol Phys. 2019 Jul 5. pii: S0360-3016(19)33441.
    Abstract     Related articles   

  851. ZHANG WY, Wang HR, Hu H, Wang Q, et al
    [Clinical Features and Diagnosis of Encrusted Bladder Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:430-434.
    Abstract     Related articles   

  852. KAWADA T
    Risk assessment of bladder cancer: lifestyle and nutritional contribution.
    Urol Oncol. 2019 Jul 4. pii: S1078-1439(19)30222.
    Abstract     Related articles   

  853. GROSSMAN HB, Bellmunt J, Black PC
    Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?
    Eur Urol Oncol. 2019 Jul 3. pii: S2588-9311(19)30077.
    Abstract     Related articles   

  854. XIAO KH, Teng K, Ye YL, Tan L, et al
    Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via the Akt/GSK3beta signaling.
    Cancer Sci. 2019 Jul 6. doi: 10.1111/cas.14126.
    Abstract     Related articles   

  855. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes.
    Eur Urol Oncol. 2019;2:390-396.
    Abstract     Related articles   

  856. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2019;2:381-389.
    Abstract     Related articles   

  857. COLE AP, Ramaswamy A, Harmouch S, Fletcher SA, et al
    Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?
    Eur Urol Oncol. 2019;2:349-354.
    Abstract     Related articles   

  858. ASHIRU O, Esteso G, Garcia-Cuesta EM, Castellano E, et al
    BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  859. LEE J, Jeh SU, Koh DH, Chung DY, et al
    Probe-Based Confocal Laser Endomicroscopy During Transurethral Resection of Bladder Tumors Improves the Diagnostic Accuracy and Therapeutic Efficacy.
    Ann Surg Oncol. 2019;26:1158-1165.
    Abstract     Related articles   

  860. DAGLI R, Dadali M, Emir L, Bagbanci S, et al
    Comparison of Classic and Inguinal Obturator Nerve Blocks Applied for Preventing Adductor Muscle Contractions in Bladder Tumor Surgeries: A Prospective Randomized Trial.
    Urol J. 2019;16:62-66.
    Abstract     Related articles   

  861. DEVRIM T, Atac F, Altunkaya C, Ozbek A, et al
    Rare Plasmacytoid Urothelial Carcinoma of the Bladder: Two Case Reports.
    Urol J. 2019;16:86-88.
    Abstract     Related articles   

  862. HENSLEY PJ, Kyprianou N, Purdom MS, He D, et al
    Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy.
    Urol Oncol. 2019 Jul 17. pii: S1078-1439(19)30249.
    Abstract     Related articles   

  863. LI Q, Wang H, Peng H, Huang Q, et al
    MicroRNAs: Key Players in Bladder Cancer.
    Mol Diagn Ther. 2019 Jul 19. pii: 10.1007/s40291-019-00410.
    Abstract     Related articles   

  864. HUISMAN H
    Solid Science of AI Supporting Bladder Cancer CT Reading.
    Acad Radiol. 2019 Jul 17. pii: S1076-6332(19)30320.
    Abstract     Related articles   

  865. MAI G, Chen L, Li R, Liu Q, et al
    Common Core Bacterial Biomarkers of Bladder Cancer Based on Multiple Datasets.
    Biomed Res Int. 2019;2019:4824909.
    Abstract     Related articles   

  866. TSUCHIYAMA K, Ito H, Seki M, Inai K, et al
    Advanced bladder cancer with malignant psoas syndrome: A case report with a focus on physical findings and complications.
    Urol Case Rep. 2019;26:100958.
    Abstract     Related articles   

  867. KIMURA Y, Honda M, Morizane S, Hikita K, et al
    Effect of Intravesical Bacilli Calmette-Guerin Therapy After Second Transurethral Resection in Stage Ta T1 High-Grade Bladder Cancer.
    Yonago Acta Med. 2019;62:191-197.
    Abstract     Related articles   

  868. JAMIL ML, Deebajah M, Sood A, Robinson K, et al
    Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guerin for patients with high-risk non-muscle invasive bladder cancer.
    BMJ Open. 2019;9:e028287.
    Abstract     Related articles   

  869. BUNCH B, Krishnan N, Greenspan RD, Ramakrishnan S, et al
    TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
    Cell Cycle. 2019 Jul 18:1-12. doi: 10.1080/15384101.2019.1638693.
    Abstract     Related articles   

  870. ZHANG YP, Liu KL, Wang YX, Yang Z, et al
    Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/beta-catenin feedback loop.
    FASEB J. 2019 Jul 18:fj201900537R. doi: 10.1096/fj.201900537.
    Abstract     Related articles   

  871. AMPONSA VO, Shuman L, Ellis J, Wang E, et al
    Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression.
    Am J Clin Exp Urol. 2019;7:139-152.
    Abstract     Related articles   

  872. XIE X, Lin J, Zhong Y, Fu M, et al
    FGFR(3S249C) mutation promotes chemoresistance by activating Akt signaling in bladder cancer cells.
    Exp Ther Med. 2019;18:1226-1234.
    Abstract     Related articles   

  873. DUENAS M, Perez-Figueroa A, Oliveira C, Suarez-Cabrera C, et al
    Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status.
    Sci Rep. 2019;9:10362.
    Abstract     Related articles   

  874. WANG Y, Li Z, Lin Q, Wei Y, et al
    Highly Sensitive Detection of Bladder Cancer-Related miRNA in Urine Using Time-Gated Luminescent Biochip.
    ACS Sens. 2019 Jul 17. doi: 10.1021/acssensors.9b00927.
    Abstract     Related articles   

  875. ZHANG S, Cao H, Ye L, Wen X, et al
    Cancer-associated methylated lncRNAs in patients with bladder cancer.
    Am J Transl Res. 2019;11:3790-3800.
    Abstract     Related articles   

  876. CASSELL A, Yunusa B, Jalloh M, Mbodji MM, et al
    Non-Muscle Invasive Bladder Cancer: A Review of the Current Trend in Africa.
    World J Oncol. 2019;10:123-131.
    Abstract     Related articles   

  877. GHANDOUR R, Singla N, Lotan Y
    Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer.
    Trends Cancer. 2019;5:426-439.
    Abstract     Related articles   

  878. HU X, Feng H, Huang H, Gu W, et al
    Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer.
    Technol Cancer Res Treat. 2019;18:1533033819846638.
    Abstract     Related articles   

  879. WU D, Lin J, Zhu Y, Zhang H, et al
    Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
    Med Sci Monit. 2019;25:5289-5298.
    Abstract     Related articles   

  880. LYU L, Xiang W, Zhu JY, Huang T, et al
    Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.
    Cancer Manag Res. 2019;11:6061-6077.
    Abstract     Related articles   

  881. DUDDERIDGE T, Stockley J, Nabi G, Mom J, et al
    A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER.
    Eur Urol Oncol. 2019 Jul 12. pii: S2588-9311(19)30081.
    Abstract     Related articles   

  882. CHENG Y, Huang C, Mo Y, Wu W, et al
    Long non-coding RNA UCA1 regulates tumor growth by impairing let-7e-dependent HMGA2 repression in bladder cancer.
    Cancer Biomark. 2019 Jul 5. pii: CBM182296. doi: 10.3233/CBM-182296.
    Abstract     Related articles   

  883. LU M, Chen S, Zhou Q, Wang L, et al
    Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients.
    Medicine (Baltimore). 2019;98:e16426.
    Abstract     Related articles   

  884. JIANG D, Zhang Y, Yang L, Lu W, et al
    Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
    J Cell Physiol. 2019 Jul 15. doi: 10.1002/jcp.29090.
    Abstract     Related articles   

  885. SU S, Gu L, Ma X, Li H, et al
    Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes.
    Clin Genitourin Cancer. 2019 Jun 19. pii: S1558-7673(18)30605.
    Abstract     Related articles   

  886. MONDAL AM, Ma AH, Li G, Krawczyk E, et al
    Fidelity of a PDX-CR model for bladder cancer.
    Biochem Biophys Res Commun. 2019 Jul 11. pii: S0006-291X(19)31325.
    Abstract     Related articles   

  887. LLORENTE C, Guijarro A, Hernandez V, Fernandez-Conejo G, et al
    Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain.
    World J Urol. 2019 Jul 13. pii: 10.1007/s00345-019-02874.
    Abstract     Related articles   

  888. DIANA M, Felipe-Sotelo M, Bond T
    Disinfection byproducts potentially responsible for the association between chlorinated drinking water and bladder cancer: A review.
    Water Res. 2019;162:492-504.
    Abstract     Related articles   

  889. YANG F, Zhou Q, Meng L, Xing N, et al
    IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.
    Medicine (Baltimore). 2019;98:e16009.
    Abstract     Related articles   

  890. QIU S, Deng L, Liao X, Nie L, et al
    Tumor-associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen.
    Cancer Sci. 2019;110:2110-2118.
    Abstract     Related articles   

  891. HU SW, Wu CC, Chen KC, Ho CH, et al
    Modified U-Shaped ileal neobladder designed for facilitating neobladder-urethral anastomosis in extracorporeal reconstruction after robotic-assisted radical cystectomy.
    J Cancer Res Ther. 2019;15.
    Abstract     Related articles   

  892. ELSHARKAWI F, Elsabah M, Shabayek M, Khaled H, et al
    Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer.
    Asian Pac J Cancer Prev. 2019;20:2219-2224.
    Abstract     Related articles   

  893. TAN GH, Kuk C, Zlotta AR
    Are there differences among Bacillus Calmette-Guerin (BCG) strains regarding their clinical efficacy in the treatment of non-muscle invasive bladder cancer? The jury is still out but the answer is likely no.
    Can Urol Assoc J. 2019 Jul 23. pii: cuaj.5923. doi: 10.5489/cuaj.5923.
    Abstract     Related articles   

  894. JIANG S, Wang J, Yang C, Tan R, et al
    Continuous culture of urine-derived bladder cancer cells for precision medicine.
    Protein Cell. 2019 Jul 25. pii: 10.1007/s13238-019-0649.
    Abstract     Related articles   

  895. STEC R, Cierniak S, Lubas A, Brzoskowska U, et al
    Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer.
    Pathol Oncol Res. 2019 Jun 19. pii: 10.1007/s12253-019-00678.
    Abstract     Related articles   

  896. CHEREMISIN D, Gavrilov P, Andropova P
    A case of renal tuberculosis following BCG therapy for bladder cancer.
    QJM. 2019 Jul 25. pii: 5538982. doi: 10.1093.
    Abstract     Related articles   

  897. PANDEY P, Siddiqui MH, Behari A, Kapoor VK, et al
    Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome.
    Anticancer Agents Med Chem. 2019 Jul 25. pii: ACAMC-EPUB-99966.
    Abstract     Related articles   

  898. TSAI TF, Lin JF, Lin YC, Chou KY, et al
    Cisplatin contributes to programmed death-ligand 1 (PD-L1) expression in bladder cancer through ERK1/2 - AP-1 signaling pathway.
    Biosci Rep. 2019 Jul 24. pii: BSR20190362. doi: 10.1042/BSR20190362.
    Abstract     Related articles   

  899. YANG Z, Fu B, Zhou L, Xu J, et al
    RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy.
    BMC Urol. 2019;19:69.
    Abstract     Related articles   

  900. KONECKI T, Kutwin P, Lowicki R, Juszczak AB, et al
    Hexaminolevulinate in the Management of Nonmuscle Invasive Bladder Cancer: A Meta-Analysis.
    Photobiomodul Photomed Laser Surg. 2019 Jul 24. doi: 10.1089/photob.2019.4634.
    Abstract     Related articles   

  901. GAO Y, Liu S, Guo Q, Zhang S, et al
    Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway.
    Int J Biol Sci. 2019;15:1488-1499.
    Abstract     Related articles   

  902. STARRETT GJ, Buck CB
    BK polyomavirus is a cause of bladder cancer.
    Curr Opin Virol. 2019;39:8-15.
    Abstract     Related articles   

  903. PAN S, Zhan Y, Chen X, Wu B, et al
    Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
    Front Oncol. 2019;9:613.
    Abstract     Related articles   

  904. CHEN Z, Liu G, Hossain A, Danilova IG, et al
    A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
    Hereditas. 2019;156:24.
    Abstract     Related articles   

  905. HAQUE W, Verma V, Aghazadeh M, Darcourt J, et al
    Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jul 2. pii: S1558-7673(19)30204.
    Abstract     Related articles   

  906. TONG Z, Sathe A, Ebner B, Qi P, et al
    Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer.
    J Exp Clin Cancer Res. 2019;38:322.
    Abstract     Related articles   

  907. SHAMALIRWA BB, Wembonyama O, Tidahy R, Mellas S, et al
    [Metastatic bladder metachrone to a kaposi sarcoma cancer at a therapeutic impasse: about a case].
    Pan Afr Med J. 2019;32:218.
    Abstract     Related articles   

  908. CHEN X
    MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma.
    Medicine (Baltimore). 2019;98:e16051.
    Abstract     Related articles   

  909. BOURAS E, Karakioulaki M, Bougioukas KI, Aivaliotis M, et al
    Gene promoter methylation and cancer: An umbrella review.
    Gene. 2019;710:333-340.
    Abstract     Related articles   

  910. FARAJ KS, Abdul-Muhsin HM, Navaratnam AK, Rose KM, et al
    Intracorporeal orthotopic neobladder formation: Why not to do it?
    Arch Esp Urol. 2019;72:318-325.
    Abstract     Related articles   

  911. GASTON R, Ramirez P
    Intracorporeal neobladder.
    Arch Esp Urol. 2019;72:309-317.
    Abstract     Related articles   

  912. MEDINA LG, Baccaglini W, Hernandez A, Rajarubendra N, et al
    Robotic intracorporeal ileal conduit: Technical aspects.
    Arch Esp Urol. 2019;72:299-308.
    Abstract     Related articles   

  913. GAYA JM, Vila-Reyes H, Gavrilov P, Territo A, et al
    Robotic radical cystectomy.
    Arch Esp Urol. 2019;72:293-298.
    Abstract     Related articles   

  914. DOTSON A, May A, Davaro F, Raza SJ, et al
    Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.
    Int J Clin Oncol. 2019;24:706-711.
    Abstract     Related articles   

  915. VOM DORP F
    [Organ preservation in cancer of the upper urinary tract].
    Urologe A. 2019;58:22-24.
    Abstract     Related articles   

  916. CHENG L, Berney DM
    Annual review issue: Urologic pathology: a remarkable journey of innovation.
    Histopathology. 2019;74:3.
    Abstract     Related articles   

  917. GUNLUSOY B, Bolat D, Degirmenci T
    Re: "Monopolar vs. bipolar transurethral resection for nonmuscle invasive bladder carcinoma: A post hoc analysis from a randomized controlled trial".
    Urol Oncol. 2019;37:177-178.
    Abstract     Related articles   

  918. LUNNEY A, Haynes A, Sharma P
    Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder.
    Int Braz J Urol. 2019;45:306-314.
    Abstract     Related articles   

  919. LI X, He S, Tian Y, Weiss RM, et al
    Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
    Cell Signal. 2019 Jul 30:109381. doi: 10.1016/j.cellsig.2019.109381.
    Abstract     Related articles   

  920. CALO B, Sanguedolce F, Fortunato F, Stallone G, et al
    The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer.
    Medicine (Baltimore). 2019;98:e16223.
    Abstract     Related articles   

  921. YAN H, Ren S, Lin Q, Yu Y, et al
    Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
    FASEB J. 2019 Aug 2:fj201900499RR. doi: 10.1096/fj.201900499.
    Abstract     Related articles   

  922. REIS LO
    Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future.
    World J Urol. 2019 Aug 1. pii: 10.1007/s00345-019-02894.
    Abstract     Related articles   

  923. D'RUMMO KA, TenNapel MJ, Shen X
    The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
    Am J Clin Oncol. 2019 Jul 25. doi: 10.1097/COC.0000000000000582.
    Abstract     Related articles   

  924. HIROTSU Y, Yokoyama H, Amemiya K, Hagimoto T, et al
    Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer.
    Cancer Sci. 2019 Aug 1. doi: 10.1111/cas.14155.
    Abstract     Related articles   

  925. KITAGAWA K, Shigemura K, Sung SY, Chen KC, et al
    Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression.
    J Cancer Res Clin Oncol. 2019 Jul 31. pii: 10.1007/s00432-019-02987.
    Abstract     Related articles   

  926. LEE JW, Lee S, Ho JN, Youn JI, et al
    Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells.
    Biosci Biotechnol Biochem. 2019 Jul 31:1-7. doi: 10.1080/09168451.2019.1648207.
    Abstract     Related articles   

  927. SAMISHINA EA, Blinova EV, Roshchin DA, Suslova IR, et al
    Programmed death-ligand 1 signaling pathway involves in bladder cancer growth and progression.
    J Carcinog. 2019;18:3.
    Abstract     Related articles   

  928. QI F, Tan B, Ma F, Zhu B, et al
    A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells.
    Int J Biol Sci. 2019;15:1630-1636.
    Abstract     Related articles   

  929. LI A, Yao L, Fang Y, Yang K, et al
    Specifically blocking the fatty acid synthesis to inhibit the malignant phenotype of bladder cancer.
    Int J Biol Sci. 2019;15:1610-1617.
    Abstract     Related articles   

  930. JOSHI SR, Sheladiya A, Agrawal VN
    High thermal amplitude auto-anti-"N" complicating pretransfusion compatibility tests on a patient with malaria and bladder cancer.
    Asian J Transfus Sci. 2019;13:30-33.
    Abstract     Related articles   

  931. CHEN X, Li A, Sun BF, Yang Y, et al
    5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs.
    Nat Cell Biol. 2019;21:978-990.
    Abstract     Related articles   

  932. CHENG S, Wang G, Wang Y, Cai L, et al
    Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARgamma-mediated pathway in bladder cancer.
    Clin Sci (Lond). 2019 Jul 29. pii: CS20190587. doi: 10.1042/CS20190587.
    Abstract     Related articles   

  933. GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
    Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Urol Oncol. 2019 Jul 26. pii: S1078-1439(19)30250.
    Abstract     Related articles   

  934. LI Y, Zhang H, Guo Y, Cai H, et al
    A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I-III Bladder Cancer Patients After Surgical Resection.
    Front Oncol. 2019;9:629.
    Abstract     Related articles   

  935. ZHANG W, Mao S, Shi D, Zhang J, et al
    MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
    Front Oncol. 2019;9:619.
    Abstract     Related articles   

  936. HABERSTROH W, Shafa S
    Pseudoachalasia secondary to metastatic bladder cancer.
    BMJ Open Gastroenterol. 2019;6:e000284.
    Abstract     Related articles   

  937. TIAN DW, Wu ZL, Jiang LM, Gao J, et al
    KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo.
    Dis Markers. 2019;2019:4824902.
    Abstract     Related articles   

  938. BAE WK, Lee HJ, Park SH, Kim JH, et al
    Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analys
    Cancer Med. 2019 Jul 29. doi: 10.1002/cam4.2446.
    Abstract     Related articles   

  939. BLACK PC
    Hope, hype and biology: the current biomarker landscape in bladder cancer.
    World J Urol. 2019 Jul 27. pii: 10.1007/s00345-019-02885.
    Abstract     Related articles   

  940. HUPE MC, Gakis G, Seiler R
    [Molecular tumor board-urothelial cancer].
    Urologe A. 2019;58:760-767.
    Abstract     Related articles   

  941. MAGERS MJ, Kaimakliotis HZ, Barboza MP, Bandali E, et al
    Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
    J Clin Pathol. 2019;72:550-553.
    Abstract     Related articles   

  942. LIU P, Li X, Guo X, Chen J, et al
    Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.
    Cell Prolif. 2019;52:e12614.
    Abstract     Related articles   

  943. AGARWAL H, Babu S, Rana C, Kumar M, et al
    Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.
    Indian J Pathol Microbiol. 2019;62:244-250.
    Abstract     Related articles   

  944. ROMAGNOLI D, Mineo Bianchi F, Sadini P, Angiolini A, et al
    Pubis bone osteomyelitys after robotic radical cystectomy with continent intracorporeal urinary diversion: Multidisciplinary approach to a complex situation.
    Arch Ital Urol Androl. 2019;91:63-67.
    Abstract     Related articles   

  945. DE ROSE AF, Balzarini F, Mantica G, Toncini C, et al
    Late urinary bladder metastasis from breast cancer.
    Arch Ital Urol Androl. 2019;91:60-62.
    Abstract     Related articles   

  946. SODO M, Spirito L, La Rocca R, Bracale U, et al
    Partial cystectomy in young male for a urachal tumor masquerading a bladder leiomyoma.
    Arch Ital Urol Androl. 2019;91:51-52.
    Abstract     Related articles   

  947. MINEO BIANCHI F, Romagnoli D, D'Agostino D, Salvaggio A, et al
    Posterior muscle-fascial reconstruction and knotless urethro-neo bladder anastomosis during robot-assisted radical cystectomy: Description of the technique and its impact on urinary continence.
    Arch Ital Urol Androl. 2019;91:5-10.
    Abstract     Related articles   

  948. LI J, Yang F, He Q, Wang M, et al
    Laparoscopic radical cystectomy with intracorporeal ileal conduit: one center experience and clinical outcomes.
    Int Braz J Urol. 2019;45:560-571.
    Abstract     Related articles   

  949. FENG J, Chen K, Dong X, Xu X, et al
    Genome-wide identification of cancer-specific alternative splicing in circRNA.
    Mol Cancer. 2019;18:35.
    Abstract     Related articles   

  950. OKANO H, Asakawa H, Nose K, Tsuruga S, et al
    Hepatic Injury without Granulomatous Formation Associated with Intravesical Bacillus Calmette-Guerin Therapy.
    Intern Med. 2019;58:1429-1432.
    Abstract     Related articles   

  951. MARTINGANO D, Ramirez LC, Bjurlin MA
    Osteopathic Evaluation of Urinary Retention Caused by Atypical Presentation of Invasive Cervical Cancer Mimicking Primary Urothelial Tumor.
    J Am Osteopath Assoc. 2018;118:685-688.
    Abstract     Related articles   

  952. SCHWARTZ E, Faller E, Akladios CY, Greget M, et al
    Total Laparoscopic Hysterectomy for Endometriosis and an Arteriovenous Malformation.
    J Minim Invasive Gynecol. 2019;26:363-364.
    Abstract     Related articles   

  953. CHAN KM, Vasilev K, Shirazi HS, Mcnicholas K, et al
    Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study.
    Photodiagnosis Photodyn Ther. 2019 Aug 5. pii: S1572-1000(19)30232.
    Abstract     Related articles   

  954. BOSSCHIETER J, van Moorselaar RJA, Nieuwenhuijzen JA
    An immediate, single instillation of mitomycin C in non-muscle invasive bladder cancer: can we define which patients do and do not benefit?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  955. SHERIF A
    The risk of oversimplification in risk-stratification of neoadjuvant chemotherapy-responses in muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  956. LEE SM
    Prognosis in high-grade T1 bladder cancer: host immune response and tumour infiltrating lymphocytes.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  957. MIYAKE M, Owari T, Hori S, Fujimoto K, et al
    Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  958. KOOL R, Joao Mansure J, Kassouf W
    Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  959. KIM J
    Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  960. SOSNOWSKI R, Kamecki H, Bjurlin MA, Przewozniak K, et al
    The diagnosis of bladder cancer: are we missing a teachable moment for smoking cessation?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  961. SAID N
    Establishing and characterization of human and murine bladder cancer organoids.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  962. TODENHOFER T, Seiler R
    Molecular subtypes and response to immunotherapy in bladder cancer patients.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  963. NIEGISCH G
    Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  964. AFFERI L, Zamboni S, Baumeister P, Mordasini L, et al
    Adjuvant chemotherapy in bladder cancer patients with histological variants: time to change the approach?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  965. MAAS M, Stenzl A
    Should every patient with muscle-invasive bladder cancer receive neoadjuvant chemotherapy?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  966. AGARWAL A, Sonpavde G
    A new subtyping model for residual invasive disease after cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  967. DAZA J, Gul Z, Sfakianos JP
    Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosis.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  968. SINGLA N, Ghandour RA, Raj GV
    Biomarkers for platinum sensitivity in bladder cancer: are we there yet?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  969. THOMA C
    Combining epigenetic and immune checkpoint inhibitors in bladder cancer.
    Nat Rev Urol. 2019 Aug 6. pii: 10.1038/s41585-019-0221.
    Abstract     Related articles   

  970. HONG SH, Cha HJ, Hwang-Bo H, Kim MY, et al
    Anti-Proliferative and Pro-Apoptotic Effects of Licochalcone A through ROS-Mediated Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  971. DUGAS SG, Muller DC, Le Magnen C, Federer-Gsponer J, et al
    Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.
    Cancer Cytopathol. 2019 Aug 6. doi: 10.1002/cncy.22167.
    Abstract     Related articles   

  972. SHARIAT SF, Enikeev DV, Mostafaei H
    Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guerin unresponsive bladder cancer.
    Immunotherapy. 2019 Aug 6. doi: 10.2217/imt-2019-0083.
    Abstract     Related articles   

  973. MIYAKE M, Hori S, Ohnishi S, Toritsuka M, et al
    Supplementary GM-CSF to chemotherapy and PD-L1 blockade decreases local recurrence after surgery in bladder cancer.
    Cancer Sci. 2019 Aug 5. doi: 10.1111/cas.14158.
    Abstract     Related articles   

  974. MIRANDA MA, Marcato PD, Carvalho IPS, Silva LB, et al
    Assessing the cytotoxic potential of glycoalkaloidic extract in nanoparticles against bladder cancer cells.
    J Pharm Pharmacol. 2019 Aug 5. doi: 10.1111/jphp.13145.
    Abstract     Related articles   

  975. BOFFETTA P, Borron C
    Low-Level Exposure to Arsenic in Drinking Water and Risk of Lung and Bladder Cancer: A Systematic Review and Dose-Response Meta-Analysis.
    Dose Response. 2019;17:1559325819863634.
    Abstract     Related articles   

  976. ZHANG J, Zhu Y, Wang Q, Kong Y, et al
    Poliovirus receptor CD155 is up-regulated in muscle-invasive bladder cancer and predicts poor prognosis.
    Urol Oncol. 2019 Aug 2. pii: S1078-1439(19)30282.
    Abstract     Related articles   

  977. MIRMOMEN SM, Shinagare AB, Williams KE, Silverman SG, et al
    Preoperative imaging for locoregional staging of bladder cancer.
    Abdom Radiol (NY). 2019 Aug 3. pii: 10.1007/s00261-019-02168.
    Abstract     Related articles   

  978. AMESTOY F, Roubaud G, Antoine M, Fonteyne V, et al
    Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.
    Crit Rev Oncol Hematol. 2019;142:76-85.
    Abstract     Related articles   

  979. SEILER R, Black PC, Williams SB, Goebell PJ, et al
    Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series.
    Urol Oncol. 2019 Jul 31. pii: S1078-1439(19)30254.
    Abstract     Related articles   

  980. BORKOWSKA EM, Traczyk-Borszynska M, Kutwin P, Pietrusinski M, et al
    Usefulness of droplet digital PCR and Sanger sequencing for detection of FGFR3 mutation in bladder cancer.
    Urol Oncol. 2019 Jul 31. pii: S1078-1439(19)30239.
    Abstract     Related articles   

  981. KIM SJ, You D, Jeong IG, Song C, et al
    Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette-Guerin immunotherapy.
    J Cancer Res Clin Oncol. 2019;145:2131-2140.
    Abstract     Related articles   

  982. YOSHIDA T, Shida D, Taniguchi H, Tsukamoto S, et al
    Long-Term Outcomes Following Partial Versus Complete Cystectomy in Advanced Colorectal Cancer with Regarding to the Extent of Bladder Invasion.
    Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07276.
    Abstract     Related articles   

  983. ZUGAIL AS, Pinar U, Irani J
    Evaluation of pain and catheter-related bladder discomfort relative to balloon volumes of indwelling urinary catheters: A prospective study.
    Investig Clin Urol. 2019;60:35-39.
    Abstract     Related articles   

  984. BOYACI C, Behzatoglu K
    Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma.
    Turk Patoloji Derg. 2019;35:22-27.
    Abstract     Related articles   

  985. DAVARO F, Schaefer J, May A, Raza J, et al
    Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database.
    World J Urol. 2019;37:497-505.
    Abstract     Related articles   

  986. O'DAY R, Michalova K, Campbell WG
    Bilateral Diffuse Uveal Melanocytic Proliferation Associated With Bladder Cancer: A Novel Imaging Finding.
    Ophthalmic Surg Lasers Imaging Retina. 2019;50:525-528.
    Abstract     Related articles   

  987. JI N, Mukherjee N, Morales EE, Tomasini ME, et al
    Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial.
    Oncoimmunology. 2019;8:1614857.
    Abstract     Related articles   

  988. WU Q, Zhou X, Li P, Wang W, et al
    High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer.
    J Cancer. 2019;10:4270-4277.
    Abstract     Related articles   

  989. WEI XC, Lv ZH
    MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGFbeta1/Smad2 signaling pathway in human bladder cancer.
    Onco Targets Ther. 2019;12:5937-5945.
    Abstract     Related articles   

  990. FISHEL ML, Xia H, McGeown J, McIlwain DW, et al
    Anti-tumor activity and mechanistic characterization of APE1/Ref-1 inhibitors in bladder cancer.
    Mol Cancer Ther. 2019 Aug 14. pii: 1535-7163.MCT-18-1166.
    Abstract     Related articles   

  991. TSE J, Singla N, Ghandour R, Lotan Y, et al
    Current advances in BCG-unresponsive non-muscle invasive bladder cancer.
    Expert Opin Investig Drugs. 2019 Aug 15:1-14. doi: 10.1080/13543784.2019.1655730
    Abstract     Related articles   

  992. SLOAN FA, Yashkin AP, Akushevich I, Inman BA, et al
    The Cost to Medicare of Bladder Cancer Care.
    Eur Urol Oncol. 2019 Feb 8. pii: S2588-9311(19)30016.
    Abstract     Related articles   

  993. KATES M, Nirschl TR, Baras AS, Sopko NA, et al
    Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer.
    Eur Urol Oncol. 2019 Feb 26. pii: S2588-9311(19)30025.
    Abstract     Related articles   

  994. GUILLAMON CF, Gimeno L, Server G, Martinez-Sanchez MV, et al
    Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers.
    Eur Urol Oncol. 2019 May 14. pii: S2588-9311(19)30058.
    Abstract     Related articles   

  995. JIN H, Ying X, Que B, Wang X, et al
    N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer.
    EBioMedicine. 2019 Aug 10. pii: S2352-3964(19)30510.
    Abstract     Related articles   

  996. YAN H, Zhou X, Wang X, Li R, et al
    Delayed (18)F FDG PET/CT Imaging in the Assessment of Residual Tumors after Transurethral Resection of Bladder Cancer.
    Radiology. 2019 Aug 13:190032. doi: 10.1148/radiol.2019190032.
    Abstract     Related articles   

  997. MAR N, Dayyani F
    Management of Urothelial Bladder Cancer in Clinical Practice: Real-World Answers to Difficult Questions.
    J Oncol Pract. 2019;15:421-428.
    Abstract     Related articles   

  998. STADLER WM
    Management of Urothelial Bladder Cancer: Predicting the Future.
    J Oncol Pract. 2019;15:429-430.
    Abstract     Related articles   

  999. PANG G, Xie Q, Yao J
    Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt/beta-catenin pathway.
    Oncol Lett. 2019;18:2434-2442.
    Abstract     Related articles   

  1000. MURAKAMI K, Hamada A, Teramoto Y, Matsumoto K, et al
    Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non-Muscle-Invasive Bladder Cancer in Real-World Clinical Practice.
    Clin Genitourin Cancer. 2019 May 30. pii: S1558-7673(19)30178.
    Abstract     Related articles   

  1001. GONG H, Chen W, Mi L, Wang D, et al
    Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Beta-catenin pathway.
    Pharm Biol. 2019;57:507-513.
    Abstract     Related articles   

  1002. LIU J, Liu C, Zhang X, Yu L, et al
    Anticancer sulfonamide hybrids that inhibit bladder cancer cells growth and migration as tubulin polymerisation inhibitors.
    J Enzyme Inhib Med Chem. 2019;34:1380-1387.
    Abstract     Related articles   

  1003. WANG J, Zhang N, Peng M, Hua X, et al
    p85alpha Inactivates MMP-2 and Suppresses Bladder Cancer Invasion by Inhibiting MMP-14 Transcription and TIMP-2 Degradation.
    Neoplasia. 2019;21:908-920.
    Abstract     Related articles   

  1004. EICH ML, Rodriguez Pena MDC, Chandrashekar DS, Chaux A, et al
    Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer.
    Transl Oncol. 2019;12:1416-1424.
    Abstract     Related articles   

  1005. DURDUX C, Fabiano E, Mejean A
    [Organ preservation by chemoradiation for bladder cancer].
    Cancer Radiother. 2019 Aug 7. pii: S1278-3218(19)30291.
    Abstract     Related articles   

  1006. SCHULZ GB, Stief CG, Schlenker B
    [Follow-up surveillance of muscle-invasive urinary bladder cancer after curative treatment].
    Urologe A. 2019 Aug 9. pii: 10.1007/s00120-019-1012.
    Abstract     Related articles   

  1007. ADAMOWICZ J, Juszczak K, Poletajew S, van Breda SV, et al
    Scented candles as an unrecognised factor that increases the risk of bladder cancer; is there enough evidence to raise a red flag?
    Cancer Prev Res (Phila). 2019 Aug 9. pii: 1940-6207.CAPR-19-0093.
    Abstract     Related articles   

  1008. GOAN YG, Wu WT, Liu CI, Neoh CA, et al
    Involvement of Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and the PI3K/AKT/mTOR Pathway in Nobiletin-Induced Apoptosis of Human Bladder Cancer Cells.
    Molecules. 2019;24.
    Abstract     Related articles   

  1009. LU S, Guo M, Fan Z, Chen Y, et al
    Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer.
    Am J Transl Res. 2019;11:4397-4410.
    Abstract     Related articles   

  1010. BURGER M, Kamat AM, McConkey D
    Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?
    Eur Urol Oncol. 2019 Aug 5. pii: S2588-9311(19)30093.
    Abstract     Related articles   

  1011. KRIPNEROVA M, Parmar HS, Pesta M, Kohoutova M, et al
    Urothelial Cancer Stem Cell Heterogeneity.
    Adv Exp Med Biol. 2019;1139:127-151.
    Abstract     Related articles   

  1012. IKEDA J, Murakami S, Kawa G, Shibuya S, et al
    [Granulomatous Prostatitis : Three Cases Report].
    Hinyokika Kiyo. 2019;65:69-73.
    Abstract     Related articles   

  1013. JAGUVA VASUDEVAN AA, Hoffmann MJ, Beck MLC, Poschmann G, et al
    HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  1014. AUGUGLIARO M, Marvaso G, Ciardo D, Zerini D, et al
    Recurrent oligometastatic transitional cell bladder carcinoma: is there room for radiotherapy?
    Neoplasma. 2019;66:160-165.
    Abstract     Related articles   

  1015. TAARNHOJ GA, Lindberg H, Johansen C, Pappot H, et al
    Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy.
    J Patient Rep Outcomes. 2019;3:56.
    Abstract     Related articles   

  1016. BURITY CRT, Ferreira FT, Veiga AF, Saade RD, et al
    Advanced small-cell bladder cancer into a ureterocele: A case report and literature review.
    Urol Case Rep. 2019;27:100986.
    Abstract     Related articles   

  1017. ZOU J, Huang R, Li H, Wang B, et al
    Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells.
    Cancer Manag Res. 2019;11:6995-7006.
    Abstract     Related articles   

  1018. HECK MM, Gschwend JE
    Extended Lymph Node Dissection for Bladder Cancer: Do Clinical Trials Rule Out a Benefit?
    Eur Urol Focus. 2019 Aug 19. pii: S2405-4569(19)30212.
    Abstract     Related articles   

  1019. PARK C, Cha HJ, Lee H, Hwang-Bo H, et al
    Induction of G2/M Cell Cycle Arrest and Apoptosis by Genistein in Human Bladder Cancer T24 Cells through Inhibition of the ROS-Dependent PI3k/Akt Signal Transduction Pathway.
    Antioxidants (Basel). 2019;8.
    Abstract     Related articles   

  1020. GATTA LB, Melocchi L, Bugatti M, Missale F, et al
    Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  1021. JOICE GA, Bivalacqua TJ, Kates M
    Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer.
    Nat Rev Urol. 2019 Aug 21. pii: 10.1038/s41585-019-0220.
    Abstract     Related articles   

  1022. HE A, He S, Peng D, Zhan Y, et al
    Prognostic value of long non-coding RNA signatures in bladder cancer.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  1023. DARRAD MP, Syed J, Ahmed Z, Syed HA, et al
    Long-Term Prospective Outcomes Of Patients With Non-Muscle Invasive Bladder Cancer Following Holmium Laser Ablation.
    J Endourol. 2019 Aug 21. doi: 10.1089/end.2019.0253.
    Abstract     Related articles   

  1024. LIM J, Kang SY, Park HS
    Low serum cholesterol as a risk factor for kidney and bladder cancer among Korean men: using a national cohort sample.
    Cancer Causes Control. 2019 Aug 20. pii: 10.1007/s10552-019-01219.
    Abstract     Related articles   

  1025. JI M, Wang Z, Chen J, Gu L, et al
    Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating beta-catenin.
    Biosci Rep. 2019 Aug 20. pii: BSR20190503. doi: 10.1042/BSR20190503.
    Abstract     Related articles   

  1026. KAWAHARA T, Takamoto D, Miyoshi Y, Yao M, et al
    Inserting a Metallic Ureteral Stent Using an Antegrade Approach Freed a Patient from Nephrostomy Created due to Hydronephrosis Caused by Bladder Cancer.
    Case Rep Oncol. 2019;12:560-563.
    Abstract     Related articles   

  1027. ABDOLMALEKI F, Ghafouri-Fard S, Taheri M, Omrani DM, et al
    P21-Associated ncRNA DNA Damage-Activated Expression in Bladder Cancer.
    Klin Onkol. 2019;32:277-280.
    Abstract     Related articles   

  1028. HUANG Z, Liu G
    Research on correlations of MiR-203 expression with onset and prognosis of bladder cancer.
    J BUON. 2019;24:1210-1218.
    Abstract     Related articles   

  1029. REN Y, Zhao C, He Y, Xu H, et al
    Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer.
    Oncol Lett. 2019;18:2050-2058.
    Abstract     Related articles   

  1030. SHIN SS, Park YJ, Hwang B, Park SL, et al
    Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo.
    Phytomedicine. 2019;64:153069.
    Abstract     Related articles   

  1031. HUANG HW, Yan B, Shang MX, Liu LB, et al
    [Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2019;51:698-705.
    Abstract     Related articles   

  1032. YANG FL, Hong K, Zhao GJ, Liu C, et al
    [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2019;51:615-622.
    Abstract     Related articles   

  1033. CHEN Z, He S, Zhan Y, He A, et al
    TGF-beta-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
    EBioMedicine. 2019 Aug 13. pii: S2352-3964(19)30528.
    Abstract     Related articles   

  1034. CHEN FV, Koru-Sengul T, Miao F, Jue JS, et al
    Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer.
    Urol Oncol. 2019 Aug 14. pii: S1078-1439(19)30251.
    Abstract     Related articles   

  1035. SHARMA M, Goto T, Yang Z, Miyamoto H, et al
    The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy.
    BMC Urol. 2019;19:77.
    Abstract     Related articles   

  1036. BI H, Tian Y, Song C, Li J, et al
    Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer.
    J Med Microbiol. 2019 Aug 16. doi: 10.1099/jmm.0.001058.
    Abstract     Related articles   

  1037. ZHU CZ, Ting HN, Ng KH, Ong TA, et al
    A review on the accuracy of bladder cancer detection methods.
    J Cancer. 2019;10:4038-4044.
    Abstract     Related articles   

  1038. REIS H, Szarvas T, Grunwald V
    [Predictive biomarkers in oncologic uropathology].
    Pathologe. 2019;40:264-275.
    Abstract     Related articles   

  1039. YANG PJ, Hsieh MJ, Hung TW, Wang SS, et al
    Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development.
    Int J Environ Res Public Health. 2019;16.
    Abstract     Related articles   

  1040. JANSEN I, Lucas M, Savci-Heijink CD, Meijer SL, et al
    Three-dimensional histopathological reconstruction of bladder tumours.
    Diagn Pathol. 2019;14:25.
    Abstract     Related articles   

  1041. MURALI-KRISHNAN S, Pang KH, Greco F, Fiori C, et al
    Bladder-sparing treatment in MIBC: where do we stand?
    Minerva Urol Nefrol. 2019;71:101-112.
    Abstract     Related articles   

  1042. REIS H, Szarvas T
    Urachal cancer-current concepts of a rare cancer.
    Pathologe. 2019;40.
    Abstract     Related articles   

  1043. GOMELLA LG
    Viral Therapy for Bladder Cancer: Everything Old is New Again.
    Can J Urol. 2019;26:9802.
    Abstract     Related articles   

  1044. PENG J, Ye L, Li T, Zhu Q, et al
    Irradiated Bladder Cancer Cells Expressing both GM-CSF and IL-21 versus Either GM-CSF or IL-21 Alone as Tumor Vaccine in a Mouse Xenograft Model.
    Biomed Res Int. 2019;2019:8262989.
    Abstract     Related articles   

  1045. CHEN S, Zhu S, Cui X, Xu W, et al
    Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy.
    Biomed Opt Express. 2019;10:3533-3544.
    Abstract     Related articles   

  1046. LU J, Zhong F, Sun B, Wang C, et al
    GPR137 is a promising novel bio-marker for the prognosis of bladder cancer patients.
    Medicine (Baltimore). 2019;98:e16576.
    Abstract     Related articles   

  1047. XIN F, Yao DW, Fan L, Liu JH, et al
    Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion.
    Clin Exp Med. 2019 Aug 28. pii: 10.1007/s10238-019-00576.
    Abstract     Related articles   

  1048. ZAMBONI S, Moschini M, Antonelli A, Simeone C, et al
    How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection.
    World J Urol. 2019 Aug 28. pii: 10.1007/s00345-019-02916.
    Abstract     Related articles   

  1049. SOUTHERN JB, Bhattacharya P, Clifton MM, Park A, et al
    Perioperative management of cold agglutinin autoimmune hemolytic anemia in an older adult undergoing radical cystectomy for bladder cancer.
    Urol Case Rep. 2019;27:100998.
    Abstract     Related articles   

  1050. WU L, Zhang M, Qi L, Zu X, et al
    ERalpha-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion.
    Cell Death Dis. 2019;10:635.
    Abstract     Related articles   

  1051. CHEN H, Chen L, Liu F, Lu J, et al
    Diffusion-weighted magnetic resonance imaging in bladder cancer: comparison of readout-segmented and single-shot EPI techniques.
    Cancer Imaging. 2019;19:59.
    Abstract     Related articles   

  1052. WU Y, Zheng Q, Li Y, Wang G, et al
    Metformin targets a YAP1-TEAD4 complex via AMPKalpha to regulate CCNE1/2 in bladder cancer cells.
    J Exp Clin Cancer Res. 2019;38:376.
    Abstract     Related articles   

  1053. SONG Y, Chen J, Liu K, Zhou K, et al
    Glutathione S-Transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: Evidence from a systematic review and meta-analysis based on 34 case-control studies.
    Gene. 2019 Aug 24:144077. doi: 10.1016/j.gene.2019.144077.
    Abstract     Related articles   

  1054. WROCLAWSKI ML, Schutz FA, Cha JD, Soares A, et al
    Alternative Therapies to Bacillus Calmette-Guerin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations.
    J Glob Oncol. 2019;5:1-9.
    Abstract     Related articles   

  1055. ZHOU J, Li L, Li X, Yu Q, et al
    Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial.
    Int J Hyperthermia. 2019;36:868-875.
    Abstract     Related articles   

  1056. PEPPAS I, Sollie S, Josephs DH, Hammar N, et al
    Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort.
    Cancer Epidemiol. 2019 Aug 23:101584. doi: 10.1016/j.canep.2019.101584.
    Abstract     Related articles   

  1057. SHI F, Deng Z, Zhou Z, Jiang CY, et al
    QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-kappaB signalling.
    J Cell Mol Med. 2019 Aug 26. doi: 10.1111/jcmm.14481.
    Abstract     Related articles   

  1058. BASTOS J, Miranda MA, Mondal A, Sachdeva M, et al
    Chemosensitizing effect of cernumidine extracted from Solanum cernuum Vell. on bladder cancer cells in vitro.
    Chem Biodivers. 2019 Aug 25. doi: 10.1002/cbdv.201900334.
    Abstract     Related articles   

  1059. OHADIAN MOGHADAM S, Nowroozi MR
    Toll-like receptors: The role in bladder cancer development, progression and immunotherapy.
    Scand J Immunol. 2019 Aug 26:e12818. doi: 10.1111/sji.12818.
    Abstract     Related articles   

  1060. YIN XH, Jin YH, Cao Y, Wong Y, et al
    Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer.
    Front Oncol. 2019;9:729.
    Abstract     Related articles   

  1061. OKSUZ E, Bugday MS
    Can intravesical application of paracetamol benefit the chemotherapy treatment of bladder cancer?
    Med Hypotheses. 2019;131:109322.
    Abstract     Related articles   

  1062. DEL POZO JIMENEZ G, Herranz Amo F, Diez Cordero JM, Monzo Gardiner JI, et al
    [Prognostic factors of mortality in patients with urothelial bladder tumor treated with radical cistectomy.]
    Arch Esp Urol. 2019;72:451-462.
    Abstract     Related articles   

  1063. KONDO A, Sasaki T, Kitaguchi D, Tsukada Y, et al
    Resection of the urinary bladder for locally advanced colorectal cancer: a retrospective comparison of partial versus total cystectomy.
    BMC Surg. 2019;19:63.
    Abstract     Related articles   

  1064. OSMANOV YI, Gaibov JA, Kogan EA, Rapoport LM, et al
    [Molecular basis of intratumoral heterogeneity of urinary tract urothelial carcinoma].
    Urologiia. 2019;:126-130.
    Abstract     Related articles   

  1065. POPOV SV, Skryabin ON, Orlov IN, Suleymanov MM, et al
    [Comparative analysis of results in laparoscopic radical cystectomy with extracorporeal and intracorporeal neobladder formation].
    Urologiia. 2019;:68-72.
    Abstract     Related articles   

  1066. GROVES A, Gleeson M, Spigelman AD
    NTHL1-associate polyposis: first Australian case report.
    Fam Cancer. 2019;18:179-182.
    Abstract     Related articles   

  1067. MA X, Hadjiiski LM, Wei J, Chan HP, et al
    U-Net based deep learning bladder segmentation in CT urography.
    Med Phys. 2019;46:1752-1765.
    Abstract     Related articles   

  1068. HONG JY, Jung GJ, Li K
    Acquired Cutaneous Lymphangiectasia Secondary to Cervical Cancer Treatment.
    Am J Dermatopathol. 2018 Oct 4. doi: 10.1097/DAD.0000000000001127.
    Abstract     Related articles   

  1069. LEI Y, Yang L, Hongwei J, Hongyuan Y, et al
    TIS111D can affect bladder cancer cells by regulating epithelial-mesenchymal transition.
    Life Sci. 2019 Sep 3:116832. doi: 10.1016/j.lfs.2019.116832.
    Abstract     Related articles   

  1070. JIAN X, Shen M, Liao G
    Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study.
    Medicine (Baltimore). 2019;98:e16873.
    Abstract     Related articles   

  1071. DELCOURT C, Gemival P, Nouhaud FX, Gobet F, et al
    Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC).
    World J Urol. 2019 Sep 5. pii: 10.1007/s00345-019-02896.
    Abstract     Related articles   

  1072. DAI L, Chai CM, Shen TY, Tian Y, et al
    LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
    Eur Rev Med Pharmacol Sci. 2019;23:6858-6867.
    Abstract     Related articles   

  1073. NIU L, Gao Z, Cui Y, Yang X, et al
    Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
    Med Sci Monit. 2019;25:6660-6668.
    Abstract     Related articles   

  1074. RELPH K, Annels N, Smith C, Kostalas M, et al
    Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus: Using a Bladder Tumor Precision-Cut Slice Model System to Assess Viral Efficacy.
    Methods Mol Biol. 2020;2058:249-259.
    Abstract     Related articles   

  1075. BIANCHI FM, Romagnoli D, D'Agostino D, Corsi P, et al
    Is robotic approach useful to palliate advanced bladder cancer? A monocentric single surgeon experience.
    Cent European J Urol. 2019;72:113-120.
    Abstract     Related articles   

  1076. GRONOSTAJ K, Czech AK, Fronczek J, Wiatr T, et al
    Implementation of neoadjuvant chemotherapy in muscle invasive bladder cancer treatment in Poland: a single institution retrospective study.
    Cent European J Urol. 2019;72:100-105.
    Abstract     Related articles   

  1077. TANDOGDU Z, Lewis R, Duncan A, Penegar S, et al
    Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectiveness.
    BMJ Open. 2019;9:e022268.
    Abstract     Related articles   


  1078. Expression of Concern: Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer.
    Cancer Prev Res (Phila). 2019 Sep 3. pii: 1940-6207.CAPR-19-0406.
    Abstract     Related articles   

  1079. RICHTERS A, Dickman PW, Witjes JA, Boormans JL, et al
    Bladder cancer survival: Women only fare worse in the first two years after diagnosis.
    Urol Oncol. 2019 Aug 31. pii: S1078-1439(19)30319.
    Abstract     Related articles   

  1080. BI J, Liu H, Dong W, Xie W, et al
    Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Mol Cancer. 2019;18:133.
    Abstract     Related articles   

  1081. MATARAZZO S, Melocchi L, Rezzola S, Grillo E, et al
    Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  1082. LIAN P, Wang Q, Zhao Y, Chen C, et al
    An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  1083. WANG X, Ni X, Tang G
    Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis.
    Front Oncol. 2019;9:757.
    Abstract     Related articles   

  1084. DANIELS MJ, Barry E, Milbar N, Schoenberg M, et al
    An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle-invasive bladder cancer.
    Urol Oncol. 2019 Aug 28. pii: S1078-1439(19)30299.
    Abstract     Related articles   

  1085. KARIM S, Mackillop WJ, Brennan K, Peng Y, et al
    Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer.
    Cancer Med. 2019 Aug 31. doi: 10.1002/cam4.2449.
    Abstract     Related articles   

  1086. HIROSE Y, Kinoshita A, Ishii A, Ishimoto U, et al
    [Successful treatment of unresectable advanced gastric cancer with bladder metastasis using mFOLFOX6:a case report].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:676-684.
    Abstract     Related articles   

  1087. ZHU F, Zhang Y, Shi L, Wu CL, et al
    Gene mutation detection of urinary sediment cells for NMIBC early diagnose and prediction of NMIBC relapse after surgery.
    Medicine (Baltimore). 2019;98:e16451.
    Abstract     Related articles   

  1088. RODRIGUEZ PENA MDC, Chaux A, Eich ML, Tregnago AC, et al
    Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
    Virchows Arch. 2019;475:349-356.
    Abstract     Related articles   

  1089. WILEY C, Wise CF, Breen M
    Novel Noninvasive Diagnostics.
    Vet Clin North Am Small Anim Pract. 2019;49:781-791.
    Abstract     Related articles   

  1090. SAGEHASHI R, Ichimura Y, Iinuma M
    [Primary Adenocarcinoma of the Bladder at the Vesicocutaneostomy Site Occuring 30 Years after the Operation].
    Hinyokika Kiyo. 2019;65:167-170.
    Abstract     Related articles   

  1091. ROMAGNOLI D, Bianchi FM, Corsi P, D'Agostino D, et al
    Robot-Assisted Radical Cystectomy with Intracorporeal Orthotopic Ileal Neobladder: A Safe Strategy in Elderly Patients? Results of Propensity Score Matching in a Single High-Volume Center.
    Surg Technol Int. 2019;34:302-309.
    Abstract     Related articles   

  1092. BERCHIOLLI R, Mocellin DM, Marconi M, Tomei F, et al
    Ruptured Mycotic Aneurysm After Intravesical Instillation for Bladder Tumor.
    Ann Vasc Surg. 2019;59:310.
    Abstract     Related articles   

  1093. AUDENET F, Sfakianos JP, Waingankar N, Ruel NH, et al
    A delay >/=8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging.
    Urol Oncol. 2019;37:116-122.
    Abstract     Related articles   

  1094. MICHELS CTJ, Wijburg CJ, Abma IL, Witjes JA, et al
    Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients.
    J Patient Rep Outcomes. 2019;3:62.
    Abstract     Related articles   

  1095. SHARIFI L, Nowroozi MR, Amini E, Arami MK, et al
    A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting.
    Int Immunopharmacol. 2019;76:105880.
    Abstract     Related articles   

  1096. ROGGISCH J, Ecke T, Koch S
    Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer.
    Urol Oncol. 2019 Sep 11. pii: S1078-1439(19)30325.
    Abstract     Related articles   

  1097. VAN HEMELRIJCK M, Sparano F, Josephs D, Sprangers M, et al
    Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review.
    BMC Urol. 2019;19:86.
    Abstract     Related articles   

  1098. PIGNOT G, Le Goux C, Vacher S, Schnitzler A, et al
    PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer.
    Oncol Lett. 2019;18:3471-3480.
    Abstract     Related articles   

  1099. WANG L, Shi J, Huang Y, Liu S, et al
    A six-gene prognostic model predicts overall survival in bladder cancer patients.
    Cancer Cell Int. 2019;19:229.
    Abstract     Related articles   

  1100. WU L, Yang F, Song L, Xiao Z, et al
    Comparison of intracorporeal and extracorporeal urinary diversions after laparoscopic radical cystectomy in females with bladder cancer.
    World J Surg Oncol. 2019;17:161.
    Abstract     Related articles   

  1101. KO SH, Han K, Yun JS, Chung S, et al
    Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0500.R2. doi: 10.1530/EJE-19-0500.
    Abstract     Related articles   

  1102. KAPOOR K, Datta C, Pal DK
    Is liquid-based cytology an alternative to conventional cytology for detection of malignant cells in urine of bladder cancer? Eastern Indian prospective observational study.
    Turk J Urol. 2019;45:351-356.
    Abstract     Related articles   

  1103. SPACHMANN PJ, Azzolina V, Weber F, Evert M, et al
    Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Pathol Oncol Res. 2019 Sep 10. pii: 10.1007/s12253-019-00745.
    Abstract     Related articles   

  1104. WU X, Chen H, Zhang G, Wu J, et al
    MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer.
    J Biosci. 2019;44.
    Abstract     Related articles   

  1105. PARK HS, Lee S, Lee J, Shin HB, et al
    Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation.
    Investig Clin Urol. 2019;60:396-404.
    Abstract     Related articles   

  1106. SAHIN Y, Yucetas U, Ates HA, Erkan E, et al
    Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response.
    Investig Clin Urol. 2019;60:343-350.
    Abstract     Related articles   

  1107. SCHNEIDER AK, Chevalier MF, Derre L
    The multifaceted immune regulation of bladder cancer.
    Nat Rev Urol. 2019 Sep 9. pii: 10.1038/s41585-019-0226.
    Abstract     Related articles   

  1108. BAO Y, Liu X, Liu Y, Wang S, et al
    Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
    Surg Oncol. 2019;30:63-71.
    Abstract     Related articles   

  1109. CHOI SY, You D, Hong B, Hong JH, et al
    Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?
    Surg Oncol. 2019;30:109-116.
    Abstract     Related articles   

  1110. NAVE O, Hareli S, Elbaz M, Iluz IH, et al
    BCG and IL - 2 model for bladder cancer treatment with fast and slow dynamics based on SPVF method-stability analysis.
    Math Biosci Eng. 2019;16:5346-5379.
    Abstract     Related articles   

  1111. BOURN J, Pandey S, Uddin J, Marnett L, et al
    Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A.
    Oncotarget. 2019;10:5168-5180.
    Abstract     Related articles   

  1112. MAN X, Liu T, Jiang Y, Zhang Z, et al
    Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating beta-catenin signaling pathway.
    Onco Targets Ther. 2019;12:6309-6322.
    Abstract     Related articles   

  1113. MCMULLEN CK, Rosetti MO, Weinmann S, Leo MC, et al
    Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer.
    Perm J. 2019;23.
    Abstract     Related articles   

  1114. LU J, Zhong F, Sun B, Wang C, et al
    Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients.
    Med Sci Monit. 2019;25:6736-6741.
    Abstract     Related articles   

  1115. WINOKER JS, Liaw CW, Galsky MD, Wiklund P, et al
    Clinical Complete Response after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Call for Standardized Assessments and Definitions.
    Eur Urol Focus. 2019 Sep 4. pii: S2405-4569(19)30227.
    Abstract     Related articles   

  1116. DAI Z, Yang L, Li Y, Zhao C, et al
    A portable dual-mode sensor based on a TiO2 nanotube membrane for the evaluation of telomerase activity.
    Chem Commun (Camb). 2019;55:10571-10574.
    Abstract     Related articles   

  1117. ARMAS-ALVAREZ AL, Fernandez-Lopez A, Donate-Moreno MJ, Salinas-Sanchez AS, et al
    [Bladder leiomyomas.]
    Arch Esp Urol. 2019;72:612-615.
    Abstract     Related articles   

  1118. LINNEHAN B, Snyman H, DeLay J, Mareschal A, et al
    URINARY BLADDER TRANSITIONAL CELL CARCINOMA AND CARCINOMATOSIS IN A LINNAEUS'S TWO-TOED SLOTH, CHOLOEPUS DIDACTYLUS.
    J Zoo Wildl Med. 2019;50:278-281.
    Abstract     Related articles   

  1119. HWANG EC, Sathianathen NJ, Imamura M, Kuntz GM, et al
    Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Cochrane Database Syst Rev. 2019;5:CD013336.
    Abstract     Related articles   

  1120. LUETHCKE KR, Ekena J, Chun R, Trepanier LA, et al
    Glutathione S-transferase theta genotypes and environmental exposures in the risk of canine transitional cell carcinoma.
    J Vet Intern Med. 2019;33:1414-1422.
    Abstract     Related articles   

  1121. DELL'OGLIO P, Tian Z, Leyh-Bannurah SR, Larcher A, et al
    Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy.
    Ann Surg Oncol. 2019;26:1942-1949.
    Abstract     Related articles   

  1122. NAYAK A, Depasquale B, Vergara N, Guzzo TA, et al
    Villous Adenoma Arising in the Native Bladder Mucosa and the Upper Urinary Tract With Coexisting Neuroendocrine Carcinoma Following Augmentation Cystoplasty.
    Int J Surg Pathol. 2019;27:450-456.
    Abstract     Related articles   

  1123. KIM JE, Martinez D
    Two uncommon cases of parathyroid hormone-related peptide mediated hypercalcemia in bladder carcinoma.
    Endocrinol Diabetes Nutr. 2019;66:69-70.
    Abstract     Related articles   

  1124. FU YR, Luo Y, Xie X, Lu W, et al
    Nanoscale bubble delivered YCD-TK/Cx26 gene therapeutic system suppresses tumor growth by inducing necrosis of tumor tissues in mouse Xenograft bladder cancer models.
    Eur Rev Med Pharmacol Sci. 2019;23:7338-7349.
    Abstract     Related articles   

  1125. SCHUBERT T, Renninger M, Schmid MA, Hassan FN, et al
    Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer.
    Urol Oncol. 2019 Sep 16. pii: S1078-1439(19)30331.
    Abstract     Related articles   

  1126. MA Y, Feng XF, Yang WX, You CG, et al
    Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.
    Biomed Res Int. 2019;2019:1093815.
    Abstract     Related articles   

  1127. GAO X, Zheng W, Ye L, Wen X, et al
    Exploration of bladder cancer-associated methylated miRNAs by methylated DNA immunoprecipitation sequencing.
    Onco Targets Ther. 2019;12:6165-6174.
    Abstract     Related articles   

  1128. ROMPRE-BRODEUR A, Shinde-Jadhav S, Ayoub M, Piccirillo CA, et al
    PD-1/PD-L1 Immune-Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects.
    Mol Cancer Ther. 2019 Sep 18. pii: 1535-7163.MCT-18-0986.
    Abstract     Related articles   

  1129. XU X
    Processed meat intake and bladder cancer risk in the prostate, lung, colorectal and ovarian (PLCO) cohort.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 18. pii: 1055-9965.EPI-19-0604.
    Abstract     Related articles   

  1130. BOLENZ C, Rother J, Meessen S, Grychtol B, et al
    [The development of real-time multispectral imaging for the diagnostics of bladder cancer].
    Urologe A. 2019 Sep 17. pii: 10.1007/s00120-019-01037.
    Abstract     Related articles   

  1131. DAI ZW, Cai KD, Li FR, Wu XB, et al
    Association between coffee consumption and risk of bladder cancer in a meta-analysis of 16 prospective studies.
    Nutr Metab (Lond). 2019;16:66.
    Abstract     Related articles   

  1132. KIM SO, Cha HJ, Park C, Lee H, et al
    Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway.
    Biosci Trends. 2019;13:324-333.
    Abstract     Related articles   

  1133. KULANDER O, Johansson J, Brudin L
    [Low frequency of cancer in the urinary organs when macroscopic hematuria is associated with bacteriuria].
    Lakartidningen. 2019;116.
    Abstract     Related articles   

  1134. NORDIN G, Eriksson Boija E
    [Achieving laboratory results you can rely on].
    Lakartidningen. 2019;116.
    Abstract     Related articles   

  1135. HAN S, Dong K, Shen M, Wang X, et al
    Observation and mechanism study of bladder wound healing after transurethral holmium laser resection of bladder tumor.
    Lasers Med Sci. 2019;34:1217-1227.
    Abstract     Related articles   

  1136. DARR C, Hadaschik BA, Tschirdewahn S
    [Systemic treatment of metastatic tumors of the upper urinary tract].
    Urologe A. 2019;58:30-33.
    Abstract     Related articles   

  1137. KNOLL T, Bach T
    [Enhanced endoscopic imaging for urothelial cancer].
    Aktuelle Urol. 2019;50:76-83.
    Abstract     Related articles   

  1138. GAKIS G, Volkmer B, Qvick B, Marteau F, et al
    [Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].
    Urologe A. 2019;58:34-40.
    Abstract     Related articles   

  1139. NESI G, Galli IC, Amorosi A, Santi R, et al
    Environment and urinary bladder cancer. A historical perspective.
    Pol J Pathol. 2019;70:21-25.
    Abstract     Related articles   

  1140. ZHANG Z, Xu H, Ji J, Shi X, et al
    Heterogeneity of PTEN and PPAR-gamma in cancer and their prognostic application to bladder cancer.
    Exp Ther Med. 2019;18:3177-3183.
    Abstract     Related articles   

  1141. SIM WJ, Iyengar PV, Lama D, Lui SKL, et al
    c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression.
    Nat Commun. 2019;10:4349.
    Abstract     Related articles   

  1142. KLEN R, Salminen AP, Mahmoudian M, Syvanen KT, et al
    Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology.
    Scand J Urol. 2019 Sep 25:1-7. doi: 10.1080/21681805.2019.1665579.
    Abstract     Related articles   

  1143. BAUMGART S, Meschkat P, Edelmann P, Heinzelmann J, et al
    MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Sep 24. pii: 10.1007/s00432-019-03035.
    Abstract     Related articles   

  1144. DATTA NR, Stutz E, Puric E, Eberle B, et al
    A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy.
    Front Oncol. 2019;9:889.
    Abstract     Related articles   

  1145. ABUDUREXITI M, Xie H, Jia Z, Zhu Y, et al
    Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.
    Front Oncol. 2019;9:856.
    Abstract     Related articles   

  1146. DAZA-CAJIGAL V, Albuquerque AS, Pearson J, Hinley J, et al
    Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer.
    Front Immunol. 2019;10:2065.
    Abstract     Related articles   

  1147. BOCHNER BH
    Lymph Node Dissection for Advanced Bladder Cancer: Is There a Role?
    Eur Urol Focus. 2019 Sep 21. pii: S2405-4569(19)30284.
    Abstract     Related articles   

  1148. PARIKH RB, Adamson BJS, Khozin S, Galsky MD, et al
    Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer.
    JAMA. 2019;322:1209-1211.
    Abstract     Related articles   

  1149. HOU G, Xu W, Jin Y, Wu J, et al
    MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D.
    Biochem Biophys Res Commun. 2019 Sep 20. pii: S0006-291X(19)31750.
    Abstract     Related articles   

  1150. LUO Y, Dong Y, Liang S, Yuan L, et al
    CpG Oligodeoxynucleotide Promotes Apoptosis of Human Bladder Cancer T24 Cells Via Inhibition of the Antiapoptotic Factors.
    Technol Cancer Res Treat. 2019;18:1533033819873636.
    Abstract     Related articles   

  1151. LI W, Li Y, Sun Z, Zhou J, et al
    Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR1231 pathway in bladder cancer progression.
    Int J Mol Med. 2019 Sep 17. doi: 10.3892/ijmm.2019.4340.
    Abstract     Related articles   

  1152. YANG C, Sun X, Wang H, Lu T, et al
    Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine.
    Int J Mol Med. 2019 Sep 23. doi: 10.3892/ijmm.2019.4347.
    Abstract     Related articles   

  1153. SHAN L, Liu W, Zhan Y
    Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  1154. LIU Y, Xiong S, Liu S, Chen J, et al
    Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.
    J Comput Biol. 2019 Sep 23. doi: 10.1089/cmb.2019.0237.
    Abstract     Related articles   

  1155. MORINAGA R, Kawahara T, Kuroda S, Inayama Y, et al
    Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer.
    Case Rep Oncol. 2019;12:603-607.
    Abstract     Related articles   

  1156. BHUSHAN S, Ray RS, Prakash J, Singh GN, et al
    Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis.
    Clin Ther. 2019 Sep 19. pii: S0149-2918(19)30422.
    Abstract     Related articles   

  1157. ORTIZ-BRUCHLE N, Muders M, Toma M, Esposito I, et al
    [Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group].
    Urologe A. 2019 Sep 20. pii: 10.1007/s00120-019-01046.
    Abstract     Related articles   

  1158. HU X, Xiong SC, Dou WC, Shao YX, et al
    Minimally invasive vs open radical cystectomy in patients with bladder cancer: A systematic review and meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2019 Sep 13. pii: S0748-7983(19)30808.
    Abstract     Related articles   

  1159. JANISCH F, Yu H, Vetterlein MW, Dahlem R, et al
    Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
    J Clin Med. 2019;8.
    Abstract     Related articles   

  1160. MOSCHINI M, Stabile A, Mattei A, Montorsi F, et al
    Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences.
    Int Braz J Urol. 2019;45:655-657.
    Abstract     Related articles   

  1161. BASATAC C, Aktepe F, Saglam S, Akpinar H, et al
    Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma.
    Int Braz J Urol. 2019;45:843-846.
    Abstract     Related articles   

  1162. CASTELLANI D, Gasparri L, Claudini R, Pavia MP, et al
    Iatrogenic foreign body in urinary bladder: Holmium laser vs. Ceramic, and the winner is....
    Int Braz J Urol. 2019;45:853.
    Abstract     Related articles   

  1163. LI D, Jiao W, Liang Z, Wang L, et al
    Variation in energy metabolism arising from the effect of the tumor microenvironment on cell biological behaviors of bladder cancer cells and endothelial cells.
    Biofactors. 2019 Oct 3. doi: 10.1002/biof.1568.
    Abstract     Related articles   

  1164. LIU J, Zhang Y, Zeng Q, Zeng H, et al
    Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes.
    Sci Adv. 2019;5:eaaw6499.
    Abstract     Related articles   

  1165. SIMON M, Elkayam N, Smerling J, Marcelin M, et al
    Opportunistic Disease or Metastatic Lesions: A Rare Finding in a Patient with Bladder Cancer.
    Curr Urol. 2019;13:54-56.
    Abstract     Related articles   

  1166. BARRY KH, Jones RR, Cantor KP, Freeman LEB, et al
    Ingested nitrate and nitrite and bladder cancer in Northern New England.
    Epidemiology. 2019 Sep 30. doi: 10.1097/EDE.0000000000001112.
    Abstract     Related articles   

  1167. HUANG Y, Wang H, Fu S, Luan T, et al
    Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.
    Eur J Cancer Prev. 2019 Oct 1. doi: 10.1097/CEJ.0000000000000551.
    Abstract     Related articles   

  1168. LIAO S, Ou M, Lai L, Lin H, et al
    Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer.
    Genes Genomics. 2019 Oct 1. pii: 10.1007/s13258-019-00868.
    Abstract     Related articles   

  1169. MAO F, Niu XB, Gu S, Ji L, et al
    The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.
    Clin Exp Med. 2019 Oct 1. pii: 10.1007/s10238-019-00582.
    Abstract     Related articles   

  1170. ZHOU HQ, Liu MS, Deng TB, Xie PB, et al
    The TGF-beta/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells.
    Onco Targets Ther. 2019;12:7809-7821.
    Abstract     Related articles   

  1171. QUAN Y, Lei H, Wahafu W, Liu Y, et al
    Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
    Biomed Pharmacother. 2019;120:109490.
    Abstract     Related articles   

  1172. MAKBOUL M, Farghaly S, Abdelkawi IF
    Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Br J Radiol. 2019 Oct 1:20190401. doi: 10.1259/bjr.20190401.
    Abstract     Related articles   

  1173. FU W, Wu X, Yang Z, Mi H, et al
    The effect of miR-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB.
    Arch Med Sci. 2019;15:1154-1162.
    Abstract     Related articles   

  1174. HAN N, Yuan F, Xian P, Liu N, et al
    GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.
    Onco Targets Ther. 2019;12:7591-7599.
    Abstract     Related articles   

  1175. ALANEE S, Deebajah M, Chen PI, Mora R, et al
    Using adaptive genetic algorithms combined with high sensitivity single cell-based technology to detect bladder cancer in urine and provide a potential noninvasive marker for response to anti-PD1 immunotherapy.
    Urol Oncol. 2019 Sep 27. pii: S1078-1439(19)30351.
    Abstract     Related articles   

  1176. LIN YH, Hou CP, Juang HH, Chang PL, et al
    Association between Bladder Outlet Obstruction and Bladder Cancer in Patients with Aging Male.
    J Clin Med. 2019;8.
    Abstract     Related articles   

  1177. YANG D, Ma Y, Zhao P, Ma J, et al
    Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
    Biomed Pharmacother. 2019;120:109433.
    Abstract     Related articles   

  1178. LIU F, Liu A, Lu X, Zhang Z, et al
    Dysbiosis signatures of the microbial profile in tissue from bladder cancer.
    Cancer Med. 2019 Sep 30. doi: 10.1002/cam4.2419.
    Abstract     Related articles   

  1179. CHI Q, Wang ZY, Li HY, Song DB, et al
    Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
    Chin Med J (Engl). 2019 Sep 17. doi: 10.1097/CM9.0000000000000455.
    Abstract     Related articles   

  1180. SHI J, Zhang P, Liu L, Min X, et al
    Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer.
    Mol Genet Genomic Med. 2019 Sep 30:e982. doi: 10.1002.
    Abstract     Related articles   

  1181. LIU X, Zhang X, Bi J, Li Z, et al
    Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells.
    J Cell Mol Med. 2019 Sep 29. doi: 10.1111/jcmm.14683.
    Abstract     Related articles   

  1182. TETTEH-QUARCOO PB, Akuetteh BK, Owusu IA, Quayson SE, et al
    Cytological and Wet Mount Microscopic Observations Made in Urine of Schistosoma haematobium-Infected Children: Hint of the Implication in Bladder Cancer.
    Can J Infect Dis Med Microbiol. 2019;2019:7912186.
    Abstract     Related articles   

  1183. WU X, Xu Q, Chen P, Yu C, et al
    Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer.
    Cancer Manag Res. 2019;11:8125-8133.
    Abstract     Related articles   

  1184. DI MASO M, Turati F, Bosetti C, Montella M, et al
    Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer.
    Cancer Epidemiol. 2019;63:101595.
    Abstract     Related articles   

  1185. YANG X, Wang P
    MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
    Pathol Res Pract. 2019 Aug 17:152598. doi: 10.1016/j.prp.2019.152598.
    Abstract     Related articles   

  1186. GRIMBERG DC, Shah A, Inman BA
    Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.
    Eur Urol Focus. 2019 Sep 24. pii: S2405-4569(19)30282.
    Abstract     Related articles   

  1187. ALBARGHOUTH MH, Hamza A
    [The impact of using intraoperative photodynamic diagnosis on the prognosis of bladder cancer].
    Aktuelle Urol. 2019 Sep 26. doi: 10.1055/a-1007-8497.
    Abstract     Related articles   

  1188. YANG L, Li YL, Li XQ, Zhang Z, et al
    Corrigendum to "High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer".
    Dis Markers. 2019;2019:5974238.
    Abstract     Related articles   

  1189. APOLO AB
    Determining superior first-line therapy in metastatic bladder cancer.
    Nat Rev Urol. 2019 Sep 26. pii: 10.1038/s41585-019-0245.
    Abstract     Related articles   

  1190. WYLIE H, Cahill F, Santaolalla A, Moss CL, et al
    Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer.
    BMJ Open. 2019;9:e029468.
    Abstract     Related articles   

  1191. ENIKEEV DV, Alyaev YG, Rapoport LM, Taratkin MS, et al
    [Multidisciplinary approach in urology. Laser technologies: faster, simpler, more efficient].
    Urologiia. 2019;.
    Abstract     Related articles   

  1192. LI G, Sun L, Mu Z, Liu S, et al
    MicroRNA-1298-5p inhibits cell proliferation and invasion of bladder cancer via downregulating connexin 43.
    Biochem Cell Biol. 2019 Oct 10. doi: 10.1139/bcb-2019-0137.
    Abstract     Related articles   

  1193. BURGESS EF, Livasy C, Trufan S, Hartman A, et al
    High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
    Urol Oncol. 2019 Oct 6. pii: S1078-1439(19)30360.
    Abstract     Related articles   

  1194. PAPADIMITRIOU MA, Avgeris M, Levis PK, Tokas T, et al
    DeltaNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
    J Cancer Res Clin Oncol. 2019 Oct 8. pii: 10.1007/s00432-019-03028.
    Abstract     Related articles   

  1195. LIU A, Xue Y, Liu F, Tan H, et al
    Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
    Cancer Biomark. 2019 Sep 27. pii: CBM182143. doi: 10.3233/CBM-182143.
    Abstract     Related articles   

  1196. CHEN C, Luo Y, He W, Zhao Y, et al
    Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.
    J Clin Invest. 2019 Oct 8. pii: 130892. doi: 10.1172/JCI130892.
    Abstract     Related articles   

  1197. ZHOU Q, Chen S, Lu M, Luo Y, et al
    EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human bladder cancer.
    Int J Biol Sci. 2019;15:2139-2155.
    Abstract     Related articles   

  1198. PARK C, Cha HJ, Choi EO, Lee H, et al
    Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  1199. CHESTNUT C, Smelser W, Dum T, Bechtel M, et al
    Glycemic impact of a diet and lifestyle intervention on diabetics and prediabetics during treatment for non-muscle invasive bladder cancer.
    Nutr Cancer. 2019 Oct 7:1-6. doi: 10.1080/01635581.2019.1672761.
    Abstract     Related articles   

  1200. GRONOSTAJ K, Czech AK, Fronczek J, Drobniak A, et al
    The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy.
    Clin Genitourin Cancer. 2019 Sep 12. pii: S1558-7673(19)30272.
    Abstract     Related articles   

  1201. TSAI TF, Chen PC, Lin YC, Chou KY, et al
    Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
    Environ Toxicol. 2019 Oct 6. doi: 10.1002/tox.22841.
    Abstract     Related articles   

  1202. ROUDAFSHANI Z, Jazayeri MH, Mahmoudi AR, Nedaeinia R, et al
    Evaluation of the frequency of CD5(+) B cells as natural immunoglobulin M producers and circulating soluble CD5 in patients with bladder cancer.
    Mol Biol Rep. 2019 Oct 5. pii: 10.1007/s11033-019-05087.
    Abstract     Related articles   

  1203. CARRION A, Huguet J, Ribal MJ, Dominguez A, et al
    Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.
    Urol Oncol. 2019 Oct 2. pii: S1078-1439(19)30358.
    Abstract     Related articles   

  1204. GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
    Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Urol Oncol. 2019 Oct 1. pii: S1078-1439(19)30376.
    Abstract     Related articles   

  1205. KASANGA TK, Ntanga DI, Musapoudi EM, Kapessa ND, et al
    [Recurrent invasive bladder urothelial carcinoma treated by cystectomy with substitutive ileal enterocystoplasty: case report].
    Pan Afr Med J. 2019;33:184.
    Abstract     Related articles   

  1206. BRIENS A, Castelli J, Barateau A, Jaksic N, et al
    [Adaptive radiotherapy: Strategies and benefits depending on tumor localization].
    Cancer Radiother. 2019;23.
    Abstract     Related articles   

  1207. OUEDRAOGO S, Traore MT, Kambire JL, Ouedraogo S, et al
    [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
    Bull Cancer. 2019;106:868-874.
    Abstract     Related articles   

  1208. BAHRAMI S, Kazemi B, Zali H, Black PC, et al
    Discovering therapeutic protein targets for muscle invasive bladder cancer by proteomic data analysis.
    Curr Mol Pharmacol. 2019 Oct 16. pii: CMP-EPUB-101531.
    Abstract     Related articles   

  1209. WANG F, Cao M, Fan M, Wu H, et al
    AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells.
    J Cell Physiol. 2019 Oct 16. doi: 10.1002/jcp.29307.
    Abstract     Related articles   

  1210. YUAN S, Luan X, Han G, Guo K, et al
    LINC01638 lncRNA mediates the postoperative distant recurrence of bladder cancer by upregulating ROCK2.
    Oncol Lett. 2019;18:5392-5398.
    Abstract     Related articles   

  1211. GRANT CM, Amdur R, Whalen MJ
    Trends in the use of neoadjuvant chemotherapy for bladder cancer with nonurothelial variant histology: An analysis of the National Cancer Database.
    Indian J Urol. 2019;35:291-298.
    Abstract     Related articles   

  1212. DE GOEIJ L, Westhoff E, Witjes JA, Aben KK, et al
    The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life.
    BMJ Open. 2019;9:e030396.
    Abstract     Related articles   

  1213. DE JONG JJ, Liu Y, Robertson AG, Seiler R, et al
    Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
    Genome Med. 2019;11:60.
    Abstract     Related articles   

  1214. WANG B, Wang Z, Zhang T, Yang G, et al
    Overexpression of thymosin beta10 correlates with disease progression and poor prognosis in bladder cancer.
    Exp Ther Med. 2019;18:3759-3766.
    Abstract     Related articles   

  1215. ZHU L, Sun J, Wang L, Li Z, et al
    Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis.
    Front Pharmacol. 2019;10:962.
    Abstract     Related articles   

  1216. WANG TW, Yuan H, Diao WL, Yang R, et al
    Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence.
    BMC Urol. 2019;19:90.
    Abstract     Related articles   

  1217. FANG C, Xu L, He W, Dai J, et al
    Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.
    Cell Cycle. 2019 Oct 15:1-12. doi: 10.1080/15384101.2019.1673633.
    Abstract     Related articles   

  1218. BORKOWSKA EM, Konecki T, Pietrusinski M, Borowiec M, et al
    MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  1219. NITTA M, Kuroda S, Nagao K, Higure T, et al
    Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.
    Jpn J Clin Oncol. 2019 Oct 15. pii: 5587304. doi: 10.1093.
    Abstract     Related articles   

  1220. DING ZS, He YH, Deng YS, Peng PX, et al
    MicroRNA-34a inhibits bladder cancer cell migration and invasion, and upregulates PTEN expression.
    Oncol Lett. 2019;18:5549-5554.
    Abstract     Related articles   

  1221. YOSHIDA T, Sopko NA, Kates M, Liu X, et al
    Impact of spheroid culture on molecular and functional characteristics of bladder cancer cell lines.
    Oncol Lett. 2019;18:4923-4929.
    Abstract     Related articles   

  1222. YANG Y, Zhang F, Huang H, Xie Z, et al
    Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis.
    J Cell Physiol. 2019 Oct 14. doi: 10.1002/jcp.29271.
    Abstract     Related articles   

  1223. CHEREMISIN D, Andropova P, Gavrilov P
    Reply to: BCG infection following immunotherapy for bladder cancer.
    QJM. 2019 Oct 14. pii: 5586893. doi: 10.1093.
    Abstract     Related articles   

  1224. MOSINA N, Kayukov I
    Renal tuberculosis following BCG therapy for bladder cancer.
    QJM. 2019 Oct 14. pii: 5586891. doi: 10.1093.
    Abstract     Related articles   

  1225. KOUBA E, Lopez-Beltran A, Montironi R, Massari F, et al
    Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
    Expert Rev Mol Diagn. 2019 Oct 17:1-10. doi: 10.1080/14737159.2019.1680284.
    Abstract     Related articles   

  1226. SZARVAS T, Olah C, Riesz P, Geczi L, et al
    [Molecular subtype classification of urothelial bladder cancer and its clinical relevance].
    Orv Hetil. 2019;160:1647-1654.
    Abstract     Related articles   

  1227. LIU S, Chen Q, Wang Y
    MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway.
    Hum Cell. 2019 Oct 11. pii: 10.1007/s13577-019-00285.
    Abstract     Related articles   

  1228. MA W, Ma J, Lei T, Zhao M, et al
    Targeting immunotherapy for bladder cancer by using anti-CD3 x CD155 bispecific antibody.
    J Cancer. 2019;10:5153-5161.
    Abstract     Related articles   

  1229. ZHOU K, Yang J, Li X, Chen W, et al
    Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer.
    Exp Ther Med. 2019;18:3475-3483.
    Abstract     Related articles   

  1230. TANG F, He Z, Lu Z, Wu W, et al
    Application of nomograms in the prediction of overall survival and cancer-specific survival in patients with T1 high-grade bladder cancer.
    Exp Ther Med. 2019;18:3405-3414.
    Abstract     Related articles   

  1231. VESKIMAE E, Espinos EL, Bruins HM, Yuan Y, et al
    What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology
    Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30144.
    Abstract     Related articles   

  1232. MARTIN KA, Hum NR, Sebastian A, He W, et al
    Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  1233. UCPINAR B, Erbin A, Ayranci A, Caglar U, et al
    Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?
    J BUON. 2019;24:1659-1665.
    Abstract     Related articles   

  1234. CHEN L, Hu W, Li G, Guo Y, et al
    Efficacy of bladder perfusion of alternating hydroxycamptothecin and gemcitabine combined with low-dose tuberculin in the treatment of non-muscle invasive bladder cancer after TURBT.
    J BUON. 2019;24:1652-1658.
    Abstract     Related articles   

  1235. WAHLIN S, Nodin B, Leandersson K, Boman K, et al
    Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens.
    Oncoimmunology. 2019;8:e1644108.
    Abstract     Related articles   

  1236. WOODFORD MR, Hughes M, Sager RA, Backe SJ, et al
    Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity.
    Oncotarget. 2019;10:5824-5834.
    Abstract     Related articles   

  1237. SHI H, Li J, Li K, Yang X, et al
    Minimally invasive versus open radical cystectomy for bladder cancer: A systematic review and meta-analysis.
    J Int Med Res. 2019;47:4604-4618.
    Abstract     Related articles   

  1238. ZHANG N, Wang X, Wang C, Chen S, et al
    Diagnostic Accuracy of Multi-Parametric Magnetic Resonance Imaging for Tumor Staging of Bladder Cancer: Meta-Analysis.
    Front Oncol. 2019;9:981.
    Abstract     Related articles   

  1239. ALDOGHACHI AF, Baharudin A, Ahmad U, Chan SC, et al
    Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer.
    Dis Markers. 2019;2019:3875147.
    Abstract     Related articles   

  1240. SATO G, Yoshida T, Yanishi M, Saito R, et al
    Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Clin Genitourin Cancer. 2019 Sep 27. pii: S1558-7673(19)30286.
    Abstract     Related articles   

  1241. SIDDIQUI Z, Srivastava AN, Sankhwar SN, Zaidi N, et al
    Oct-4: a prognostic biomarker of urinary bladder cancer in North India.
    Ther Adv Urol. 2019;11:1756287219875576.
    Abstract     Related articles   

  1242. WU ZS, Ding W, Cai J, Bashir G, et al
    Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.
    Onco Targets Ther. 2019;12:8161-8177.
    Abstract     Related articles   

  1243. WANG RJ, Liu W, Mu XY, Yao ZX, et al
    Preoperative CD4(+)CD25(+)/CD4(+) and tumor diameter predict prognosis in male patients with bladder cancer.
    Biomark Med. 2019;13:1387-1397.
    Abstract     Related articles   

  1244. LI WM, Wu WJ
    Transgelin in bladder cancer: A potential biomarker and therapeutic target.
    EBioMedicine. 2019 Oct 17. pii: S2352-3964(19)30609.
    Abstract     Related articles   

  1245. FERNANDEZ MI, Valdebenito P, Delgado I, Segebre J, et al
    Impact of arsenic exposure on clinicopathological characteristics of bladder cancer: A comparative study between patients from an arsenic-exposed region and nonexposed reference sites.
    Urol Oncol. 2019 Oct 17. pii: S1078-1439(19)30364.
    Abstract     Related articles   

  1246. FUKUOKAYA W, Kimura T, Miki J, Kimura S, et al
    Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non-muscle-invasive Bladder Cancer: A Propensity Score-matched Analysis.
    Clin Genitourin Cancer. 2019 Sep 27. pii: S1558-7673(19)30274.
    Abstract     Related articles   

  1247. VOSKUILEN CS, Bosschieter J, van Werkhoven E, Hendricksen K, et al
    Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer.
    Radiother Oncol. 2019 Oct 17. pii: S0167-8140(19)33115.
    Abstract     Related articles   

  1248. FARAJ K, Chang YH, Rose KM, Habermann EB, et al
    Single-dose perioperative mitomycin-C versus thiotepa for low-grade noninvasive bladder cancer.
    Can J Urol. 2019;26:9922-9930.
    Abstract     Related articles   

  1249. CHEN C, Huang H, Zhao Y, Liu H, et al
    Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.
    BMJ Open. 2019;9:e028173.
    Abstract     Related articles   

  1250. NGUYEN HT, Shah ZK, Mortazavi A, Pohar KS, et al
    Periodically rotated overlapping parallel lines with enhanced reconstruction acquisition to improve motion-induced artifacts in bladder cancer imaging: Initial findings.
    Medicine (Baltimore). 2019;98:e17075.
    Abstract     Related articles   

  1251. FUJIMI A, Nagamachi Y, Yamauchi N, Tamura F, et al
    Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 That Was Successfully Treated with Regorafenib.
    Intern Med. 2019;58:1865-1870.
    Abstract     Related articles   

  1252. YANG G, Liu M, Liu Q, Duan X, et al
    Granulocytic myeloid-derived suppressor cells correlate with outcomes undergoing neoadjuvant chemotherapy for bladder cancer.
    Urol Oncol. 2019 Oct 28. pii: S1078-1439(18)30235.
    Abstract     Related articles   

  1253. FURUYA H, Pagano I, Chee K, Kobayashi T, et al
    Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic Signature.
    Diagnostics (Basel). 2019;9.
    Abstract     Related articles   

  1254. DE KEUKELEIRE S, De Maeseneer D, Jacobs C, Rottey S, et al
    Targeting FGFR in bladder cancer: ready for clinical practice?
    Acta Clin Belg. 2019 Oct 31:1-8. doi: 10.1080/17843286.2019.1685738.
    Abstract     Related articles   

  1255. APOLO AB, Milowsky MI, Kim L, Inman BA, et al
    Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.
    JAMA Oncol. 2019 Oct 31:1-9. doi: 10.1001/jamaoncol.2019.4114.
    Abstract     Related articles   

  1256. WANG Y, Shen Y, Hu X, Li Z, et al
    Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer.
    AJR Am J Roentgenol. 2019 Oct 31:1-7. doi: 10.2214/AJR.19.21668.
    Abstract     Related articles   

  1257. RUSSELL B, Liedberg F, Khan MS, Nair R, et al
    A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients.
    Eur Urol Oncol. 2019 Oct 23. pii: S2588-9311(19)30151.
    Abstract     Related articles   

  1258. BRAICU C, Buiga R, Cojocneanu R, Buse M, et al
    Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
    J Exp Clin Cancer Res. 2019;38:433.
    Abstract     Related articles   

  1259. ALJABERY F, Liedberg F, Haggstrom C, Strock V, et al
    Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe).
    Scand J Urol. 2019 Oct 30:1-7. doi: 10.1080/21681805.2019.1681504.
    Abstract     Related articles   

  1260. WANG R, Yan Y, Liu S, Yao X, et al
    Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Biomed Res Int. 2019;2019:3628384.
    Abstract     Related articles   

  1261. TEY J, Soon YY, Cheo T, Ooi KH, et al
    Efficacy of Palliative Bladder Radiotherapy for Hematuria in Advanced Bladder Cancer Using Contemporary Radiotherapy Techniques.
    In Vivo. 2019;33:2161-2167.
    Abstract     Related articles   

  1262. LIU YC, Lin KH, Hsieh JH, Chung JG, et al
    Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-kB-modulated Survival and Invasion Potential in Bladder Cancer.
    In Vivo. 2019;33:1865-1877.
    Abstract     Related articles   

  1263. SUN N, Liang Y, Chen Y, Wang L, et al
    Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis.
    Int J Mol Med. 2019 Oct 25. doi: 10.3892/ijmm.2019.4385.
    Abstract     Related articles   

  1264. CAO R, Yuan L, Ma B, Wang G, et al
    An EMT-related gene signature for the prognosis of human bladder cancer.
    J Cell Mol Med. 2019 Oct 28. doi: 10.1111/jcmm.14767.
    Abstract     Related articles   

  1265. JAIN H, Gada K, Zaidi S, Asiago-Reddy E, et al
    Mycobacterium bovis epidural abscess following Bacillus Calmette-Guerin therapy for bladder cancer.
    Proc (Bayl Univ Med Cent). 2019;32:577-578.
    Abstract     Related articles   

  1266. DONG F, Chen L, Wang R, Yang W, et al
    4-nitrophenol exposure in T24 human bladder cancer cells promotes proliferation, motilities and epithelial-to-mesenchymal transition.
    Environ Mol Mutagen. 2019 Oct 26. doi: 10.1002/em.22345.
    Abstract     Related articles   

  1267. QUERIDO S, Fernandes I, Weigert A, Casimiro S, et al
    High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: the first evidence of JC virus as a potential oncovirus in bladder cancer.
    Am J Transplant. 2019 Oct 25. doi: 10.1111/ajt.15663.
    Abstract     Related articles   

  1268. CHRISTOPH F, Herrmann F, Werthemann P, Janik T, et al
    Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancer.
    BMC Urol. 2019;19:100.
    Abstract     Related articles   

  1269. KOUBA E, Cheng L
    Clinical utility versus futility: a tipping point for liquid biopsies in bladder cancer.
    Future Oncol. 2019 Oct 25. doi: 10.2217/fon-2019-0522.
    Abstract     Related articles   

  1270. LIU P, Li X, Cui Y, Chen J, et al
    LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer.
    Acta Biochim Biophys Sin (Shanghai). 2019 Oct 23. pii: 5603543.
    Abstract     Related articles   

  1271. PENG M, Deng J, Zhou S, Xiao D, et al
    Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth.
    Front Pharmacol. 2019;10:1159.
    Abstract     Related articles   

  1272. YAN D, Dong W, He Q, Yang M, et al
    Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation.
    EBioMedicine. 2019 Oct 21. pii: S2352-3964(19)30596.
    Abstract     Related articles   

  1273. KISLYAKOV DA, Severgina LO, Tsarichenko DG, Rapoport LM, et al
    [Novel approaches for transurethral en-bloc resection of large bladder tumors].
    Urologiia. 2019;:105-111.
    Abstract     Related articles   

  1274. DARENKOV SP, Pinchuk IS, Proskokov AA, Trofimchuk AD, et al
    [Radical cystectomy: therapeutic aspects of preoperative and early postoperative management].
    Urologiia. 2019;:44-50.
    Abstract     Related articles   

  1275. HOLMANG S, Hedelin H, Malmstrom PU

    Lakartidningen. 2019;116.
    Abstract     Related articles   

  1276. ZHANG B, Fu Z, Liu L, Qiao B, et al
    Non-functional paraganglioma of urinary bladder managed by transurethral resection.
    Int Braz J Urol. 2019;45:910-915.
    Abstract     Related articles   

  1277. ZHANG M, Chen Y, Cong X, Zhao X, et al
    Utility of intravoxel incoherent motion MRI derived parameters for prediction of aggressiveness in urothelial bladder carcinoma.
    J Magn Reson Imaging. 2018 May 8. doi: 10.1002/jmri.26165.
    Abstract     Related articles   

  1278. FERNANDEZ-CONEJO G, de la Pena E, Hernandez V, Castro A, et al
    Incidence and prognosis of clinically significant incidental prostate cancer after radical cystectomy for bladder cancer.
    Arch Esp Urol. 2019;72:915-920.
    Abstract     Related articles   

  1279. ZHANG L, Wang CZ, Ma M, Shao GF, et al
    MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:8813-8822.
    Abstract     Related articles   

  1280. ZHU QL, Zhan DM, Chong YK, Ding L, et al
    MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.
    Eur Rev Med Pharmacol Sci. 2019;23:8806-8812.
    Abstract     Related articles   

  1281. XIONG M, Chen L, Zhou L, Ding Y, et al
    NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Theranostics. 2019;9:7156-7167.
    Abstract     Related articles   

  1282. MAZZONE E, Knipper S, Mistretta FA, Palumbo C, et al
    Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies.
    J Natl Compr Canc Netw. 2019;17:1344-1352.
    Abstract     Related articles   

  1283. TAE JH, Pyun JH, Shim JS, Cho S, et al
    Oncological and functional outcomes of robot-assisted radical cystectomy in bladder cancer patients in a single tertiary center: Can these be preserved throughout the learning curve?
    Investig Clin Urol. 2019;60:463-471.
    Abstract     Related articles   

  1284. ZHANG C, Chang X, Chen D, Yang F, et al
    Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.
    Cancer Manag Res. 2019;11:7909-7923.
    Abstract     Related articles   

  1285. DE NUNZIO C, Giannatempo P, Passalacqua R, Fiorini E, et al
    Epidemiology and unmet needs of bladder cancer in Italy: a critical review.
    Minerva Urol Nefrol. 2019 Nov 4. pii: S0393-2249.19.03498.
    Abstract     Related articles   

  1286. YAO J, Zhang Z, Li S, Li B, et al
    Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays.
    J Cell Mol Med. 2019 Nov 5. doi: 10.1111/jcmm.14775.
    Abstract     Related articles   

  1287. HURLE R, Casale P, Saita A, Colombo P, et al
    Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) proj
    World J Urol. 2019 Nov 5. pii: 10.1007/s00345-019-03002.
    Abstract     Related articles   

  1288. ZHANG Y, Hong YK, Zhuang DW, He XJ, et al
    Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
    Medicine (Baltimore). 2019;98:e17725.
    Abstract     Related articles   

  1289. LI Z, Wei D, Zhu C, Zhang Q, et al
    Effect of a patient education and rehabilitation program on anxiety, depression and quality of life in muscle invasive bladder cancer patients treated with adjuvant chemotherapy.
    Medicine (Baltimore). 2019;98:e17437.
    Abstract     Related articles   

  1290. ALLEN BC, Oto A, Akin O, Alexander LF, et al
    ACR Appropriateness Criteria(R) Post-Treatment Surveillance of Bladder Cancer.
    J Am Coll Radiol. 2019;16.
    Abstract     Related articles   

  1291. YU H, Wu CL, Wang X, Ban Q, et al
    SP600125 enhances C-2-induced cell death by the switch from autophagy to apoptosis in bladder cancer cells.
    J Exp Clin Cancer Res. 2019;38:448.
    Abstract     Related articles   

  1292. BOUBAKER NS, Gurtner A, Trabelsi N, Manni I, et al
    Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer.
    Cancer Biomark. 2019 Oct 25. pii: CBM190483. doi: 10.3233/CBM-190483.
    Abstract     Related articles   

  1293. HWANG B, Shin SS, Song JH, Choi YH, et al
    Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis.
    J Nutr Biochem. 2019;74:108230.
    Abstract     Related articles   

  1294. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    External Replication of Urinary Bladder Cancer Prognostic Polymorphisms in the UK Biobank.
    Front Oncol. 2019;9:1082.
    Abstract     Related articles   

  1295. WANG Y, Chen L, Ju L, Qian K, et al
    Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
    Front Oncol. 2019;9:1030.
    Abstract     Related articles   

  1296. WENTLAND AL, Desser TS, Troxell ML, Kamaya A, et al
    Bladder cancer and its mimics: a sonographic pictorial review with CT/MR and histologic correlation.
    Abdom Radiol (NY). 2019 Nov 1. pii: 10.1007/s00261-019-02276.
    Abstract     Related articles   

  1297. RICHTERS A, Aben KKH, Kiemeney LALM
    The global burden of urinary bladder cancer: an update.
    World J Urol. 2019 Nov 1. pii: 10.1007/s00345-019-02984.
    Abstract     Related articles   

  1298. KAUSHIK D, Shi Z, Liss MA, Wang H, et al
    Screening logs from a pilot randomized controlled trial of radical cystectomy versus chemoradiation therapy for muscle-invasive bladder cancer.
    Urol Oncol. 2019 Oct 29. pii: S1078-1439(19)30359.
    Abstract     Related articles   

  1299. BLACK AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, et al
    The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
    Urol Oncol. 2019 Oct 29. pii: S1078-1439(19)30374.
    Abstract     Related articles   

  1300. JIANG C, Zhao W, Qin M, Jin M, et al
    CD56-chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report.
    Medicine (Baltimore). 2019;98:e17572.
    Abstract     Related articles   

  1301. TATEOKA J, Wada N, Tamaki G, Kikuchi D, et al
    [A Case of Adenocarcinoma of the Reconstructed Bladder 45 Years after Ileocystoplasty].
    Hinyokika Kiyo. 2019;65:305-308.
    Abstract     Related articles   

  1302. CAI H, Yang X, Gao Y, Xu Z, et al
    Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer.
    Mol Ther Nucleic Acids. 2019;18:787-800.
    Abstract     Related articles   

  1303. WAHAFU W, Liu S, Xu W, Wang M, et al
    The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study.
    BMC Urol. 2019;19:117.
    Abstract     Related articles   

  1304. KOCSMAR I, Pajor G, Gyongyosi B, Szekely E, et al
    Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer.
    Am J Clin Pathol. 2019 Nov 16. pii: 5626496. doi: 10.1093.
    Abstract     Related articles   

  1305. BALBAY MD, Canda AE, Kiremit MC, Koseoglu E, et al
    Intracorporeal Studer pouch formation with Balbay's technique following robotic radical cystectomy for bladder cancer: Experience with 22 cases with oncologic and functional outcomes.
    J Endourol. 2019 Nov 15. doi: 10.1089/end.2019.0559.
    Abstract     Related articles   

  1306. LIN GB, Zhang CM, Chen XY, Wang JW, et al
    Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
    Math Biosci Eng. 2019;17:834-844.
    Abstract     Related articles   

  1307. RASSY E, Assi T, Kattan J
    Is there a role for maintenance therapy after platinum chemotherapy in bladder cancer in the era of immune therapy?
    Future Oncol. 2019 Nov 15. doi: 10.2217/fon-2019-0542.
    Abstract     Related articles   

  1308. ZHU D, Li H
    Case Study: Landscape of Chimeric RNAs in Bladder Cancer.
    Methods Mol Biol. 2020;2079:233-241.
    Abstract     Related articles   

  1309. TAO K, Liu S, Wang L, Qiu H, et al
    Targeted multifunctional nanomaterials with MRI, chemotherapy and photothermal therapy for the diagnosis and treatment of bladder cancer.
    Biomater Sci. 2019 Nov 14. doi: 10.1039/c9bm01377.
    Abstract     Related articles   

  1310. KIM A, Kim MS, Ahn JH, Choi WS, et al
    Clinical significance of 5-alpha reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review.
    Aging Male. 2019 Nov 14:1-8. doi: 10.1080/13685538.2019.1646238.
    Abstract     Related articles   

  1311. MEHROTRA S, Rowland M, Zhang H, Russell B, et al
    Scoping review protocol: is there a role for physical activity interventions in the treatment pathway of bladder cancer?
    BMJ Open. 2019;9:e033518.
    Abstract     Related articles   

  1312. QI Y, Chang Y, Wang Z, Chen L, et al
    Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
    Cancer Immunol Immunother. 2019 Nov 12. pii: 10.1007/s00262-019-02429.
    Abstract     Related articles   

  1313. CZECH AK, Gronostaj K, Frydrych J, Fronczek J, et al
    Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer.
    Cent European J Urol. 2019;72:252-257.
    Abstract     Related articles   

  1314. STROMYER ML, Southerland MR, Satyal U, Sikder RK, et al
    Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines.
    Eur J Med Chem. 2019 Oct 31:111832. doi: 10.1016/j.ejmech.2019.111832.
    Abstract     Related articles   

  1315. SIDDIQUI Z, Srivastava AN, Sankhwar SN, Dalela D, et al
    Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
    Br J Biomed Sci. 2019 Nov 13. pii: 10.1080/09674845.2019.1692761.
    Abstract     Related articles   

  1316. LIU MK, Ma T, Yu Y, Suo Y, et al
    MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Technol Cancer Res Treat. 2019;18:1533033819886897.
    Abstract     Related articles   

  1317. ROSIELLO G, Knipper S, Palumbo C, Pecoraro A, et al
    Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Clin Genitourin Cancer. 2019 Oct 17. pii: S1558-7673(19)30316.
    Abstract     Related articles   

  1318. LEO MC, McMullen CK, O'Keeffe-Rosetti M, Weinmann S, et al
    External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system.
    Urol Oncol. 2019 Nov 8. pii: S1078-1439(19)30404.
    Abstract     Related articles   

  1319. MOTTERLE G, Andrews JR, Morlacco A, Karnes RJ, et al
    Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer.
    Eur Urol Focus. 2019 Nov 7. pii: S2405-4569(19)30338.
    Abstract     Related articles   

  1320. LI W, Li Y, Ma W, Zhou J, et al
    Long noncoding RNA AC114812.8 promotes the progression of bladder cancer through miR-371b-5p/FUT4 axis.
    Biomed Pharmacother. 2019;121:109605.
    Abstract     Related articles   

  1321. REIS H, Szarvas T
    [Predictive biomarkers in bladder cancer].
    Pathologe. 2019 Nov 8. pii: 10.1007/s00292-019-00688.
    Abstract     Related articles   

  1322. SIM WJ, Iyengar PV, Lama D, Lui SKL, et al
    Author Correction: c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression.
    Nat Commun. 2019;10:5148.
    Abstract     Related articles   

  1323. MORII Y, Osawa T, Suzuki T, Shinohara N, et al
    Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs.
    BMC Urol. 2019;19:110.
    Abstract     Related articles   

  1324. NGUYEN EK, Yu H, Pond G, Shayegan B, et al
    Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2019 Nov 5. pii: cuaj.5945. doi: 10.5489/cuaj.5945.
    Abstract     Related articles   

  1325. ZHANG W, Wang R, Ma W, Wu Y, et al
    Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy.
    Ann Transl Med. 2019;7:431.
    Abstract     Related articles   

  1326. WANG QH, Ji JL, Li H, He PL, et al
    [Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:622-629.
    Abstract     Related articles   

  1327. ZHANG Y, Wang Y, Song B, Li H, et al
    Patients' self-report anxiety, depression and quality of life and their predictive factors in muscle invasive bladder cancer patients receiving adjuvant chemotherapy.
    Psychol Health Med. 2019 Nov 8:1-11. doi: 10.1080/13548506.2019.1687912.
    Abstract     Related articles   

  1328. TAN S, Kang Y, Li H, Zheng L, et al
    [Early complications after robot-assisted laparoscopic radical cystectomy and their risk factors].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44:1003-1008.
    Abstract     Related articles   

  1329. TOKURA T, Watanabe N, Morita T
    [A Case of Urachal Cancer at the Inserted Site of Cystostomy after 23 Years].
    Gan To Kagaku Ryoho. 2019;46:1656-1658.
    Abstract     Related articles   

  1330. RAMIREZ BACKHAUS M, Calatrava-Fons A, Gomez-Ferrer A, Collado-Serra A, et al
    [ICG lymphography and fluorescence in pelvic lymphadenectomy for bladder and prostate cancer.]
    Arch Esp Urol. 2019;72:831-841.
    Abstract     Related articles   

  1331. LUZZAGO S, Palumbo C, Rosiello G, Pecoraro A, et al
    The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
    J Surg Oncol. 2019;120:1266-1275.
    Abstract     Related articles   

  1332. ANAND V, Khandelwal M, Appunni S, Gupta N, et al
    CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.
    J Cancer Res Clin Oncol. 2019;145:2649-2661.
    Abstract     Related articles   

  1333. YOON HY, Chang IH, Goo YT, Kim CH, et al
    Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
    Int J Nanomedicine. 2019;14:6249-6268.
    Abstract     Related articles   

  1334. BILLGER M, Kirk J, Chang J, Bedard A, et al
    Response to letter from Dr Oliviera in relation to our publication: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Regul Toxicol Pharmacol. 2019;106:347-348.
    Abstract     Related articles   

  1335. OLIVEIRA PA, Seixas F
    Re: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Regul Toxicol Pharmacol. 2019;106:346.
    Abstract     Related articles   

  1336. MEUNIER ME, Neuzillet Y, Raynaud JP, Radulescu C, et al
    Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
    Prostate. 2019;79:272-280.
    Abstract     Related articles   

  1337. ZALESKI M, Gogoj A, Walter V, Raman JD, et al
    Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
    Hum Pathol. 2019;84:275-282.
    Abstract     Related articles   

  1338. BARRESI V, Nunnari CM, Lionti S
    Immunohistochemical stains to detect residual tumor in cystectomy specimens taken shortly after transurethral resection of bladder tumors.
    Ann Diagn Pathol. 2019;40:176-179.
    Abstract     Related articles   

  1339. LI M, Liu Y, Liu J, Li W, et al
    Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  1340. LARSEN ES, Joensen UN, Poulsen AM, Goletti D, et al
    Bacillus Calmette-Guerin immunotherapy for bladder cancer: A review of immunological aspects, clinical effects and BCG infections.
    APMIS. 2019 Nov 22. doi: 10.1111/apm.13011.
    Abstract     Related articles   

  1341. BASU A, Sadeghi S
    Neoadjuvant Therapies for Bladder Cancer in Cisplatin-ineligible Patients: What Options Do We Have?
    Eur Urol Focus. 2019 Nov 18. pii: S2405-4569(19)30339.
    Abstract     Related articles   

  1342. YAN L, Wang P, Fang W, Liang C, et al
    Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion.
    Cell Biochem Funct. 2019 Nov 21. doi: 10.1002/cbf.3462.
    Abstract     Related articles   

  1343. ZHANG WY, Liu QH, Wang TJ, Zhao J, et al
    CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling.
    Biosci Rep. 2019 Nov 20. pii: 221189. doi: 10.1042/BSR20192779.
    Abstract     Related articles   

  1344. WASEDA Y, Kobayashi S, Kanda E, Yokoyama M, et al
    Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model.
    Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30309.
    Abstract     Related articles   

  1345. AL-AHMADIE H, Netto GJ
    Updates on the Genomics of Bladder Cancer and Novel Molecular Taxonomy.
    Adv Anat Pathol. 2019 Nov 14. doi: 10.1097/PAP.0000000000000252.
    Abstract     Related articles   

  1346. HECHLER V, Rink M, Beyersdorff D, Beer M, et al
    [The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics-status quo].
    Urologe A. 2019 Nov 18. pii: 10.1007/s00120-019-01061.
    Abstract     Related articles   

  1347. HORWICH A, Babjuk M, Bellmunt J, Bruins HM, et al
    EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committeesdagger.
    Ann Oncol. 2019 Nov 19. pii: 5629133. doi: 10.1093.
    Abstract     Related articles   

  1348. PAN S, Zhan Y, Chen X, Wu B, et al
    Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors.
    Front Oncol. 2019;9:1101.
    Abstract     Related articles   

  1349. CHEN S, Zhang N, Shao J, Wang T, et al
    A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
    J Cancer. 2019;10:5744-5753.
    Abstract     Related articles   

  1350. SONG BN, Kim SK, Mun JY, Choi YD, et al
    Identification of an immunotherapy-responsive molecular subtype of bladder cancer.
    EBioMedicine. 2019 Nov 15. pii: S2352-3964(19)30733.
    Abstract     Related articles   

  1351. DENG LH, Xu FH, Zeng T, Xu XD, et al
    [Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:601-608.
    Abstract     Related articles   

  1352. NOFUJI S, Kato R, Sakai Y, Konishi Y, et al
    [A Case of paraganglioma of Urinary Bladder].
    Hinyokika Kiyo. 2019;65:421-424.
    Abstract     Related articles   

  1353. KIMURA H, Uemura Y, Megumi Y, Tachibana M, et al
    [A Case Of cT3bN2M0 Pleomorphic Giant Cell Carcinoma of the Bladder without Recurrence after Neoadjuvant Chemotherapy and Radical Cystectomy for 4 Years].
    Hinyokika Kiyo. 2019;65:377-380.
    Abstract     Related articles   

  1354. LOU Y, Fan L, Hou X, Dominiczak AF, et al
    Paroxysmal Hypertension Associated With Urination.
    Hypertension. 2019 Sep 30:HYPERTENSIONAHA11913140.
    Abstract     Related articles   

  1355. LOUARDI N, Elbahri A, Alami M, Ameur A, et al
    [Taeniasis and enterocystoplasty].
    Presse Med. 2019;48:987-989.
    Abstract     Related articles   

  1356. KIRIGIN M, Lez C, Sarcevic B, Soipi S, et al
    PRIMARY MALIGNANT MELANOMA OF THE URINARY BLADDER: CASE REPORT.
    Acta Clin Croat. 2019;58:180-182.
    Abstract     Related articles   

  1357. ZHOU Q, Yu J, Zheng Q, Wu T, et al
    Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
    FEBS Open Bio. 2019 Nov 27. doi: 10.1002/2211-5463.12768.
    Abstract     Related articles   

  1358. ZHAO X, Li D, Zhao ST, Zhang Y, et al
    MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
    Eur Rev Med Pharmacol Sci. 2019;23:9304-9312.
    Abstract     Related articles   

  1359. XU S, Yao Q, Liu G, Jin D, et al
    Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
    Eur Radiol. 2019 Nov 26. pii: 10.1007/s00330-019-06484.
    Abstract     Related articles   

  1360. YAJIMA K, Akise Y
    A Case Report of Graves' Disease Induced by the Anti-Human Programmed Cell Death-1 Monoclonal Antibody Pembrolizumab in a Bladder Cancer Patient.
    Case Rep Endocrinol. 2019;2019:2314032.
    Abstract     Related articles   

  1361. CHEN L, Liu Y, Zhang Q, Zhang M, et al
    p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer.
    J Cancer. 2019;10:6207-6216.
    Abstract     Related articles   

  1362. YAMASHITA H, Kawasawa YI, Shuman L, Zheng Z, et al
    Repression of transcription factor AP-2 alpha by PPARgamma reveals a novel transcriptional circuit in basal-squamous bladder cancer.
    Oncogenesis. 2019;8:69.
    Abstract     Related articles   

  1363. WEI X, Yang X, Wang B, Yang Y, et al
    LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Cancer Med. 2019 Nov 25. doi: 10.1002/cam4.2684.
    Abstract     Related articles   

  1364. WU S, Nitschke K, Heinkele J, Weis CA, et al
    ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  1365. CHIANG Y, Wang CC, Tsai YC, Huang CY, et al
    Nuclear Factor-kappaB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer.
    J Clin Med. 2019;8.
    Abstract     Related articles   

  1366. JIN H, Lin T, Han P, Yao Y, et al
    Efficacy of Raman spectroscopy in the diagnosis of bladder cancer: A systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e18066.
    Abstract     Related articles   

  1367. LI Y, Zu X, Hu X, Wang L, et al
    Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
    Med Sci Monit. 2019;25:8928-8939.
    Abstract     Related articles   

  1368. ROSIELLO G, Palumbo C, Knipper S, Pecoraro A, et al
    Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer.
    Urol Oncol. 2019 Nov 21. pii: S1078-1439(19)30442.
    Abstract     Related articles   

  1369. SLOAN FA, Yashkin AP, Akushevich I, Inman BA, et al
    Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer.
    Urol Oncol. 2019 Nov 21. pii: S1078-1439(19)30440.
    Abstract     Related articles   

  1370. EROGLU A, Ekin RG, Koc G, Divrik RT, et al
    The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial.
    Int J Clin Oncol. 2019 Nov 23. pii: 10.1007/s10147-019-01581.
    Abstract     Related articles   

  1371. ALVAEUS J, Rosenblatt R, Johansson M, Alamdari F, et al
    Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy.
    World J Urol. 2019 Nov 23. pii: 10.1007/s00345-019-03025.
    Abstract     Related articles   

  1372. SHIMIZU T, Yamaguchi K, Yamamoto M, Kurioka R, et al
    Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug.
    Bioorg Med Chem Lett. 2019 Nov 8:126744. doi: 10.1016/j.bmcl.2019.126744.
    Abstract     Related articles   

  1373. YANG D, Qian H, Fang Z, Xu A, et al
    Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
    Cancer Med. 2019 Nov 23. doi: 10.1002/cam4.2650.
    Abstract     Related articles   

  1374. KONETY BR
    Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Twenty-First Century Edition.
    Urol Clin North Am. 2020;47:xiii.
    Abstract     Related articles   

  1375. ARENDS TJH, Alfred Witjes J
    Apaziquone for Nonmuscle Invasive Bladder Cancer: Where Are We Now?
    Urol Clin North Am. 2020;47:73-82.
    Abstract     Related articles   

  1376. FABA OR, Pisano F, Krajewski W, Breda A, et al
    Salvage Therapies for Non-muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guerin? Predictors and Nomograms.
    Urol Clin North Am. 2020;47:5-13.
    Abstract     Related articles   

  1377. COOLEY LF, McLaughlin KA, Meeks JJ
    Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.
    Urol Clin North Am. 2020;47:35-46.
    Abstract     Related articles   

  1378. KHALED D, Taylor J, Holzbeierlein J
    Salvage Therapy for Non-muscle-invasive Bladder Cancer: Novel Intravesical Agents.
    Urol Clin North Am. 2020;47:119-128.
    Abstract     Related articles   

  1379. CHU CE, Porten SP, Grossfeld GD, Meng MV, et al
    Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer.
    Urol Clin North Am. 2020;47:111-118.
    Abstract     Related articles   

  1380. SATHIANATHEN NJ, Regmi S, Gupta S, Konety BR, et al
    Immuno-Oncology Approaches to Salvage Treatment for Non-muscle invasive Bladder Cancer.
    Urol Clin North Am. 2020;47:103-110.
    Abstract     Related articles   

  1381. ABULIZI R, Li B, Zhang CG
    Circ_0071662, a novel tumor biomarker, suppresses bladder cancer cell proliferation and invasion by sponging miR-146b-3p.
    Oncol Res. 2019 Nov 18. doi: 10.3727/096504019X15740729375088.
    Abstract     Related articles   

  1382. SHEN J, Wu JF, Zhang J, Song ZQ, et al
    [An animal model of bladder reconstruction by autologous peritoneum transplantation].
    Zhonghua Wai Ke Za Zhi. 2019;57:853-859.
    Abstract     Related articles   

  1383. KALDYBEKOV DB, Filippov SK, Radulescu A, Khutoryanskiy VV, et al
    Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery.
    Eur J Pharm Biopharm. 2019;143:24-34.
    Abstract     Related articles   

  1384. SAKAMOTO A, Okamoto T, Ikeguchi R, Matsuda S, et al
    MRI examination of resected malignant bone tumor can be an option for assessment of the osseous surgical margin.
    Br J Radiol. 2019 Aug 6:20190518. doi: 10.1259/bjr.20190518.
    Abstract     Related articles   

  1385. SHAN M, Zhang L, Liu Y, Gao C, et al
    DNA Methylation Profiles and Their Diagnostic Utility in BC.
    Dis Markers. 2019;2019:6328503.
    Abstract     Related articles   

  1386. YAMAMICHI G, Nakata W, Tani M, Tsujimura G, et al
    High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.
    Int J Clin Oncol. 2019;24:1075-1080.
    Abstract     Related articles   

  1387. ITO K, Kanno T, Sawada A, Saito R, et al
    Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort.
    Int J Clin Oncol. 2019;24:1081-1088.
    Abstract     Related articles   

  1388. CHEN X, Kost J, Sulovari A, Wong N, et al
    A virome-wide clonal integration analysis platform for discovering cancer viral etiology.
    Genome Res. 2019;29:819-830.
    Abstract     Related articles   

  1389. THE M, Kall L
    Integrated Identification and Quantification Error Probabilities for Shotgun Proteomics.
    Mol Cell Proteomics. 2019;18:561-570.
    Abstract     Related articles   

  1390. GUPTA S, Albertson DJ, Parnell TJ, Butterfield A, et al
    Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma.
    Mol Cancer Ther. 2019;18:185-195.
    Abstract     Related articles   

  1391. SU Y, Du Z, Zhong G, Ya Y, et al
    circ5912 suppresses cancer progression via inducing MET in bladder cancer.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  1392. CHEN M, Nie ZY, Wen XH, Gao YH, et al
    m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Biosci Rep. 2019 Dec 6. pii: 221434. doi: 10.1042/BSR20192892.
    Abstract     Related articles   

  1393. IKEDA A, Nosato H, Kochi Y, Kojima T, et al
    Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence.
    J Endourol. 2019 Dec 6. doi: 10.1089/end.2019.0509.
    Abstract     Related articles   

  1394. CHO CJ, Yang CW, Wu CL, Ho JY, et al
    The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol.
    Oncol Lett. 2019;18:6869-6876.
    Abstract     Related articles   

  1395. TAN S, Bian X, Wu B, Chen X, et al
    RASSF6 Is Downregulated In Human Bladder Cancers And Regulates Doxorubicin Sensitivity And Mitochondrial Membrane Potential Via The Hippo Signaling Pathway.
    Onco Targets Ther. 2019;12:9189-9200.
    Abstract     Related articles   

  1396. WANG J, Tan X, Guo Q, Lin X, et al
    FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.
    Pharmacol Res. 2019 Dec 2:104575. doi: 10.1016/j.phrs.2019.104575.
    Abstract     Related articles   

  1397. SANGUEDOLCE F, Cormio L, Carrieri G, Calo B, et al
    Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Histol Histopathol. 2019 Dec 5:18189. doi: 10.14670.
    Abstract     Related articles   

  1398. SATYAL U, Srivastava A, Abbosh PH
    Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer.
    Front Oncol. 2019;9:1266.
    Abstract     Related articles   

  1399. CASADEI C, Dizman N, Schepisi G, Cursano MC, et al
    Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors.
    Ther Adv Med Oncol. 2019;11:1758835919890285.
    Abstract     Related articles   

  1400. LI Y, Chen R, Li Z, Cheng H, et al
    miR-204 Negatively Regulates Cell Growth And Metastasis By Targeting ROBO4 In Human Bladder Cancer.
    Onco Targets Ther. 2019;12:8515-8524.
    Abstract     Related articles   

  1401. GUO Y, Yuan X, Li K, Dai M, et al
    GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
    Cell Death Differ. 2019 Dec 4. pii: 10.1038/s41418-019-0466.
    Abstract     Related articles   

  1402. WU S, Liu Y, Michalek JE, Mesa RA, et al
    Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysis.
    Adv Nutr. 2019 Dec 4. pii: 5652213. doi: 10.1093.
    Abstract     Related articles   

  1403. YU X, Wang ZL, Han CL, Wang MW, et al
    LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:9814-9820.
    Abstract     Related articles   

  1404. LIM JH, Sundar S
    Prognosis of early stage small cell bladder cancer is not always dismal.
    ESMO Open. 2019;4:e000559.
    Abstract     Related articles   

  1405. BA M, Cui S, Long H, Gong Y, et al
    Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study.
    BMC Urol. 2019;19:126.
    Abstract     Related articles   

  1406. LOPEZ-BELTRAN A, Cheng L, Gevaert T, Blanca A, et al
    Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
    Expert Rev Mol Diagn. 2019 Dec 4. doi: 10.1080/14737159.2020.1699791.
    Abstract     Related articles   

  1407. ZHANG C, Shen K, Zheng Y, Qi F, et al
    Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
    Cancer Med. 2019 Dec 3. doi: 10.1002/cam4.2665.
    Abstract     Related articles   

  1408. WISSING MD, Kassouf W, Tanguay S, Aprikian AG, et al
    The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec (Canada), 2000-2016.
    Can Urol Assoc J. 2019 Nov 29. pii: cuaj.6094. doi: 10.5489/cuaj.6094.
    Abstract     Related articles   

  1409. PENG W, Dong N, Wu S, Gui D, et al
    miR-4500 suppresses cell proliferation and migration in bladder cancer via inhibition of STAT3/CCR7 pathway.
    J Cell Biochem. 2019 Dec 1. doi: 10.1002/jcb.29558.
    Abstract     Related articles   

  1410. GUO J, Chen Z, Jiang H, Yu Z, et al
    The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/beta-catenin signaling pathway.
    Cancer Cell Int. 2019;19:312.
    Abstract     Related articles   

  1411. LI X, Shu K, Zhou J, Yu Q, et al
    Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30329.
    Abstract     Related articles   

  1412. RADKIEWICZ C, Edgren G, Johansson ALV, Jahnson S, et al
    Sex Differences in Urothelial Bladder Cancer Survival.
    Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30324.
    Abstract     Related articles   

  1413. D'ANDREA D, Soria F, Abufaraj M, Pones M, et al
    Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30325.
    Abstract     Related articles   

  1414. LIU Y, Wu G
    NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway.
    Neurourol Urodyn. 2019 Nov 29. doi: 10.1002/nau.24238.
    Abstract     Related articles   

  1415. PACKIAM VT, Werntz RP, Steinberg GD
    Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage.
    Curr Urol Rep. 2019;20:84.
    Abstract     Related articles   

  1416. ARON M
    Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.
    Curr Urol Rep. 2019;20:80.
    Abstract     Related articles   

  1417. GURRAM S, Muthigi A, Egan J, Stamatakis L, et al
    Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging?
    Curr Urol Rep. 2019;20:82.
    Abstract     Related articles   

  1418. BOSSHARD P, Roth B
    [Cisplatin-based chemotherapy in muscle-invasive bladder cancer: soon outdated ?]
    Rev Med Suisse. 2019;15:2190-2194.
    Abstract     Related articles   

  1419. ZHANG N, Chen S, Wu L, Wu Y, et al
    Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer.
    J Cancer. 2019;10:6761-6766.
    Abstract     Related articles   

  1420. SONG Z, Zhang Q, Zhu J, Yin G, et al
    Identification of urinary hsa_circ _0137439 as potential biomarker and tumor regulator of bladder cancer.
    Neoplasma. 2019 Nov 18. pii: 181214N970. doi: 10.4149/neo_2018_181214.
    Abstract     Related articles   

  1421. NARAYAN VM, Dinney CPN
    Intravesical Gene Therapy.
    Urol Clin North Am. 2020;47:93-101.
    Abstract     Related articles   

  1422. BROOKS NA, O'Donnell MA
    Combination Intravesical Therapy.
    Urol Clin North Am. 2020;47:83-91.
    Abstract     Related articles   

  1423. TAN WP, Longo TA, Inman BA
    Heated Intravesical Chemotherapy: Biology and Clinical Utility.
    Urol Clin North Am. 2020;47:55-72.
    Abstract     Related articles   

  1424. HAAS CR, McKiernan JM
    Salvage Therapy Using Bacillus Calmette-Guerin Derivatives or Single Agent Chemotherapy.
    Urol Clin North Am. 2020;47:47-54.
    Abstract     Related articles   

  1425. LI R, Kamat AM
    Predictors of Response to Intravesical Therapy.
    Urol Clin North Am. 2020;47:23-33.
    Abstract     Related articles   

  1426. BECKER REN, Kates MR, Bivalacqua TJ
    Identification of Candidates for Salvage Therapy: The Past, Present, and Future of Defining Bacillus Calmette-Guerin Failure.
    Urol Clin North Am. 2020;47:15-21.
    Abstract     Related articles   

  1427. KONETY BR, Narayan VM, Dinney CPN
    Bacillus Calmette-Guerin Salvage Therapy: Definitions and Context.
    Urol Clin North Am. 2020;47:1-4.
    Abstract     Related articles   

  1428. SOUKUP V, Capoun O, Pesl M, Vavrova L, et al
    The significance of calprotectin, CD147, APOA4 and DJ-1 in non-invasive detection of urinary bladder carcinoma.
    Neoplasma. 2019;66:1019-1023.
    Abstract     Related articles   

  1429. GIANNARINI G, Crestani A, Inferrera A, Rossanese M, et al
    Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies.
    Minerva Urol Nefrol. 2019;71:309-323.
    Abstract     Related articles   

  1430. HURLE R, Lazzeri M, Saita A, Naselli A, et al
    Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS.
    Minerva Urol Nefrol. 2019;71:406-412.
    Abstract     Related articles   

  1431. HSU YH, Huang HP, Chang HR
    The uremic toxin p-cresol promotes the invasion and migration on carcinoma cells via Ras and mTOR signaling.
    Toxicol In Vitro. 2019;58:126-131.
    Abstract     Related articles   

  1432. ATAKA R, Sato S, Matsubara K, Takagi M, et al
    Small bowel obstruction due to internal hernia caused by the ureter after laparoscopic radical cystectomy and ileal conduit: A case report.
    Asian J Endosc Surg. 2019;12:189-191.
    Abstract     Related articles   

  1433. SHAFIEIAN Z, Bahari G, Hashemi M, Nakhaee A, et al
    SIRT1 Gene Polymorphisms Are Associated with Urinary Bladder Cancer in an Iranian Population.
    Rep Biochem Mol Biol. 2019;8:194-199.
    Abstract     Related articles   

  1434. RUAN H, Li Y, Wang X, Sun B, et al
    CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.
    Jpn J Clin Oncol. 2019 Dec 12. pii: 5673759. doi: 10.1093.
    Abstract     Related articles   

  1435. CHEN Q, Hu J, Deng J, Fu B, et al
    Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
    Biomed Res Int. 2019;2019:3917982.
    Abstract     Related articles   

  1436. VANTAKU V, Donepudi SR, Ambati CR, Jin F, et al
    Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer.
    Oncotarget. 2019;10:6843-6844.
    Abstract     Related articles   

  1437. WANG J, Zhang H, Situ J, Li M, et al
    KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis.
    Cancer Cell Int. 2019;19:325.
    Abstract     Related articles   

  1438. ZAITSU M, Lee HE, Lee S, Takeuchi T, et al
    Occupational disparities in bladder cancer survival: A population-based cancer registry study in Japan.
    Cancer Med. 2019 Dec 11. doi: 10.1002/cam4.2768.
    Abstract     Related articles   

  1439. JOSEPH M, Enting D
    Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications.
    Front Oncol. 2019;9:1270.
    Abstract     Related articles   

  1440. LUO Y, Zeng G, Wu S
    Identification of Microenvironment-Related Prognostic Genes in Bladder Cancer Based on Gene Expression Profile.
    Front Genet. 2019;10:1187.
    Abstract     Related articles   

  1441. SONPAVDE G, Necchi A, Gupta S, Steinberg GD, et al
    ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer.
    Future Oncol. 2019 Dec 11. doi: 10.2217/fon-2019-0611.
    Abstract     Related articles   

  1442. ZIRAKZADEH AA, Sherif A, Rosenblatt R, Ahlen Bergman E, et al
    Tumour-associated B cells in urothelial urinary bladder cancer.
    Scand J Immunol. 2019 Dec 10:e12830. doi: 10.1111/sji.12830.
    Abstract     Related articles   

  1443. CHEN S, Zhou Q, Guo Z, Wang Y, et al
    Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.
    J Cell Mol Med. 2019 Dec 10. doi: 10.1111/jcmm.14878.
    Abstract     Related articles   

  1444. HE Q, Huang L, Yan D, Bi J, et al
    CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  1445. SU Y, Feng W, Zhong G, Ya Y, et al
    ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  1446. MOHAMMED A, Miller MS, Lubet RA, Suen CS, et al
    Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers.
    Cancer Prev Res (Phila). 2019 Dec 9. pii: 1940-6207.CAPR-19-0339.
    Abstract     Related articles   

  1447. YOON HY, Yang HM, Kim CH, Goo YT, et al
    Enhanced Intracellular Delivery of BCG Cell Wall Skeleton into Bladder Cancer Cells Using Liposomes Functionalized with Folic Acid and Pep-1 Peptide.
    Pharmaceutics. 2019;11.
    Abstract     Related articles   

  1448. POLIKARPOV D, Liang L, Care A, Sunna A, et al
    Functionalized Upconversion Nanoparticles for Targeted Labelling of Bladder Cancer Cells.
    Biomolecules. 2019;9.
    Abstract     Related articles   

  1449. YAO Z, Zheng Z, Ke W, Wang R, et al
    Prognostic nomogram for bladder cancer with brain metastases: a National Cancer Database analysis.
    J Transl Med. 2019;17:411.
    Abstract     Related articles   

  1450. LI F, Su M, Zhao H, Xie W, et al
    HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer.
    Am J Transl Res. 2019;11:7035-7048.
    Abstract     Related articles   

  1451. WEI Y, Zhang Y, Meng Q, Cui L, et al
    Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA.
    Am J Transl Res. 2019;11:6838-6849.
    Abstract     Related articles   

  1452. GRIVAS P, Bismar TA, Alva AS, Huang HC, et al
    Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy.
    Urol Oncol. 2019 Dec 4. pii: S1078-1439(19)30459.
    Abstract     Related articles   

  1453. YI S, Park H
    A rare case of aquaporin-4-antibody-positive neuromyelitis optica associated with bladder cancer.
    Mult Scler Relat Disord. 2019;38:101499.
    Abstract     Related articles   

  1454. BULKLEY JE, O'Keeffe-Rosetti M, Wendel CS, Davis JV, et al
    The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomy.
    Qual Life Res. 2019 Dec 6. pii: 10.1007/s11136-019-02379.
    Abstract     Related articles   

  1455. CRISPEN PL, Kusmartsev S
    Mechanisms of immune evasion in bladder cancer.
    Cancer Immunol Immunother. 2019 Dec 6. pii: 10.1007/s00262-019-02443.
    Abstract     Related articles   

  1456. XU J, Hua X, Yang R, Jin H, et al
    XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion.
    Oncogenesis. 2019;8:71.
    Abstract     Related articles   

  1457. MONTAZERI K, Bellmunt J
    Erdafitinib for the treatment of metastatic bladder cancer.
    Expert Rev Clin Pharmacol. 2019 Dec 6. doi: 10.1080/17512433.2020.1702025.
    Abstract     Related articles   

  1458. MANI J, Fleger J, Rutz J, Maxeiner S, et al
    Curcumin combined with exposure to visible light blocks bladder cancer cell adhesion and migration by an integrin dependent mechanism.
    Eur Rev Med Pharmacol Sci. 2019;23:10564-10574.
    Abstract     Related articles   

  1459. VARTOLOMEI L, Vartolomei MD, Shariat SF
    Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients.
    Eur Urol Focus. 2019 Dec 10. pii: S2405-4569(19)30330.
    Abstract     Related articles   

  1460. LV S, Yu J, Zhao Y, Li H, et al
    A Microfluidic Detection System for Bladder Cancer Tumor Cells.
    Micromachines (Basel). 2019;10.
    Abstract     Related articles   

  1461. RADES D, Sondermann L, Motisi L, Janssen S, et al
    Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder.
    Anticancer Res. 2018;38:6841-6846.
    Abstract     Related articles   

  1462. KUSUHARA Y, Daizumoto K, Kawai K, Hirayama K, et al
    Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.
    Anticancer Res. 2019;39:703-711.
    Abstract     Related articles   

  1463. VASYUTIN I, Zerihun L, Ivan C, Atala A, et al
    Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling.
    Anticancer Res. 2019;39:1105-1118.
    Abstract     Related articles   

  1464. KUMAGAI-TOGASHI A, Uozaki H, Kikuchi Y, Watabe S, et al
    Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10.
    Anticancer Res. 2019;39:635-640.
    Abstract     Related articles   

  1465. HANADA E, Kageyama S, Murai R, Kubota S, et al
    Pro-GA, a Novel Inhibitor of gamma-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth.
    Anticancer Res. 2019;39:1893-1898.
    Abstract     Related articles   

  1466. HUANG AC, Cheng YD, Huang LH, Hsiao YT, et al
    Casticin Induces DNA Damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells.
    Anticancer Res. 2019;39:1839-1847.
    Abstract     Related articles   

  1467. NAKAMURA Y, Miyata Y, Takehara K, Asai A, et al
    The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.
    Anticancer Res. 2019;39:2317-2324.
    Abstract     Related articles   

  1468. CHIANG CH, Yeh CY, Chung JG, Chiang IT, et al
    Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer.
    Anticancer Res. 2019;39:3641-3649.
    Abstract     Related articles   

  1469. AKITAKE M, Yamaguchi A, Shiota M, Imada K, et al
    Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
    Anticancer Res. 2019;39:4325-4328.
    Abstract     Related articles   

  1470. CHEN M, Tsai YT, Chang WS, Shih LC, et al
    Association of Caspase-8 Genotypes With Bladder Cancer Risk.
    Anticancer Res. 2019;39:4767-4773.
    Abstract     Related articles   

  1471. LIU J, Li S, Cheng X, DU P, et al
    HOXB2 is a Putative Tumour Promotor in Human Bladder Cancer.
    Anticancer Res. 2019;39:6915-6921.
    Abstract     Related articles   

  1472. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre expe
    BJU Int. 2019 Jan 8. doi: 10.1111/bju.14612.
    Abstract     Related articles   

  1473. BAJIC P, Wolfe AJ, Gupta GN
    Old Instillations and New Implications in Bladder Cancer: The Urinary Microbiome and Intravesical BCG.
    BJU Int. 2019 Jan 21. doi: 10.1111/bju.14683.
    Abstract     Related articles   

  1474. D'ANDREA D, Soria F, Zehetmayer S, Gust KM, et al
    Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.
    BJU Int. 2019 Jan 17. doi: 10.1111/bju.14673.
    Abstract     Related articles   

  1475. TAN WS, Teo CH, Chan D, Heinrich M, et al
    Mix methods approach to explore patients' perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy in bladder cancer surveillance.
    BJU Int. 2019 Jan 29. doi: 10.1111/bju.14690.
    Abstract     Related articles   

  1476. MMEJE CO, Benson CR, Nogueras-Gonzalez GM, Jayaratna IS, et al
    Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
    BJU Int. 2018;122:89-98.
    Abstract     Related articles   

  1477. JEFFERIES ER, Cresswell J, McGrath JS, Miller C, et al
    Open radical cystectomy in England: the current standard of care - an analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit and Hospital Episodes Statistics (HES) data.
    BJU Int. 2018;121:880-885.
    Abstract     Related articles   

  1478. HUGAR LA, Lopa SH, Yabes JG, Yu JA, et al
    Palliative Care Use Among Patients with Bladder Cancer.
    BJU Int. 2019 Feb 13. doi: 10.1111/bju.14708.
    Abstract     Related articles   

  1479. BRASSETTI A, Moller A, Laurin O, Hoijer J, et al
    Evolution of cystectomy care over an 11-year period in a high-volume tertiary referral centre.
    BJU Int. 2018;121:752-757.
    Abstract     Related articles   

  1480. KIJIMA T, Tanaka H, Koga F, Masuda H, et al
    Selective Tetramodal Bladder Preservation Therapy Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.
    BJU Int. 2019 Feb 27. doi: 10.1111/bju.14736.
    Abstract     Related articles   

  1481. TARIQ A, Khan SR, Vela I, Williams ED, et al
    Assessment of bladder cancer patients and carers use of internet, social media and quality of available patient centric online resources: A systematic review.
    BJU Int. 2019 Feb 24. doi: 10.1111/bju.14720.
    Abstract     Related articles   

  1482. SOLOWAY MS
    Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?
    BJU Int. 2018;122:525-526.
    Abstract     Related articles   

  1483. GROSS T, Furrer M, Schorno P, Wuethrich PY, et al
    Reproductive organ-sparing cystectomy significantly improves continence in women after orthotopic bladder substitution without affecting oncological outcome.
    BJU Int. 2018;122:227-235.
    Abstract     Related articles   

  1484. MOSSANEN M, Kibel AS
    The bladder cancer conundrum: how do we treat the right tumour with the right treatment, at the right time?
    BJU Int. 2019;123:748-749.
    Abstract     Related articles   

  1485. SEILER R, Wyatt AW, Black PC
    Molecular landscape of muscle-invasive bladder cancer: Patient age matter?
    BJU Int. 2019 May 9. doi: 10.1111/bju.14802.
    Abstract     Related articles   

  1486. WARD DG, Gordon NS, Boucher RH, Pirrie SJ, et al
    Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.
    BJU Int. 2019 May 11. doi: 10.1111/bju.14808.
    Abstract     Related articles   

  1487. YU EY, Nekeman D, Aaronson NK, Billingham LJ, et al
    Health-Related Quality of Life in Bladder Cancer Patients around the Time of Diagnosis.
    BJU Int. 2019 May 11. doi: 10.1111/bju.14804.
    Abstract     Related articles   

  1488. MCCLINTOCK TR
    Palliative care in patients with bladder cancer: an opportunity for value improvement?
    BJU Int. 2019;123:913-914.
    Abstract     Related articles   

  1489. FILIPPOU P, Smith AB
    A new horizon for bladder preservation in muscle-invasive bladder cancer.
    BJU Int. 2019;124:184-185.
    Abstract     Related articles   

  1490. MARTINI A, Sfakianos JP, Renstrom-Koskela L, Mortezavi A, et al
    The Natural History of Untreated Muscle Invasive Bladder Cancer.
    BJU Int. 2019 Jul 16. doi: 10.1111/bju.14872.
    Abstract     Related articles   

  1491. RAI BP, Bondad J, Vasdev N, Adshead J, et al
    Robotic versus open radical cystectomy for bladder cancer in adults.
    BJU Int. 2019 Jul 15. doi: 10.1111/bju.14870.
    Abstract     Related articles   

  1492. JUNG A, Nielsen ME, Crandell JL, Palmer MH, et al
    Health-Related Quality of Life among Non-Muscle-Invasive Bladder Cancer Survivors: A Population-Based Study.
    BJU Int. 2019 Aug 5. doi: 10.1111/bju.14888.
    Abstract     Related articles   

  1493. JAIN RK, Grivas P, Pal SK
    Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?
    BJU Int. 2019;124:361-362.
    Abstract     Related articles   

  1494. TAN WS, Sarpong R, Khetrapal P, Rodney S, et al
    Does urinary cytology have a role in haematuria investigations?
    BJU Int. 2019;123:74-81.
    Abstract     Related articles   

  1495. DHARIWAL R, Pindoria N, Dasgupta P, Khan MS, et al
    #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
    BJU Int. 2019;123:203-207.
    Abstract     Related articles   

  1496. NURMINEN P, Ettala O, Seppanen M, Taimen P, et al
    Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guerin (BCG) treatment.
    BJU Int. 2019;123:246-251.
    Abstract     Related articles   

  1497. KINNEAR N, O'Callaghan M, Hennessey D, Liddell H, et al
    Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies.
    BJU Int. 2019;123:210-219.
    Abstract     Related articles   

  1498. TAYLOR J, Becher E, Steinberg GD
    Update on the Guideline of Guidelines: Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2019 Oct 9. doi: 10.1111/bju.14915.
    Abstract     Related articles   

  1499. KHETRAPAL P, Kelly JD, Catto JWF, Vasdev N, et al
    Does the robot have a role in radical cystectomy?
    BJU Int. 2019;123:380-382.
    Abstract     Related articles   

  1500. DUFOUR F, Silina L, Neyret-Kahn H, Moreno-Vega A, et al
    TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
    Br J Cancer. 2019 Feb 15. pii: 10.1038/s41416-019-0397.
    Abstract     Related articles   

  1501. KITA Y, Hamada A, Saito R, Teramoto Y, et al
    Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.
    Br J Cancer. 2019 Nov 1. pii: 10.1038/s41416-019-0609.
    Abstract     Related articles   

  1502. VANTAKU V, Donepudi SR, Piyarathna DWB, Sekhar Amara C, et al
    Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
    Cancer. 2019 Jan 2. doi: 10.1002/cncr.31890.
    Abstract     Related articles   

  1503. COLE AP, Fletcher SA, Berg S, Nabi J, et al
    Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
    Cancer. 2019 Jan 11. doi: 10.1002/cncr.31926.
    Abstract     Related articles   

  1504. CHU AT, Holt SK, Wright JL, Ramos JD, et al
    Delays in radical cystectomy for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32048.
    Abstract     Related articles   

  1505. MASIC S, Smaldone MC
    Treatment delays for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32047.
    Abstract     Related articles   

  1506. SCHROECK FR, Lynch KE, Li Z, MacKenzie TA, et al
    The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32185.
    Abstract     Related articles   

  1507. MARTINI A, Jia R, Ferket BS, Waingankar N, et al
    Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.
    Cancer. 2019 May 31. doi: 10.1002/cncr.32169.
    Abstract     Related articles   

  1508. TAKAHASHI T
    Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer?
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32415.
    Abstract     Related articles   

  1509. ZHENG J, Kong J, Wu S, Li Y, et al
    Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach.
    Cancer. 2019 Aug 30. doi: 10.1002/cncr.32490.
    Abstract     Related articles   

  1510. FLETCHER SA, Cole AP, Lu C, Marchese M, et al
    The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
    Cancer. 2019 Oct 18. doi: 10.1002/cncr.32562.
    Abstract     Related articles   

  1511. YU C, Liu Z, Chen Q, Li Y, et al
    Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of Twist1.
    Cancer Res. 2018;78:1241-1252.
    Abstract     Related articles   

  1512. WANG Z, Cao D, Qi Z, Pang Y, et al
    Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1/ITGB6/STAT3 signaling axis in bladder cancer.
    Cancer Res. 2019 Feb 26. pii: 0008-5472.CAN-18-3842.
    Abstract     Related articles   

  1513. AVGERIS M, Tsilimantou A, Levis PK, Rampias T, et al
    Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Carcinogenesis. 2019 Feb 27. pii: 5366409. doi: 10.1093.
    Abstract     Related articles   

  1514. CUI H, Tang M, Zhang M, Liu S, et al
    Variants in the PSCA gene associated with risk of cancer and nonneoplastic diseases: systematic research synopsis, meta-analysis and epidemiological evidence.
    Carcinogenesis. 2019;40:70-83.
    Abstract     Related articles   

  1515. SOTTNIK JL, Mallaredy V, Chauca-Diaz A, Ritterson Lew C, et al
    Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice.
    Carcinogenesis. 2019;40:194-201.
    Abstract     Related articles   

  1516. VANTAKU V, Dong J, Ambati CR, Perera D, et al
    sMulti-omics integration analysis robustly predicts high-grade patient survival and identifies CPT1B effect on fatty acid metabolism in Bladder Cancer.
    Clin Cancer Res. 2019 Mar 7. pii: 1078-0432.CCR-18-1515.
    Abstract     Related articles   

  1517. KISS B, van den Berg NS, Ertsey R, McKenna K, et al
    CD47-targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
    Clin Cancer Res. 2019 Mar 19. pii: 1078-0432.CCR-18-3267.
    Abstract     Related articles   

  1518. BATISTA DA COSTA J, Gibb EA, Bivalacqua TJ, Liu Y, et al
    Molecular characterization of neuroendocrine-like bladder cancer.
    Clin Cancer Res. 2019 Apr 5. pii: 1078-0432.CCR-18-3558.
    Abstract     Related articles   

  1519. ANNELS NE, Mansfield D, Arif M, Ballesteros-Merino C, et al
    Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21.
    Clin Cancer Res. 2019 Jul 4. pii: 1078-0432.CCR-18-4022.
    Abstract     Related articles   

  1520. GRIVAS P
    DNA Damage Response Gene Alterations in Urothelial Cancer: Ready for Practice?
    Clin Cancer Res. 2019;25:907-909.
    Abstract     Related articles   

  1521. KATES M, Matoso A, Choi W, Baras AS, et al
    Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG Unresponsive Trials.
    Clin Cancer Res. 2019 Nov 11. pii: 1078-0432.CCR-19-1920.
    Abstract     Related articles   

  1522. CHENG THT, Jiang P, Teoh JYC, Heung MMS, et al
    Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
    Clin Chem. 2019 Apr 15. pii: clinchem.2018.301341.
    Abstract     Related articles   

  1523. NASER-TAVAKOLIAN A, Ghodoussipour S, Djaladat H
    Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000598.
    Abstract     Related articles   

  1524. MUKHERJEE N, Wheeler KM, Svatek RS
    Bacillus Calmette-Guerin treatment of bladder cancer: a systematic review and commentary on recent publications.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000595.
    Abstract     Related articles   

  1525. MUN DH, Kimura S, Shariat SF, Abufaraj M, et al
    The impact of gender on oncologic outcomes of bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000606.
    Abstract     Related articles   

  1526. EULITT PJ, Bjurlin MA, Milowsky MI
    Perioperative systemic therapy for bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000600.
    Abstract     Related articles   

  1527. SMELSER WW, Woolbright BL, Taylor JA 3rd
    Molecular subtyping of bladder cancer: current trends and future directions in 2019.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000599.
    Abstract     Related articles   

  1528. PHAM A, Ballas LK
    Trimodality therapy for bladder cancer: modern management and future directions.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000601.
    Abstract     Related articles   

  1529. BHAT A, Ritch CR
    Urinary biomarkers in bladder cancer: where do we stand?
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000605.
    Abstract     Related articles   

  1530. JANISCH F, Shariat SF, Schernhammer E, Rink M, et al
    The interaction of gender and smoking on bladder cancer risks.
    Curr Opin Urol. 2019 Mar 14. doi: 10.1097/MOU.0000000000000602.
    Abstract     Related articles   

  1531. DASON S, Goh AC
    Contemporary techniques and outcomes of robotic cystectomy and intracorporeal urinary diversions.
    Curr Opin Urol. 2018;28:115-122.
    Abstract     Related articles   

  1532. SATYAL U, Sikder RK, McConkey D, Plimack ER, et al
    Clinical implications of molecular subtyping in bladder cancer.
    Curr Opin Urol. 2019;29:350-356.
    Abstract     Related articles   

  1533. SADIGHIAN M, Porten S
    Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion.
    Curr Opin Urol. 2019 Jul 15. doi: 10.1097/MOU.0000000000000660.
    Abstract     Related articles   

  1534. MORI K, D'Andrea D, Enikeev DV, Egawa S, et al
    En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature.
    Curr Opin Urol. 2019 Nov 12. doi: 10.1097/MOU.0000000000000697.
    Abstract     Related articles   

  1535. CAPURSO G, Archibugi L, Tessieri L, Petrone MC, et al
    Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis?
    Eur J Cancer. 2018;95:123-126.
    Abstract     Related articles   

  1536. ROUANNE M, Betari R, Radulescu C, Goubar A, et al
    Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
    Eur J Cancer. 2019;108:111-119.
    Abstract     Related articles   

  1537. NECCHI A, Raggi D, Giannatempo P, Alessi A, et al
    Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure.
    Eur J Cancer. 2018;96:128-130.
    Abstract     Related articles   

  1538. GIANNARINI G, Crestani A, Ficarra V
    Re: Stenting Prior to Cystectomy Is an Independent Risk Factor for Upper Urinary Tract Recurrence.
    Eur Urol. 2018;74:395-396.
    Abstract     Related articles   

  1539. SZABADOS B, van Dijk N, Tang YZ, van der Heijden MS, et al
    Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.
    Eur Urol. 2018;73:149-152.
    Abstract     Related articles   

  1540. YUH B, Chan K, Wilson T
    Robotic Cystectomy-Moving from Innovation to Measurable Impact.
    Eur Urol. 2018;74:472-473.
    Abstract     Related articles   

  1541. ZUIVERLOON TCM, Theodorescu D
    Re: Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Eur Urol. 2019 Jan 17. pii: S0302-2838(18)31024.
    Abstract     Related articles   

  1542. CHOUDHURY A, Hoskin PJ
    Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.
    Eur Urol. 2019 Feb 4. pii: S0302-2838(19)30086.
    Abstract     Related articles   

  1543. EFSTATHIOU JA, Mouw KW, Gibb EA, Liu Y, et al
    Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30012.
    Abstract     Related articles   

  1544. BESSA A, Maclennan S, Enting D, Bryan R, et al
    Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30075.
    Abstract     Related articles   

  1545. RADZISZEWSKI P, Poletajew S
    Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guerin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-G
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30074.
    Abstract     Related articles   

  1546. VOGELZANG NJ
    Bladder Tumors with Mixed Histology: What Is the Basis for the Heterogeneity?
    Eur Urol. 2018;74:754-755.
    Abstract     Related articles   

  1547. GOLDSTEIN MR, Mascitelli L
    Re: John L. Gore, Jonathan L. Wright. Can We Prevent Bladder Cancer Recurrences? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.008.
    Eur Urol. 2019 Feb 11. pii: S0302-2838(19)30093.
    Abstract     Related articles   

  1548. KAMAT AM, Li R, O'Donnell MA, Black PC, et al
    Predicting Response to Intravesical Bacillus Calmette-Guerin Immunotherapy: Are We There Yet? A Systematic Review.
    Eur Urol. 2018;73:738-748.
    Abstract     Related articles   

  1549. WITJES JA
    Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    Eur Urol. 2019 Feb 25. pii: S0302-2838(19)30163.
    Abstract     Related articles   

  1550. PICHLER R, Heidegger I
    Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.11.055.
    Eur Urol. 2019 Feb 22. pii: S0302-2838(19)30159.
    Abstract     Related articles   

  1551. LI R, Spiess PE, Gilbert SM, Necchi A, et al
    Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30174.
    Abstract     Related articles   

  1552. NARAYAN VM, Lim AH, Dinney CPN
    Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30165.
    Abstract     Related articles   

  1553. MONTORSI F, Gandaglia G
    Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2.
    Eur Urol. 2019;75:e31.
    Abstract     Related articles   

  1554. CAMPI R, Roupret M
    Re: Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-institutional Cohort Study.
    Eur Urol. 2019 Mar 14. pii: S0302-2838(19)30187.
    Abstract     Related articles   

  1555. GAKIS G
    Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    Eur Urol. 2019 Mar 13. pii: S0302-2838(19)30181.
    Abstract     Related articles   

  1556. UENO Y, Takeuchi M, Tamada T, Sofue K, et al
    Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
    Eur Urol. 2019 Mar 25. pii: S0302-2838(19)30198.
    Abstract     Related articles   

  1557. MOUW KW, Miyamoto DT, Efstathiou JA
    Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.01.040: Towards Biomarker-Informed M
    Eur Urol. 2019 Mar 22. pii: S0302-2838(19)30195.
    Abstract     Related articles   

  1558. SHI MJ, Meng XY, Lamy P, Banday AR, et al
    APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
    Eur Urol. 2019 Apr 8. pii: S0302-2838(19)30261.
    Abstract     Related articles   

  1559. GUST KM, Shariat SF
    Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study.
    Eur Urol. 2019;75:695-696.
    Abstract     Related articles   

  1560. LERNER SP, Svatek RS
    What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy?
    Eur Urol. 2019;75:612-614.
    Abstract     Related articles   

  1561. SORIA F, Gontero P
    Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    Eur Urol. 2019 Apr 12. pii: S0302-2838(19)30275.
    Abstract     Related articles   

  1562. SAITA A, Lughezzani G, Buffi NM, Hurle R, et al
    Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging.
    Eur Urol. 2019 Apr 10. pii: S0302-2838(19)30277.
    Abstract     Related articles   

  1563. DIJKSTRA S, Wijburg CJ
    Re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71: Can the Pattern of Cancer Recurrence T
    Eur Urol. 2019;75:e137.
    Abstract     Related articles   

  1564. BOCHNER BH, Dalbagni G
    Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outc
    Eur Urol. 2019;75:e138-e139.
    Abstract     Related articles   

  1565. GSCHWEND JE, Heck M
    Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jurgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy:
    Eur Urol. 2019 May 2. pii: S0302-2838(19)30346.
    Abstract     Related articles   

  1566. LI R, Spiess PE, Gilbert SM, Necchi A, et al
    Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.101
    Eur Urol. 2019 May 2. pii: S0302-2838(19)30344.
    Abstract     Related articles   

  1567. YANG Y, Wei X, Han P
    Re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.027.
    Eur Urol. 2019 May 1. pii: S0302-2838(19)30343.
    Abstract     Related articles   

  1568. TAGUCHI S, Nakagawa T, Fukuhara H
    Re: Jurgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.
    Eur Urol. 2019 May 1. pii: S0302-2838(19)30345.
    Abstract     Related articles   

  1569. CAO L, Yang Z, Wang B
    Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol. 2019; 75,5: 853-860.
    Eur Urol. 2019 May 10. pii: S0302-2838(19)30364.
    Abstract     Related articles   

  1570. VARMA M, Delahunt B, van der Kwast T
    Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question.
    Eur Urol. 2019 May 10. pii: S0302-2838(19)30362.
    Abstract     Related articles   

  1571. BESSA A, Maclennan S, Enting D, Bryan R, et al
    Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy Y.C. Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Usi
    Eur Urol. 2019 May 17. pii: S0302-2838(19)30379.
    Abstract     Related articles   

  1572. INARRITU JM, Castellani D, Teoh JYC
    Re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol. In press. https://doi.org/10.1016/j.eururo.
    Eur Urol. 2019 May 15. pii: S0302-2838(19)30378.
    Abstract     Related articles   

  1573. LI R, Tabayoyong WB, Guo CC, Gonzalez GMN, et al
    Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease.
    Eur Urol. 2019;75:8-10.
    Abstract     Related articles   

  1574. FICARRA V, Giannarini G, Crestani A, Palumbo V, et al
    Retrosigmoid Versus Traditional Ileal Conduit for Urinary Diversion After Radical Cystectomy.
    Eur Urol. 2019;75:294-299.
    Abstract     Related articles   

  1575. KETTUNEN K, Bostrom PJ, Lamminen T, Heinosalo T, et al
    Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells.
    Eur Urol. 2019 Jun 27. pii: S0302-2838(19)30501.
    Abstract     Related articles   

  1576. PEDERZOLI F, Bandini M, Briganti A, Plimack ER, et al
    Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.
    Eur Urol. 2019 Jul 11. pii: S0302-2838(19)30522.
    Abstract     Related articles   

  1577. COMPERAT E, Amin M, Reuter V
    Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.05.001: Two Decades of Wor
    Eur Urol. 2019 Jul 23. pii: S0302-2838(19)30541.
    Abstract     Related articles   

  1578. RIJNDERS M, van der Veldt AAM, Zuiverloon TCM, Grunberg K, et al
    PD-L1 Antibody Comparison in Urothelial Carcinoma.
    Eur Urol. 2019;75:538-540.
    Abstract     Related articles   

  1579. VAN DIJK N, Funt SA, Blank CU, Powles T, et al
    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.
    Eur Urol. 2019;75:435-444.
    Abstract     Related articles   

  1580. ELANDER NO, Hussain SA
    Mutation Analysis of the FGFR3-encoding gene Does Not Predict Response to Checkpoint Inhibitor Treatment in Metastatic Bladder Cancer.
    Eur Urol. 2019 Jul 26. pii: S0302-2838(19)30593.
    Abstract     Related articles   

  1581. VOSKUILEN CS, van der Heijden MS, van Rhijn BWG
    Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Jul 24. pii: S0302-2838(19)30543.
    Abstract     Related articles   

  1582. MARKOWSKI MC, Boorjian SA, Burton JP, Hahn NM, et al
    The Microbiome and Genitourinary Cancer: A Collaborative Review.
    Eur Urol. 2019;75:637-646.
    Abstract     Related articles   

  1583. ABUFARAJ M, Foerster B, Schernhammer E, Moschini M, et al
    Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes.
    Eur Urol. 2019;75:649-658.
    Abstract     Related articles   

  1584. KELLY JD, Tan WS, Porta N, Mostafid H, et al
    BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004).
    Eur Urol. 2019;75:593-601.
    Abstract     Related articles   

  1585. LU M, Zhang Y, Xiao Y
    Re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.016.
    Eur Urol. 2019 Aug 13. pii: S0302-2838(19)30605.
    Abstract     Related articles   

  1586. KETTUNEN K, Bostrom PJ, Taimen P
    Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In
    Eur Urol. 2019 Aug 13. pii: S0302-2838(19)30610.
    Abstract     Related articles   

  1587. BABJUK M, Burger M, Comperat EM, Gontero P, et al
    European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
    Eur Urol. 2019 Aug 20. pii: S0302-2838(19)30660.
    Abstract     Related articles   

  1588. VARMA M, Delahunt B, Kwast TV
    Reply to Eva Comperat, Mahul Amin, Victor Reuter's Editorial Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol. In press. htt
    Eur Urol. 2019 Aug 29. pii: S0302-2838(19)30676.
    Abstract     Related articles   

  1589. YANG A, Cannataro VL, Townsend JP
    Re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer. Eur Urol 2019;76:9-13.
    Eur Urol. 2019 Aug 29. pii: S0302-2838(19)30662.
    Abstract     Related articles   

  1590. SHI MJ, Meng XY, Chen CL, Dyrskjot L, et al
    Reply to Alexander Yang, Vincent L. Cannataro, Jeffrey P. Townsend's Letter to the Editor, re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as, a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Can
    Eur Urol. 2019 Sep 4. pii: S0302-2838(19)30656.
    Abstract     Related articles   

  1591. KETTUNEN K, Bostrom P, Taimen P
    Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://do
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30731.
    Abstract     Related articles   

  1592. LIU X
    Re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.016: Can Patie
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30734.
    Abstract     Related articles   

  1593. KAMOUN A, Reynies A, Allory Y, Sjodahl G, et al
    A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30695.
    Abstract     Related articles   

  1594. LEOW JJ, Catto JWF, Efstathiou JA, Gore JL, et al
    Quality Indicators for Bladder Cancer Services: A Collaborative Review.
    Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30690.
    Abstract     Related articles   

  1595. KRIEGMAIR MC, Rother J, Grychtol B, Theuring M, et al
    Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral Imaging.
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30674.
    Abstract     Related articles   

  1596. YATAI KB, Tran H, Dunning MJ, Wang D, et al
    Sources of Bias Within Consensus Subtypes of Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Oct 23. pii: S0302-2838(19)30760.
    Abstract     Related articles   

  1597. DEL GIUDICE F, Barchetti G, De Berardinis E, Pecoraro M, et al
    Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Eur Urol. 2019 Nov 4. pii: S0302-2838(19)30757.
    Abstract     Related articles   

  1598. WITJES JA, Babjuk M, Bellmunt J, Bruins HM, et al
    EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort(dagger): Under the Auspices of the EAU-ESMO Guidelines Committees.
    Eur Urol. 2019 Nov 16. pii: S0302-2838(19)30763.
    Abstract     Related articles   

  1599. WILLIAMS SB, Black PC, Dyrskjot L, Seiler R, et al
    Re: Aurelie Kamoun, Aurelien de Reynies, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.09.006: A Statement from the International Bladder Cancer Ne
    Eur Urol. 2019 Nov 28. pii: S0302-2838(19)30874.
    Abstract     Related articles   

  1600. THIBAULT C, Lavaud P, Loriot Y
    Studying Rarity in Bladder Cancer.
    Eur Urol. 2019 Dec 4. pii: S0302-2838(19)30891.
    Abstract     Related articles   

  1601. DUGUE PA, Brinkman MT, Hodge AM, Bassett JK, et al
    Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study.
    Int J Cancer. 2018;143:298-306.
    Abstract     Related articles   

  1602. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32136.
    Abstract     Related articles   

  1603. SUN M, Zhao W, Chen Z, Li M, et al
    Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 Via Mapk Signaling Pathway.
    Int J Cancer. 2019 Apr 2. doi: 10.1002/ijc.32311.
    Abstract     Related articles   

  1604. WU Q, Fu C, Li M, Li J, et al
    CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.
    Int J Cancer. 2019;144:582-594.
    Abstract     Related articles   

  1605. LAAKSONEN MA, MacInnis RJ, Canfell K, Giles GG, et al
    The future burden of kidney and bladder cancers preventable by behaviour modification in Australia: a pooled cohort study.
    Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32420.
    Abstract     Related articles   

  1606. NAMEKAWA T, Ikeda K, Horie-Inoue K, Suzuki T, et al
    ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
    Int J Cancer. 2019 Jun 12. doi: 10.1002/ijc.32505.
    Abstract     Related articles   

  1607. STROGGILOS R, Mokou M, Latosinska A, Makridakis M, et al
    Proteome-based classification of Non-Muscle Invasive Bladder Cancer.
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32556.
    Abstract     Related articles   

  1608. BASSETT JK, Brinkman MT, Dugue PA, Ueland PM, et al
    Circulating concentrations of B group vitamins and urothelial cell carcinoma.
    Int J Cancer. 2019;144:1909-1917.
    Abstract     Related articles   

  1609. ZHANG K, Dai H, Liang W, Zhang L, et al
    Fermented dairy foods intake and risk of cancer.
    Int J Cancer. 2019;144:2099-2108.
    Abstract     Related articles   

  1610. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Reply to: Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32632.
    Abstract     Related articles   

  1611. KAWADA T
    Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32633.
    Abstract     Related articles   

  1612. ZENG H, Liu Z, Wang Z, Zhou Q, et al
    Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32715.
    Abstract     Related articles   

  1613. JACK S, Madhivanan K, Ramadesikan S, Subramanian S, et al
    A Novel, Safe, Fast, Efficient Treatment for Her2-positive and Negative Bladder Cancer Utilizing an EGF-Anthrax Toxin Chimera.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32719.
    Abstract     Related articles   

  1614. HUANG Z, Zhang M, Chen G, Wang W, et al
    Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4729.
    Abstract     Related articles   

  1615. SUGITA S, Yoshino H, Yonemori M, Miyamoto K, et al
    Tumorsuppressive microRNA223 targets WDR62 directly in bladder cancer.
    Int J Oncol. 2019 Mar 22. doi: 10.3892/ijo.2019.4762.
    Abstract     Related articles   

  1616. LIN JF, Tsai TF, Lin YC, Chen HE, et al
    Benzyl isothiocyanate suppresses IGF1R, FGFR3 and mTOR expression by upregulation of miR-99a-5p in human bladder cancer cells.
    Int J Oncol. 2019 Mar 26. doi: 10.3892/ijo.2019.4763.
    Abstract     Related articles   

  1617. HORI S, Miyake M, Onishi S, Morizawa Y, et al
    Evaluation of pro and antitumor effects induced by three colonystimulating factors, GCSF, GMCSF and MCSF, in bladder cancer cells: Is GCSF a friend of bladder cancer cells?
    Int J Oncol. 2019;54:2237-2249.
    Abstract     Related articles   

  1618. MORAN JD, Kim HH, Li Z, Moreno CS, et al
    SOX4 regulates invasion of bladder cancer cells via repression of WNT5a.
    Int J Oncol. 2019 Jun 26. doi: 10.3892/ijo.2019.4832.
    Abstract     Related articles   

  1619. XU M, Gu M, Zhou J, Da J, et al
    Interaction of YAP1 and mTOR promotes bladder cancer progression.
    Int J Oncol. 2019 Nov 25. doi: 10.3892/ijo.2019.4922.
    Abstract     Related articles   

  1620. LIN F, Yin HB, Li XY, Zhu GM, et al
    Bladder cancer cellsecreted exosomal miR21 activates the PI3K/AKT pathway in macrophages to promote cancer progression.
    Int J Oncol. 2019 Dec 3. doi: 10.3892/ijo.2019.4933.
    Abstract     Related articles   

  1621. MIYATA Y, Matsuo T, Sakai H
    Editorial Comment from Dr Miyata et al. to Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.
    Int J Urol. 2019 Jan 22. doi: 10.1111/iju.13893.
    Abstract     Related articles   

  1622. KOIE T, Ohyama C, Makiyama K, Shimazui T, et al
    Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13900.
    Abstract     Related articles   

  1623. TEISHIMA J, Matsubara A
    Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13906.
    Abstract     Related articles   

  1624. LEE A, Lee HJ, Huang HH, Ho H, et al
    Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13913.
    Abstract     Related articles   

  1625. ZACHOS I
    Editorial Comment to Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13929.
    Abstract     Related articles   

  1626. NAKAYAMA M, Ito Y, Hatano K, Nakai Y, et al
    Impact of sex difference on survival of bladder cancer: A population-based registry data in Japan.
    Int J Urol. 2019 Mar 27. doi: 10.1111/iju.13955.
    Abstract     Related articles   

  1627. YANG J, Zhang P, Zhou H, Feng S, et al
    Prospective, randomized controlled study of the preventive effect of fosfomycin tromethamine on post-transurethral resection of bladder tumor urinary tract infection.
    Int J Urol. 2018 Jul 12. doi: 10.1111/iju.13719.
    Abstract     Related articles   

  1628. YASUI M, Kawahara T, Takamoto D, Izumi K, et al
    Distribution of androgen receptor expression in the urinary bladder.
    Int J Urol. 2019;26:305-306.
    Abstract     Related articles   

  1629. TOIDE M, Yokoyama M, Fujiwara M, Kijima T, et al
    Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cyst
    Int J Urol. 2019 Jul 8. doi: 10.1111/iju.14054.
    Abstract     Related articles   

  1630. KOBAYASHI T
    Editorial Comment from Dr Kobayashi to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induc
    Int J Urol. 2019 Jul 21. doi: 10.1111/iju.14075.
    Abstract     Related articles   

  1631. OSAWA T, Wei JT, Abe T, Kako Y, et al
    Development of the Japanese version of the health-related quality of life questionnaire for bladder cancer patients using the Bladder Cancer Index: A pilot study.
    Int J Urol. 2019 Jul 16. doi: 10.1111/iju.14073.
    Abstract     Related articles   

  1632. YOSHIDA T, Kates M, Fujita K, Bivalacqua TJ, et al
    Predictive biomarkers for drug response in bladder cancer.
    Int J Urol. 2019 Aug 1. doi: 10.1111/iju.14082.
    Abstract     Related articles   

  1633. FUJIMURA T
    Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14076.
    Abstract     Related articles   

  1634. TEISHIMA J, Matsubara A
    Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14086.
    Abstract     Related articles   

  1635. KOJIMA T
    Editorial Comment from Dr Kojima to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, inductio
    Int J Urol. 2019 Jul 28. doi: 10.1111/iju.14074.
    Abstract     Related articles   

  1636. NOHARA T, Kato Y, Nakano T, Nakagawa T, et al
    Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14099.
    Abstract     Related articles   

  1637. CHOO SH, Nishiyama H, Kitamura H, Chen CH, et al
    Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey.
    Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14105.
    Abstract     Related articles   

  1638. MATSUMOTO H
    Editorial Comment from Dr Matsumoto to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 6. doi: 10.1111/iju.14131.
    Abstract     Related articles   

  1639. FUKUHARA H
    Editorial Comment from Dr Fukuhara to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 11. doi: 10.1111/iju.14124.
    Abstract     Related articles   

  1640. KIKUCHI E, Hayakawa N, Fukumoto K, Shigeta K, et al
    Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer: Its definition and future therapeutic strategies.
    Int J Urol. 2019 Dec 3. doi: 10.1111/iju.14153.
    Abstract     Related articles   

  1641. AMINI E, Ahmadi N, Clifford TG, Hugen CM, et al
    Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
    Int Urol Nephrol. 2019 Jan 31. pii: 10.1007/s11255-019-02087.
    Abstract     Related articles   

  1642. TEKE K, Yilmaz H, Uslubas AK, Akpinar G, et al
    Histopathologic and molecular comparative analyses of intravesical Aurora kinase-A inhibitor Alisertib with bacillus Calmette-Guerin on precancerous lesions of bladder in a rat model.
    Int Urol Nephrol. 2018;50:1417-1425.
    Abstract     Related articles   

  1643. ZEWIN TS, El-Assmy A, Harraz AM, Bazeed M, et al
    Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial.
    Int Urol Nephrol. 2018;50:2007-2014.
    Abstract     Related articles   

  1644. MAO W, Ma B, Huang X, Gu S, et al
    Which treatment is best for patients with AJCC stage IV bladder cancer?
    Int Urol Nephrol. 2019 Apr 4. pii: 10.1007/s11255-019-02105.
    Abstract     Related articles   

  1645. MILOJEVIC B, Dzamic Z, Bojanic N, Durutovic O, et al
    Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival.
    Int Urol Nephrol. 2019 Apr 1. pii: 10.1007/s11255-019-02133.
    Abstract     Related articles   

  1646. TSENG WH, Liu CL, Huang SK, Liao AC, et al
    Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Int Urol Nephrol. 2019 May 25. pii: 10.1007/s11255-019-02172.
    Abstract     Related articles   

  1647. SLUSARCZYK A, Zapala P, Zapala L, Piecha T, et al
    Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics.
    Int Urol Nephrol. 2019 Jun 1. pii: 10.1007/s11255-019-02183.
    Abstract     Related articles   

  1648. WU S, Lin SX, Lu M, Subtelny AO, et al
    Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy.
    Int Urol Nephrol. 2019 Jun 10. pii: 10.1007/s11255-019-02181.
    Abstract     Related articles   

  1649. WU J, Wang YC, Dai B, Ye DW, et al
    Optical biopsy of bladder cancer using confocal laser endomicroscopy.
    Int Urol Nephrol. 2019 Jun 13. pii: 10.1007/s11255-019-02197.
    Abstract     Related articles   

  1650. XU R, Li H, Wu S, Qu J, et al
    MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53.
    Int Urol Nephrol. 2019 Jun 24. pii: 10.1007/s11255-019-02210.
    Abstract     Related articles   

  1651. GORGEL SN, Akin Y, Koc EM, Kose O, et al
    Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
    Int Urol Nephrol. 2019 Oct 28. pii: 10.1007/s11255-019-02325.
    Abstract     Related articles   

  1652. GULLU AMURAN G, Tinay I, Filinte D, Ilgin C, et al
    Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Int Urol Nephrol. 2019 Nov 2. pii: 10.1007/s11255-019-02328.
    Abstract     Related articles   

  1653. OTTOSSON K, Pelander S, Johansson M, Huge Y, et al
    The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation.
    Int Urol Nephrol. 2019 Nov 19. pii: 10.1007/s11255-019-02338.
    Abstract     Related articles   

  1654. YAMASHITA R, Nakamura M, Notsu A, Hashizume A, et al
    The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer.
    Int Urol Nephrol. 2019 Nov 22. pii: 10.1007/s11255-019-02341.
    Abstract     Related articles   

  1655. ZHANG S
    Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: Time to Change Clinical Practice?
    J Clin Oncol. 2019 Feb 27:JCO1801864. doi: 10.1200/JCO.18.01864.
    Abstract     Related articles   

  1656. ATALA A
    Re: Identification of MicroR-106b as a Prognostic Biomarker of p53-Like Bladder Cancers by ActMiR.
    J Urol. 2019;201:231.
    Abstract     Related articles   

  1657. CHANG SS
    Re: Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: .
    J Urol. 2019;201:225-226.
    Abstract     Related articles   

  1658. EBRAHIMI H, Amini E, Pishgar F, Moghaddam SS, et al
    Global, Regional, and National Burden of Bladder Cancer, 1990 - 2016: Results from the Global Burden of Disease Study 2016.
    J Urol. 2019 Jan 25. doi: 10.1097/JU.0000000000000025.
    Abstract     Related articles   

  1659. CHANG SS
    Re: Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    J Urol. 2019 Jan 15. doi: 10.1097/JU.0000000000000097.
    Abstract     Related articles   

  1660. CHANG SS
    Re: Next-Generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
    J Urol. 2019 Jan 15. doi: 10.1097/01.JU.0000553308.83315.
    Abstract     Related articles   

  1661. ATALA A
    Re: LNMAT1 Promotes Lymphatic Metastasis of Bladder Cancer via CCL2 Dependent Macrophage Recruitment.
    J Urol. 2019 Jan 15. doi: 10.1097/01.JU.0000553307.75692.
    Abstract     Related articles   

  1662. HAIFLER M
    Editorial Comment.
    J Urol. 2018;200:59-60.
    Abstract     Related articles   

  1663. FILSON CP
    Editorial Comment.
    J Urol. 2018;200:59.
    Abstract     Related articles   

  1664. MEEKS JJ, Glaser AP
    Editorial Comment.
    J Urol. 2018;200:60.
    Abstract     Related articles   

  1665. WANG DS
    Re: A Prospective Randomized Pilot Study Evaluating an ERAS Protocol versus a Standard Protocol for Patients Treated with Radical Cystectomy and Urinary Diversion for Bladder Cancer.
    J Urol. 2019 Feb 1. doi: 10.1097/JU.0000000000000154.
    Abstract     Related articles   

  1666. CHANG SS
    Re: Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: .
    J Urol. 2019;201:442.
    Abstract     Related articles   

  1667. CHANG SS
    Re: Human Epidermal Growth Factor Receptor 2 Expression is More Important than bacillus Calmette Guerin Treatment in Predicting the Outcome of T1G3 Bladder Cancer.
    J Urol. 2019;201:441-442.
    Abstract     Related articles   

  1668. CHANG SS
    Re: Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer.
    J Urol. 2019;201:441.
    Abstract     Related articles   

  1669. GRIEBLING TL
    Re: Impact of Psychiatric Illness on Decreased Survival in Elderly Patients with Bladder Cancer in the United States.
    J Urol. 2019 Feb 7. doi: 10.1097/JU.0000000000000162.
    Abstract     Related articles   

  1670. GRIEBLING TL
    Re: Comparing Survival Outcomes and Costs Associated with Radical Cystectomy and Trimodal Therapy for Older Adults with Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Feb 7. doi: 10.1097/01.JU.0000553996.66966.
    Abstract     Related articles   

  1671. GRIEBLING TL
    Re: The Challenges of Bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients.
    J Urol. 2019 Feb 7. doi: 10.1097/01.JU.0000553995.59343.
    Abstract     Related articles   

  1672. CHANG SS
    Re: Predicting Local Failure after Radical Cystectomy in Patients with Bladder Cancer: .
    J Urol. 2019 Feb 8. doi: 10.1097/JU.0000000000000166.
    Abstract     Related articles   

  1673. CHANG SS
    Re: National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.
    J Urol. 2019 Feb 8. doi: 10.1097/01.JU.0000554054.35801.
    Abstract     Related articles   

  1674. CHANG SS
    Re: Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Feb 8. doi: 10.1097/01.JU.0000554055.35801.
    Abstract     Related articles   

  1675. KIMURA S, Mari A, Foerster B, Abufaraj M, et al
    Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis.
    J Urol. 2019;201:46-53.
    Abstract     Related articles   

  1676. WINTERS BR, Wen L, Holt SK, Dash A, et al
    Does the diagnosis of bladder cancer lead to higher rates of smoking cessation? Findings from the Medicare Health Outcomes Survey.
    J Urol. 2019 Mar 5:101097JU0000000000000206. doi: 10.1097/JU.0000000000000206.
    Abstract     Related articles   

  1677. LEO MC, Gilbert SM, Wendel CS, Krouse RS, et al
    Development of a goal elicitation measure to support bladder cancer patients' choice about urinary diversion.
    J Urol. 2019 Mar 5:101097JU0000000000000203. doi: 10.1097/JU.0000000000000203.
    Abstract     Related articles   

  1678. CHANG SS
    Re: Safety and Efficacy of Temsirolimus as Second Line Treatment for Patients with Recurrent Bladder Cancer.
    J Urol. 2019 Mar 13:10109701JU000055464194059.
    Abstract     Related articles   

  1679. CHANG SS
    Re: Partial Bladder Boost Using Lipiodol Marking during Image-Guided Radiotherapy for Bladder Cancer.
    J Urol. 2019 Mar 13:101097JU0000000000000218. doi: 10.1097/JU.0000000000000218.
    Abstract     Related articles   

  1680. GRIEBLING TL
    Re: Comparative Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives Concerning the Risk of Bladder Cancer in Older US Adults with Type 2 Diabetes.
    J Urol. 2019 Mar 13:10109701JU00005546361960937.
    Abstract     Related articles   

  1681. GRIEBLING TL
    Re: Outcomes of Radiosensitisation in Elderly Patients with Advanced Bladder Cancer.
    J Urol. 2019 Mar 13:10109701JU00005546347386712.
    Abstract     Related articles   

  1682. GRIEBLING TL
    Re: Real-World Effectiveness of Chemotherapy in Elderly Patients with Metastatic Bladder Cancer in the United States.
    J Urol. 2019 Mar 13:10109701JU0000554635814908.
    Abstract     Related articles   

  1683. FEUERSTEIN MA
    Editorial Comment.
    J Urol. 2018;200:290.
    Abstract     Related articles   

  1684. PATEL S, Cookson MS
    Editorial Comment.
    J Urol. 2018;200:290-291.
    Abstract     Related articles   

  1685. ZARGAR-SHOSHTARI K, Sexton WJ
    Re: Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence: B. Kiss, M. A. Furrer, P. Y. Wuethrich, F. C. Burkhard, G. N. Thalmann and B. Roth J Urol 2017;198:1263-1268.
    J Urol. 2018;200:457-458.
    Abstract     Related articles   

  1686. CHANG SS
    Re: Genomic Differences between "Primary" and "Secondary" Muscle-Invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-Based Neoadjuvant Chemotherapy.
    J Urol. 2019 Mar 29:10109701JU0000557728168538.
    Abstract     Related articles   

  1687. CHANG SS
    Re: Contemporary Treatment Patterns and Outcomes of Sarcomatoid Bladder Cancer.
    J Urol. 2019 Mar 29:101097JU0000000000000252. doi: 10.1097/JU.0000000000000252.
    Abstract     Related articles   

  1688. CHANG SS
    Re: Mutational Patterns in Chemotherapy Resistant Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Mar 29:10109701JU000055772739723.